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Self-assembling building blocks have become of increasing interest in the field of 
bionanotechnology due to their ability to self-assemble into defined geometrical 
shapes. Nature is abundant with examples of functional biological assemblies that 
are either rich in β-sheets or coiled coils. This research work investigates peptide 
sequences derived from simple protein interfaces, as molecular tectons for use in 
bionanotechnology. Protein interface sequences were chosen as a design source of 
peptide tectons, as they are naturally optimized to drive self-assembly in a highly 
controlled and regulated manner. This thesis work focused primarily on the simple 
β-continuous and the helical coiled coil protein interfaces. 
 
The peptide sequences designed from different protein-β interfaces all self-
assembled into well-ordered nanostructures that were β-sheet rich and exhibited 
liquid crystallinity. SAXS and FTIR confirmed that the extended peptide 
nanostructures have the common architecture of β-sheets organized in a repetitive 
manner over long distances. The self-assembly of the peptide designed from the 
homodimer interface of bovine Prx3 was studied by thoughtfully altering appropriate 
residue in the peptide sequence. The peptide sequence was tolerant to the different 
variations introduced, with variant peptide β-sheet assemblies judged by ThT 
binding assays and SAXS consistent with the parent peptide. The self-assembling 
peptide sequences were used to template micron long nanotubes of the hPrx3 protein. 
Peptides designed from the coiled-coil interface of ovine keratin protein self-
assembled into extended filament-like nanostructures with dimensions consistent 
with that of full-length keratin IFs.  
 
The results presented in this thesis work aid in understanding the natural self-
assembly process through in vitro self-assembly of peptide mimics. The self-
assembling peptide sequences were used to produce extended nanotubes and 
nanosheets of hPrx3 protein. Future work is needed to show the functionalization of 
such extended peptide and protein structures, though, this work showcases the 
potential of these peptide sequences as building blocks for hybrid biomaterials.  
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1.1   Context 
Self-assembly is a process wherein building blocks orient and organize themselves in an 
energetically favored assembly, both in synthetic and biological systems1. Self-assembling 
peptides are a burgeoning area of attracting interest from both a fundamental viewpoint and 
due to their many potential applications in biomedical sciences such as tissue engineering and 
drug delivery as well as biosensors, conductive nanowires and nanocircuit fabrication in 
nanotechnology2,3. Tectons are simple building blocks that assemble into well-ordered 
supramolecular structures through self-assembly1. This research explores the potential of small 
peptide sequences inspired from self-assembling proteins as molecular tecton. This chapter 
presents an overview of the current understanding of short self-assembling peptide systems and 
an introduction to novel sources of short sequence design.  
 
1.2   Molecular interactions in self-assembly 
The interactions governing self-assembly of biomolecules in biology are mainly non-covalent 
forces such as electrostatic interactions, hydrophobic interactions, hydrogen bonding, van der 
Waals’ interactions, aromatic stacking, and metal coordination. Molecular self-assembly is a 
ubiquitous process in biological systems and underlies the formation of a range of complex, 
well-defined biological structures joined by non-covalent bonds. Non-covalent interactive 
forces are weak individually but in synergy and higher number can generate stable and ordered 
assemblies4 (Figure 1.1).  




Figure 1.1: Illustration of the non-covalent interactions involved in molecular self-assembly5. 
Reproduced with permission from Mendes et al. (2013)5. 
 
Electrostatic or charge interactions are Columbic forces that arise due to attraction or repulsion 
between dissimilar or similar charged entities. In proteins, ionic self-assembly is a direct result 
of the charge interactions between side chains of charged amino acid residues, furthermore also 
between terminal ammonium and carboxylate groups of the peptide chain. This leads to strong 
and long range forces in peptides and proteins6.  
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Hydrogen bonds are the primary driver of peptide self-assembly, resulting from the association 
of an electronegative atom with a hydrogen atom attached to a relatively electronegative atom. 
Usually, the electronegative atoms are nitrogen (N) and oxygen (O) in natural systems and 
fluorine (F) in synthetic molecules. Hydrogen bonding forces are strong and directional (short 
or long) intermolecular bonds with high bond strength (10-40 kJ/mol)6. A salt bridge is a 
combinatorial force arising as a result of a combination of hydrogen bond and electrostatic 
interactions formed between the anionic carboxylate (RCOO-) and the cationic ammonium 
(RNH3
+) or guanidinium [(RNHC(NH2)2)
+] 6.  
 
Hydrophobic effects arise due to the repulsion of the solute by the solvent. Non-polar molecules 
and motifs tend to come together to avoid aqueous surroundings. Hydrophobic interactions 
occur via side chain interactions between complementary non-polar amino acid residues. They 
are key driving forces in self-assembly of peptide amphiphiles7. 
 
van der Waals’ forces are comparatively weak repulsive or attractive forces. They arise from a 
dipole or induced dipole interactions at the atomic and molecular level, due to continuous 
oscillation of various atoms of the side chain within a peptide chain8. Though weak 
individually, several van der Waals’ forces collectively have a significant effect, they influence 
tertiary structure of proteins9 and higher order peptide assemblies10.  
 
Aromatic stacking known as π-π stacking is an attractive interaction between aromatic rings in 
close contact oriented face to face like two heads of a coin11. It is an important non-covalent 
interaction reported in peptide motifs with short continuous stretches of single aromatic amino 
acid residues. 
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1.3   Self-assembly in synthetic systems 
The spontaneous organization of individual components into well-ordered supramolecular 
structures is the key feature of self-assembly. Self-assembly in this context is the association 
of two or more chemical species held together by intermolecular forces. Strategies for building 
synthetic building blocks that can self-assemble in a highly efficient and selective manner have 
relied on manipulation of the different non-covalent interactions within a molecular 
architecture12. Early design principles for synthetic self-assembly focused on molecular 
recognition of a guest molecule (substrate) by a host molecule (receptor). The organization of 
the receptor molecule with intermolecular cavities around the guest molecule through 
numerous non-covalent interactions yielded an inclusion complex, called a “crypt”12. An array 
of architectures of different sizes and shapes were created by manipulation of the receptor 
chemistry and stereochemistry of non-covalent interactions. An important example is the Nobel 
Prize winning work by Lehn, Cram, and Pedersen on cryptands (a family of polycyclic 
multidentate ligands that bind to substrates in a crypt). Lehn & co-workers designed alkali 
metal cryptates inspired from the structure of the cyclopeptide valinomycin that mediates 
potassium ion transport in mitochondria. The design model comprises a three-dimensional 
interior cavity of macrocyclic polyethers (crown ethers), creating a binding site for the guest 
ions13.  
 
Diverse set of cryptands has been developed using the design model including macro-bicyclic 
cryptates selective for cations (Li+, Na+ and K+) and anionic cryptates from protonated 
polyamines selective for the spherical halide ions F- and Cl-. Manipulation of the macro-
polycyclic ether allowed for control of the recognition site and overall size of the crypt, such 
as the cryptate with a tetrahedral recognition site selective for the NH4
+ cation14,15. The host-
guest chemistry was further explored through molecular recognition, multivalent ligands, and 
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molecular hosts. An important example of self-assembly through molecular recognition is the 
bowl-shaped ligand structure named “carcerand” that interacts specifically with the guest 
molecules like a receptor16. Aoyama and co-workers described different assemblies of the 
carcerand resorcin[4]arenes with diacids, alcohols, and steroids as guests in organic solvents 
held stably through intermolecular hydrogen bonding17,18. Figure 1.2 shows some important 
examples of supramolecular structures created from host-guest chemistry. 
 
Figure 1.2: Examples of synthetic self-assembled architectures: (A) 3-dimensional structure 
of the potassium complex of a 2,2,2-cryptand19. (B) Hexameric capsules from the self-assembly 
of resorcin[4]arenes20. (C) The structure of the helical rosette nanotubes that result from the 
entropically driven self-assembly of synthetic G^C motifs in water. The TEM micrographs 
showing the 2-dimensional view of the hollow nanotubes21. Taken with permission from Vicens 
et al. (2006)19, Evan-Salem et al. (2006)20 and Fenniri et. al. (2002)21. 
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Multivalent ligands are another class of ligand complexes that are composed of recognition 
elements (REs) conjugated to a core scaffold. Ligand Complexes with controlled size and 
stoichiometry have been created that resemble natural protein-protein receptor-substrate 
complexes. An important example includes the β-cyclodextrin grafted with hyaluronic acid 
(HA-β-CD) multivalent binding to self-assembled monolayers (SAMs) functionalized with 
ferrocene (SAM-Fc), that resembles the multivalent binding of hyaluronic acid to cell surfaces. 
The system shows potential application as clinical products for cell therapy in biomedical 
science22.  
 
Molecular hosts are an important example of polytopic receptor molecules containing two or 
more discrete binding subunits for simultaneous complexation of identical or different guest 
molecules. This design has allowed for the production of tailor-made polymer assemblies in 
water; an example is the cucurbit[8]uril (CB[8]) molecular host that was used to create a redox-
sensitive molecular loop lock complex23. Tailored chemical motifs tuned to self-assemble into 
oligomer complexes of specific lengths include the rosette tubes with an open central channel 
of 1.1 nm diameter21 and analogs of the guanosine tetrad motifs24.  
 
Amphiphilic copolymer and amphiphilic diblock copolymers are another important class of 
synthetic building blocks that can self-assemble into vesicles and micelles25. This model has 
been successfully exploited to produce pH-responsive multivesicular structures that mimic 
natural transmembrane channels26. The ability to tune self-assembly of building blocks enables 
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1.4   Self-assembly in biological systems 
Biological systems have evolved to utilize building blocks naturally tuned to work in synergy 
with each other and their environment to produce well-ordered structures with functionality. 
The next paragraphs present a few examples of some biological systems.  
 
Nucleic acids: 
Deoxiribonucleic acid (DNA) that carries the genetic information is an important example of 
self-assembled architecture. DNA architecture comprises of four different nucleotide building 
blocks organized into the thermostable double helical DNA complex stabilized through 
intermolecular hydrogen bonding27.  
 
Lipids:  
Lipids are essential biomolecules that show variety in structure and are important structural 
components of the cell membranes. Amphipathic lipids self-assemble in vitro into different 
structures, the most common architectures encountered being the bilayer arrangement as found 
in the cell membrane28, micelle structure, and vesicles29.  
 
Carbohydrates: 
Carbohydrates have a rich topological portfolio and make up a huge repertoire of structures 
that are part of the exoskeleton and cell wall30.  
 
Proteins: 
Proteins are complex macromolecules made up of 20 different amino which defines by their 
amino acid sequence which controls their secondary structure conformation and the complex 
3-dimensional tertiary structure31. Proteins commonly assemble into oligomeric complexes that 
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exhibit diverse quaternary structure arrangements. The ability of fully folded protein units to 
assemble into a diverse set of structures have made them attractive for the design of self-
assembling biomaterials.  
 
1.4.1   Self-assembly of proteins  
The primary level organization is the linear sequence of amino acids, called the peptide chain. 
The peptide chain folds into a second level of the organization through hydrogen bonding and 
other covalent interactions, the β-sheets, and α-helices. Folding of the peptide chains into an 
energetically favorable conformation constitutes the third level of organization, the 3-
dimensional tertiary structure. The fourth level of organization is the self-assembly of fully 
folded protein units through non-covalent interactions to give rise to the quaternary structure32. 
Figure 1.3 shows the different levels of organization of proteins. 
 
 
Figure 1.3: Schematic showing the different levels of organization of protein (PDB: 2O0T). 
 
Most of the characterized proteins reported in literature organize themselves in quaternary 
structures either as homo-oligomers (proteins made of identical polypeptide chains) or hetero-
oligomers (proteins made of different polypeptide chains). These higher order protein 
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structures are typically maintained through multiple weak non-covalent interactions, 
sometimes including covalent interactions33. Oligomerization of protein into the 
supramolecular quaternary complex exhibits various advantages such as higher order 
complexity, allosteric regulation, functional control, and stability. Such complex protein 
assemblies can result from either permanent or transient interactions34. The subtle equilibria 
that allow proteins to achieve diverse supramolecular architecture rely on their flexibility to 
undergo large conformational changes in solution33. Visualization of such protein assemblies 
in vitro has been possible through a range of low- and high-resolution techniques such as X-
ray crystallography, nuclear magnetic resonance (NMR) spectroscopy and electron microscopy 
(EM)35,36. 
 
More recently, cryo-EM has made it possible to observe such native assemblies in solution at 
angstrom resolution37. The different types of naturally occurring architectures of proteins 
characterized in the context of self-assembly include linear assemblies, rings, tubes, catenanes, 
knots, cages, and vaults38. Important examples of linear protein assemblies are the collagen 
fibers that make up mammalian connective tissue39 and keratin fibers that make up the nail, 
hooves, horns, feathers, hair and wool fibers40.  
 
Ring shaped protein complexes are another important assembly of proteins and certain ring 
shaped complexes show DNA/RNA binding and are connected with DNA and RNA 
manipulations. Important examples include the DNA helicases41 and the RNA-binding 
attenuation protein (TRAP) involved in the termination of transcription of trp operon that forms 
an undecameric ring structure with a pore diameter of 25 Å42. An example of homo-oligomeric 
protein that self-assembles into different oligomer complexes is 2-Cys peroxiredoxins (Prxs) 
that protect the cells against oxidative damage43.  
Chapter one: Introduction 
 
10 
Prx protein is a stable homodimer that self-assembles into ring-shaped oligomers of different 
sizes including, octamer, decamer and dodecamer conformations, clusters, cages, and tubes44.  
Cylindrical assembly of proteins consisting of stacked rings have been described in the case of 
chaperonins45 and peroxiredoxin46,47. Tubular protein assemblies are another class of 
cylindrical protein self-assembly that were identified in the context of host infection and 
storage of genetic material in viruses48, and the transmembrane channels of S. aureus 
heptameric α-hemolysin protein complex that is 100 Å in length and has a pore diameter of 14-
46 Å49. Other interesting natural topologies encountered include the knotted proteins50, vaults 
formed by ribonucleoproteins51 and bacterial nano-compartments formed by encapsulin52.  
 
Many proteins that form oligomer complexes and serve different functions within living 
systems are rich in a specific type of secondary structure element. For example, the natural 
cross-β rich conformation of peptides and protein hormones stored in the secretory granules of 
the endocrine system53 and in the case of amyloid fibrils as a consequence of protein 
misfolding54. 
 
1.4.2   Self-assembly through misfolding  
The folding and misfolding of protein is a thermodynamically driven process in which the 
native state of the protein corresponds to the most thermodynamically stable conformation 
under physiological conditions. Proteins can achieve a variety of conformations ranging from 
unfolded peptide chains to partially folded intermediates and fully folded native conformation. 
The lowest energy state is the local minima in the highly complex energy landscape of the 
protein55 (Figure 1.4). There are numerous local minima within the protein energy landscape 
and a change in the physiological conditions such as pH, ionic strength, temperature, and 
concentration can significantly influence the local minima56.  




Figure 1.4: Energy landscape of protein folding and aggregation. The purple surface shows 
the multitude of conformations via intramolecular contacts and the pink area shows 
conformations moving towards amorphous aggregates or the ordered amyloid fibrils via 
intermolecular contacts. Aggregate formation can occur from intermediates populated during 
de novo folding or by destabilization of the native state into partially folded states. Diagram 
taken with permission from Hartl et al. (2009)55. 
 
Depending on the external environment, aggregation of protein can be disordered leading to 
amorphous aggregates or result in highly ordered aggregates in which the peptide or 
polypeptide chains are arranged in a specific fashion that is a hallmark of aggregated protein 
assemblies54 (Figure 1.5). 




Figure 1.5: Protein self-assembly: An overview of the different types of structures formed by 
peptide/polypeptide chains54. Reproduced with permission from Chiti et al. (2006)54. 
 
1.4.3   Amyloid fibrils – A generic protein assembly 
Amyloid fibrils are insoluble fibrous, proteinaceous aggregate deposits, structurally dominated 
by an extended β-sheets57. Amyloid fibrils are associated with protein misfolding diseases such 
as Alzheimer’s, Huntington’s, Creutzfeldt-Jakob, and type II diabetes54,58,59. Though largely 
associated with diseases, functional amyloid assemblies are evident in nature in varied life 
forms60 (Table 1.1). The diversity in the sequence of amyloid-forming proteins and the 
existence of non-disease associated proteins to form amyloid fibrils suggests that the amyloid 
state is possibly a generic protein fold of all polypeptide chains69. 
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Table 1.1: Native protein assemblies rich in β-sheets  
Protein Role Assembly Reference 
TMV capsid protein 
Encapsulates the viral RNA and 




Produce biofilms that help in 
surface adhesion and colony 
formation. 
Fibrillar Networks 62 
ChpE and ChpH 
Chaplin proteins 
Produce fibrous amphipathic 
films that facilitate the aerial 
growth of hyphae for spore 
formation. 
Fibers 63 
Fungal class I 
hydrophobins 
Fibrous networks on fungal coat 
help to adhere to hydrophobic 





GvpA and GvpC 
Function as floatation organelle Fibrillar Networks 65 
Chorion protein 
Makeup eggshell layers in insect 












Amyloid fibril formation is posited to occur through nucleated polymerization70. Nucleated 
polymerization involves the growth of filamentous structures through development of growth 
nuclei (primary nucleation). Development of the growth nuclei occurs through individual 
nucleating events which creates a templates for the conformational induction of new 
monomers70,71. Time course studies on amyloid fibril formation using techniques such as 
Thioflavin-T (ThT) binding assays, light scattering, and electronic microscopy show the 
presence of a lag phase, exponential growth phase, and stationary phase. The lag phase 
observed is thought to be due to the formation of nuclei that are largely β-sheet seeds. Once 
formed, the growth and extension of fibrils occur rapidly through the addition of monomers or 
oligomers71,72,73. A three state equilibrium is proposed for amyloid forming peptides: the 
monomer, oligomer, and fibrils74. Similarly, with other nucleation-dependent assembly, the 
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equilibrium between monomer to fibrils can be changed by the addition of preformed fibrils or 
“seeds” which shortens the lag phase in assembly71,72 (Figure 1.6). 
 
 
Figure 1.6: Self-assembly process of amyloid fibril formation through nucleation: State A: 
Peptide monomer isolated in solution. State B: Oligomer complex of few peptide chains. State 
C: Nucleus of β-sheet structure. The peptide backbone runs perpendicular to the fiber axis. 
State D: Postcritical nucleus structure is showing more β-sheet structure. State E: The 
protofilament is a single long thread of β-structure consisting of a β-sandwich and two face-
to-face β-sheet planes. State F; The full fibril, a bundle of protofilaments shown here to contain 
p = two protofilament threads74. Taken with permission from Schmit et al. (2011)74. 
 
1.4.4   Amyloid fibril structure 
Preliminary structures of amyloid fibrils came from transmission electron microscopy 
(TEM)75, X-ray fiber diffraction76, atomic force spectroscopy (AFM), and X-ray 
crystallography77. These techniques provided important information about the size, shape, 
unbranched morphology, presence of the characteristic repetitive cross-β architecture and 
polymorphism in fibrils78,79,80,81. Amyloid fibrils are straight, unbranched fibers with a typical 
diameter of 70-120 Å and several hundred nanometers in length. The cross-β architecture of 
amyloids is a generic feature observed for different amyloid fibrils in which the β-strands are 
organized perpendicular to the fiber axis78,79. More recently, cryo-EM coupled with 3D 
reconstruction provided a high-resolution model of amyloid fibrils up to 8 Å82 (Figure 1.7).  




Figure 1.7: Structure of amyloid fibrils: (A) 3D structure of amyloid fibril of Aβ1-42 (PDB: 
3BEG). (B) side views of reconstructions of Aβ (1-42) and Aβ (1-40) amyloid fibrils, taken with 
permission from Schmidt et al. (2009)82. 
 
Solid state nuclear magnetic resonance (ssNMR) data supplemented with low-resolution 
structures from electron microscopy allowed for the development of molecular models of full-
length amyloid fibrils83. Atomic structures of amyloid fibrils have been difficult to determine 
due to their non-crystalline and insoluble nature.  
 
The first atomic-level structure of amyloid fibrils was published in 200584. Different atomic 
models from X-ray crystallography of short peptide sequences that self-assemble into amyloid 
fibrils suggest that all amyloid fibrils share a common cross-β structure with different 
arrangements of β-sheets and peptide monomers within β-sheets83,85.  
 
 




One significant feature of amyloid fibrils highlighted utilizing contemporary technology is the 
polymorphism of amyloid fibrils. Polymorphism in amyloid fibrils is defined as the presence 
of different forms of fibrils resulting from substantially different arrangements of the β-strands 
in the fibrils81. A high-resolution model of Aβ1-40 amyloid fibrils obtained using ssNMR 
revealed polymorphic amyloid fibrils having different folds for mature fibrils86. Such 
polymorphism had been earlier noted in amylin fibrils87 and also consistently observed in many 
new peptide assemblies88. Polymorphism in the fibril structure is thought to arise due to 
different inter-sheet and intra-sheet packing of the peptide strands that gives rise to staggered 
arrangements with the side-chain of the terminal residues exposed. These exposed arms of the 
residues interact with each other to give rise to ultrastructural differences in the fibril 
morphology89. These structural constraints that are typical of amyloid fibrils make them more 
malleable.  
 
Structural polymorphism is noted not only in amyloid fibrils of different proteins or peptides 
but diverse polymorphic amyloid fibrils are identified within same amyloid forming protein. 
Therefore, it is unlikely that a single model can provide an accurate view of all amyloid fibril-
forming proteins and peptides.  
 
More recently magic angle spinning (MAS) NMR spectroscopy coupled with high-resolution 
electron density maps from cryo-EM microscopy, X-fiber diffraction along with AFM 
measurements illuminated the molecular basis of stability of polymorphic amyloid fibrils 
formed by self-assembling peptide sequences90. The MAS-NMR structure fitted to the cryo-
EM reconstruction revealed twisted amyloid fibrils made up of two, three or four in register β-
sheets, laterally associated arranged in the extended fibril structure (Figure 1.8). 




Figure 1.8: Representative cryo-EM images of averaged fibrils (class averages), surface 
representations of reconstructions, 2D projections, and contoured density cross-sections of the 
three types of fibril formed by TTR (105–115). (A) Doublet class average; (B) Triplet class 
average; (C) Quadruplet class average on the left. 3D reconstructions are shown in the center 
(Doublet: orange, Triplet: yellow, and Quadruplet: purple).2D projections of the fibril 
reconstruction are shown in right. (D–F) Contoured density cross-sections of the doublet (D), 
triplet (E), and quadruplet (F) fibrils89. Taken with permission from Fitzpatrick et al. (2013)89. 
 
Amyloid fibril assembly shows a near perfect “design” and is estimated to have only one 
misalignment per 30,000 strands91. Amyloid fibrils show resistance to denaturants, detergents, 
thermal treatment and proteases57. These properties make amyloid fibril assemblies highly 
attractive candidates for use as as biomaterial in the emerging field of bionanotechnology for 
fabrication of nanostructures serving specific functions. 
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1.5   Bionanotechnology  
Bionanotechnology is a branch of nanotechnology that links biology to physics and deals with 
the study of biological molecules and macromolecules at the nano-level92. The field aims to 
utilize biological designs and use biological or bio-inspired starting materials to build 
nanomaterials. This thesis focuses on peptide and protein-based nanostructures. The increasing 
interest in designing building blocks that can self-assemble into ordered hierarchical assemblies 
similar to those formed by protein and peptides in nature have suggested several design 
strategies.  
 
Two main approaches define the design strategy for production of well-ordered nanostructures 
in vitro (Figure 1.9). The top-down approach is the processing of a larger piece of material 
using fining tools to create a small structure that can be used for an application. In contrast, the 
bottom-up approach uses smaller components of atomic/molecular dimension that self-
assemble naturally or through the application of an external driving force giving rise to large 
and more ordered system93. The process of simple building blocks known as tectons coming 
together to form nanoscale structures is the basis of the bottom-up approach. It relies on the 
tendency of the building blocks to interact with each other in a coordinated way to form large 
and complex structures. The natural self-assembly of peptides and proteins observed in 
biological systems95,96 provides a good starting point to explore their potential in vitro for this 
purpose. It is generally aggreed that “bottom up” approach is relatively cheap and energy 
efficient for the mass production of artificial constructs97,98. 
 
Nucleic acids, lipids, carbohydrates, and proteins have all been explored as building blocks to 
create non-biological architectures. 




Figure 1.9: A comparison of the “top-down” and “bottom-up” approaches applied to produce 
self-assembling biomaterials. The top-down approach is the patterning of assemblies on a 
surface by nanofabrication/lithography. The basis of the bottom-up approach is the self-
assembly of simple building blocks through molecular recognition and self-assembly. 
Reproduced with permission from Gazit et al. (2008)94. 
 
Nucleic acids offer a simple mechanism of interaction and assembly, and possess the spatial 
periodicity like the DNA double helix to build supramolecular structures with functionality99.. 
DNA origami has been a useful tool to produce tailored building blocks with predictable self-
assembly. DNA based nanostructures are attractive as scaffolds to conjugate other 
biomolecules that can be spatially displayed with high precision to produce rigid scaffolds with 
functionality or switchable architectures. For example, DNA based polyhedron structures were 
successfully used as delivery vehicles to ferry encapsulated molecular payload to cell in vivo. 
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DNAzymes or RNAzymes that show change in fluorescence upon activation in the presence 
of metal ion have been successful as tools for ionsensing. DNA aptamers that have found utility 
in diagnostics and biosensing applications, such as the DNA aptamer linked to antibody for 
reporter-linked aptamer assay to detect vascular endothelial growth factor (VEGF) and the 
adenosine binding aptamer to screen for inhibitors of adenosine deaminase (ADA)99,100.. Lipid 
based nanostructures have been successful in nanomedicine as delivery vehicles, for example 
the cationic multilamellar vesicle (MLV) liposomes containing potent expression promoter-
enhancer and transcriptional activator high mobility chromatic protein as gene therapy vector 
in metastatic breast cancer mice models101. DNA and lipid based nanostructures are promising 
for different applications in bionanotechnology however; they lack the advantage of 
functionality and higher order complexity of 3D structures offered by proteins. Significant 
success has been achieved with bioinspired and synthetic protein chips (peptide sequences) 
with a propensity to self-assemble into a peptide hydrogel biomaterial102, nanofibrils or 
nanowires for fabrication of biosensors103,104, tissue engineering, and 3D cell culture105.  
 
1.6   Protein as building blocks of self-assembly 
Proteins have long been known as versatile biological building blocks. Their ability to form a 
range of different 3-dimensional architectures is unquestioned as nature is filled with a large 
number of such examples (section 1.4.1). It is relatively cheap and easy to produce such protein 
building blocks in the laboratory using synthetic or recombinant methods. An algorithm based 
approach has been successfully utilized to create a library of nanomaterials with unique 
configurations, and this has also allowing a large number of energetically favorable 
conformations to be tested106.  
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Using special design programs like the Rosetta and extending it for modeling protein-protein 
interface interactions has allowed for the production of protein tectons with different 
symmetries combined in specific geometries107,108. Proteins usually assemble through a 
modular approach with protein units self-assembling into well-ordered oligomer complexes 
through both permanent and transient interactions34,109. Taking advantage of gene mutation 
tools and the intrinsic tolerance of many proteins to mutation non-biological assemblies of 
natural proteins have been created. For example, the engineered mutant of heat stable bacterial 
TRAP protein that self-assembles into a 12-mer protein ring with a pore diameter of 2 nm110. 
The ring structure has been further modified through the incorporation of disulfide and 
hydrophobic interactions to create extended nanotubes111.  
 
With the advent of new methods in protein engineering, it is now possible to engineer proteins 
incorporated with specific metal binding sites. For example, peroxiredoxin containing a peptide 
tag with six or more consecutive histidine residues (6*His tag) at the N-terminal end was used 
to sort Ni2+ functionalized gold nanoparticles into 1D clusters112. In a more recent effort to 
create designer material, the human SMAC protein that self-assembles as a V-shaped oligomer 
has been utilized to produce stable 1D zigzag nanowires and 2D wavy nanostructures through 
the incorporation of bis-histidine motifs that direct stable metal mediated interaction with Zn2+ 
ions113.  
 
Increasing interest has been shown for the development of biopolymers from renewable 
sources and more recently from nonfood sources. Amongst them, keratins that make up the 
wool fibers, feathers and horns, fibroin fibers and silk fibers have proven to be useful for 
production of nanofibers with the eventuality of nanofabrication. Electrospinning has proven 
to be highly useful for creating nanofibers with controlled fiber diameter114,115. Keratin based 
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nanofibers116, films117 have been used to filter heavy metal118 or volatile organics and scaffolds 
in tissue engineering119. Gerrard et al. presents an excellent overview of different approaches 
to building protein-based nanostructures and their applications in applied biology in varied 
ways97.  
 
1.7   Peptides as building blocks of self-assembly 
Peptide sequences have been designed from different unrelated native protein sequences with 
motifs that exhibit self-assembling properties and associate to form well-ordered hierarchical 
structures. Much work has been carried out with amyloid forming sequences120,121, peptide 
amphiphiles7, peptide-polymer block copolymers122 and coiled-coil motifs123. Peptides can be 
customized due to their small size, short length and ease of large scale production.  
 
Increasing efforts in the direction of de novo peptide design have introduced a library of peptide 
tectons with designs inspired from different biological systems, proteins motifs, and synthetic 
modeling124. The current library of peptide sequences known to self-assemble belong to two 
classes: one that shows a propensity to form extended β-sheets and the second that form α-
helical assemblies.  
 
1.7.1   Self-assembly of β-sheet forming peptides 
The β-sheet forming peptide sequences first characterized in the context of human pathologies 
were found to from extended fibrils by organizing themselves into extended β-sheets laminated 
onto each other54,57. Peptide sequences that self-assemble into extended β-sheet based 
nanostructures include nanofibrils, nanowires, nanotubes, nanovesicles and nanosheets. They 
exhibit the defining characteristics described for amyloid fibrils (section 1.4.3 and 1.4.4).  
Chapter one: Introduction 
 
23 
High-resolution models developed from X-ray crystallography of short peptide sequences 
show the peptide β-strands organized into ladders of β-sheets stabilized by hydrogen bonding 
between neighboring amide backbone groups and individual complementary interacting 
residues. The in-register alignment of matching residues generates very tight packing and also 
maximizes the favorable hydrophobic and van der Waals side-chain contacts along the 
assembly axis84,85. The hierarchical structure called the “steric zipper” has two extended β-
sheet laminated onto each other with a wet (hydrophilic) and a dry (hydrophobic) interface, 
with polar residues of the wet interface hydrated with water molecules and that of the dry 
interface tightly interdigitated complementary to each other84. 
 
 The different organizations of the peptide sequences is classified into eight different types of 
steric zipper classes based on the arrangement of the β-strands in the sheet and the orientation 
of the β-sheets in the extended amyloid fibrils (Figure 1.10). 




Figure 1.10: Cartoon model representation of the eight different classes of steric zippers. 
Reproduced with permission from Sawaya et al. (2007)125. 
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1.7.2   Defining characteristics of β-sheet peptide assembly 
General methods used for recognizing amyloid or amyloid-like assembly includes binding of 
fluorescent dyes such as Congo Red (CR) and ThT. Defining characteristics of the self-
assembled extended peptide nanostructures can be resolved by AFM and TEM, the β-sheet 
secondary structure is measured by circular dichroism (CD) spectroscopy and Fourier 
transform infrared (IR) spectroscopy126,127, and the organization of β-sheets within the fibrils 
done by X-ray diffraction and scattering techniques128.  
 
X-ray fiber diffraction is a standard method to characterize amyloid fibrils, which give 
characteristic diffraction patterns that correspond to the specific alignment distances of the 
peptide β-strands in the cross-β structure. The specific reflection pattern at 4.8 Å in the 
meridional region corresponds to the hydrogen bonding distance between the side chains in 
one β-sheet. The diffuse reflection at 10-11 Å in the equatorial region corresponds to the 
distance between the β-sheets129,130 (Figure 1.11). Successive studies on aggregating peptides 
designed from amyloidogenic motifs within proteins have elucidated a third reflection observed 
at 9.6 Å specific to the repeat distance between the anti-parallel orientations of the β-strands131.  
 
Small angle X-ray scattering (SAXS) and wide angle X-ray scattering (WAXS) have proven 
to be useful tools that can provide molecular level information on extended protein/peptide 
assemblies under hydrated and physiological conditions within relevant millisecond time scale. 
SAXS measures the elastic scaterring of X-rays by a sample with inhomogeneities in the nm 
range and is generally recorded at small angles (typically 0 to 10°). WAXS is similar to SAXS, 
however the distance of the sample to the detector in shorter and thus the diffraction maxima 
is observed at larger angles128.  




Figure 1.11: Structure of β-sheets and X-ray diffraction of amyloid fibril: (A). Schematic of 
the assembly of β-strand motifs into ordered parallel and antiparallel β-sheets. The chemical 
structure shows the backbone hydrogen bonding132. (B) X-ray fiber diffraction model from 
amyloid fibrils showing the major reflections. The cartoon model shows the anti-parallel cross-
β architecture that is the hallmark of amyloid fibril structure. Reproduced with permission 
from Serpell et al. (2000)133. 
 
The techniques have proven to be really useful in elucidating that the strongest repetitive 
structure in the amyloid fibril architecture is the set of β-sheets aligned parallel to the fibril axis 
and the β-strands perpendicular to the fibril axis133. Studies on self-assembling β-sheet forming 
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peptides showed that X-ray scattering at small and wide angles can be used to model the 
arrangement of β-sheets in the large embedded architectures like peptide nanotubes134.  
 
Congo red (CR) is an amphiphilic dye and are widely used for staining and detection of amyloid 
fibril assembly. CR shows absorption maxima at 490 nm in aqueous solution leading to the 
characteristic red color solution. CR molecules upon binding to β-sheet rich amyloid fibrils 
become torsionally restricted (long axis of the CR molecules oriented parallel to the fibril axis). 
This induces a characteristic increase in the absorption as well as a red shift in the absorption 
maximum from 490 to 540 nm. Furthermore, this type of binding results in green birefringence 
when observed under cross-polarized light135.  
 
ThT is a benzothiazole dye that exhibits enhanced fluorescence intensity due to the shift of the 
excitation maximum from 385 nm to ~ 450 nm and emission maximum from 445 nm to ~ 482 
nm upon binding to extended β-sheet assemblies like amyloid fibrils136. ThT binds to diverse 
fibrils despite their distinct amino acid sequences which suggest that it recognizes a structural 
feature that is generic to amyloid fibrils. Recent theory suggests that ThT binds to the β-sheet 
surface along cavities running parallel to the fibril axis, between the protofilaments136,137. 
Binding modes of ThT to amyloid fibrils studied by NMR show that ThT binds orthogonal to 
the fibrils and complexes differently to fibrils of different proteins138. Other fluorescent dyes 
such as amino derivatives of benzanthrone, squaraine dye SQ-1, and polymethine dye V2 are 
currently being investigated as alternate fluorescent probes due to their property to associate 
with amyloid assemblies with greater sensitivity and relatively lower background 
fluorescence139.  
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TEM is an effective technique to visualize and distinguish nanostructures of different 
morphologies from disordered peptide and protein aggregates. In TEM, a beam of electrons is 
produced using a hot filament and focused on the sample. Under TEM, amyloid-like fibrillar 
assemblies usually appear as extended nanostructures that are unbranched, twisted in 
appearance, may be intertwined, with dimensions of 6-20 nm in width and several microns in 
lengths140.  
 
Aside from TEM, scanning electron microscopy (SEM) and Atomic force microscopy (AFM) 
are widely used to image amyloid fibrils. In SEM, the surface of the sample is scanned by 
focusing the electron beam on the sample using deflection coils and focusing lenses. SEM has 
been notably helpful for detection of small and thin amyloid fibrils of diameters as small as 3.5 
nm, as the apparent width of amyloid fibrils observed by SEM is much broader than the original 
value. In AFM on the other hand a cantilever tip scans the surface contour of the sample 
adsorbed onto atomically flat smooth surfaces (typically mica), and provides high resolution 
topography (≤ 1 nm) of the sample. AFM provides an added advantage to TEM and SEM to 
visualize amyloid fibril assembly, as it allows for continuous monitoring of the sample. This 
has been really useful for monitoring and imaging the growth of oligomer and fibrils in 
solution140.  
 
For the experiments in this thesis, the fluorescent dye ThT along with CD spectroscopy, SAXS 
and FTIR was used to detect and estimate the extended β-sheet based amyloid-like fibrillar 
assemblies in solution. TEM was used to visualize both peptide and protein self-assembled 
nanostructures126,33. Also, EM micrographs were used for measurement of the nanostructures 
using the software ImageJ141.  
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1.7.3   Current sources of self-assembling β-sheet type peptides 
The current library of peptides self-assembling into extended β-sheet based structures includes 
sequences designed from functional amyloids, amyloid-forming polypeptides and proteins, 
structural proteins, antibiotics, natural biological assemblies and de novo designs made from 
permutation of these sequences124.The next section presents an overview of the different 
peptide designs that self-assemble into extended β-sheet based structures. 
 
1.7.3.1   Functional amyloid inspired peptides 
Some peptides that function as hormones are thought to be stored in secretory granules, with 
an amyloid-like cross-β-sheet rich conformation53. Somatostatin-14, a small cyclic 
neuropeptide that regulates the growth hormone glucagon, insulin and gastric secretions has a 
high propensity to form antiparallel β-sheet structures in water142. Valery & co-workers 
designed the peptide Lanreotide, an analog of somatostatin hormone; that self-assembles into 
liquid crystalline nanotubes in aqueous solution143. The peptide formulation is currently 
marketed as a treatment for acromegaly144. 
 
1.7.3.2   Amyloid-inspired peptides  
Exploiting the natural amyloidogenic sequences, a library of peptide sequences have been 
designed that self-assemble in solution into different nanoscale assemblies. A variety of 
sequences able to form amyloid-like fibrils raised the idea of a generic feature coming from the 
intrinsic properties of peptide chains under appropriate conditions. Short peptide sequences 
comprised of 4-6 amino acid residues self-assemble into typical amyloid fibrils formed by a 
full-length polypeptide chain. Examples include, the hexapeptide “NFGAIL” derived from the 
islet amyloid polypeptide (IAPP)145, the pentapeptide “DFNKF” derived from the human 
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calcitonin146 and hexapeptide “NFGSVQ” derived from human medin147, that self-assembles 
into fibrils with ultrastructure and biophysical properties of amyloid structures.  
 
An important observation in many amyloid inspired self-assembling peptide sequences is the 
presence of phenylalanine residue. It is considered to be an important residue involved in 
amyloid fibril formation through aromatic stacking. Studies on variant peptide sequences 
designed with the phenylalanine residue replaced with aliphatic amino acids exhibited 
substantially reduced fibril-forming ability148. Peptide sequences comprised of one or more 
phenylalanine residues self-assembles into extended nanotubes, nanofibrils, and nanoribbons 
that are responsive to acidic pH, ionic strength, temperature and divalent metal ions149,150,151. 
Diphenylalanine nanowires have been successfully fabricated on surfaces for the design of 
biosensing devices152.  
 
1.7.3.3   Cyclic peptides  
Cyclic peptides were one of the earliest set of synthetic peptides designed from natural 
antimicrobial peptides produced in microorganisms, plants, and animals, as part of the innate 
immune response153. The rationally designed peptide analog of gramicidin A, cyclo-[-(L-Gln-
D-Ala-L-Glu-D-Ala)n-] adopts a flat ring conformation which stacks through backbone 
hydrogen bonds to form extended cylindrical structures with a pore diameter of ~1 nm154. 
Variations in the design strategy have given rise to peptide sequences that have been utilized 
to produce transmembrane channel mimics155 similar to the natural transport protein channels 
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1.7.3.4   Amphiphilic peptides  
Amphiphilic peptides contain hydrophobic and hydrophilic residues arranged in a two-faced 
design. Peptide sequences Ac-A6D, Ac-V6D, Ac-V6D2, Ac- L6D2 and Ac-A6K-NH2 reportedly 
self-assembled into organized nanostructures including micelles, vesicles, and tubes of 
nanoscale dimension with dense β-sheet networks157,158. The overall design of amphiphilic 
peptides is similar to native phospholipids in the cell membrane except they have not only 
hydrophobic tail packing but also intermolecular hydrogen bonds along the backbone159. 
Peptide amphiphiles (PA) are short peptide sequences covalently joined to an alkyl chain. PA 
sequences designed with hydrophobic sequences to promote β-sheet formation yielded well-
ordered cylindrical nanostructures7. Variation of this design through the introduction of 
charged residues in the peptide segment allowed linking of specific chemical moieties and 
biologically active sequences160,161. Another important design is the drug amphiphiles (DA) 
which self-assembles into discrete extended nanofibers/nanotubes with applications as 
independent drug delivery vehicles162.  
 
1.7.3.5   Ionic self-complementary peptides 
Ionic-complementary peptides have alternating arrangement of negatively and positively 
charged residues. To have ionic complementarity, the distribution of the charges follow 
specific patterns, such as +˗+˗+˗+ or ˗ ˗++˗ ˗++ or ˗ ˗ ˗ ˗ ++++. A prominent example is the 
EAK16 peptide inspired from zoutin protein, a putative Z-DNA binding protein in yeast that 
self-assembles into highly pH tolerant thermostable nanofibrils. Peptide sequences with the 
alanine residue changed to hydrophobic residues self-assembled into interwoven nanofibers 
and nanopores with a diameter between 50-200 nm163. Zhang & co-workers utilized this design 
strategy to create molecular switches with the ability to change their molecular structure under 
different conditions of temperature and pH164. 
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1.7.3.6   Multi-domain peptides 
A set of interesting peptide sequences has been designed by combining domains with different 
properties such as the ABA block motif with the B block comprised of alternating hydrophilic 
and hydrophobic amino acid residues surrounded by the A block made of charged residues. 
Examples include the K2(QL)6K2, K2(SL)6K2, E(QL)6E and E(SL)6E sequences that self-
assemble into well-defined nanofibers165. Table 1.2 presents some important biologically 
inspired peptide sequences that self-assemble into extended β-sheet based nanostructures. 
 













KLVFFE Amyloid Fibrils 149 
KFFEAAAKKFFE Amyloid fibrils 167 
PrP GNNNQQNY Amyloid Fibrils 167 
Cyclic peptides 





Lanreotide  Nanotubes 143 
Amphiphilic peptides  
Phospholipid like 
structure 
AAAAAAD Nanotubes 7 
GGGGGGGGGGDD Nanovesicles 157 
Zoutin  
(yeast protein) 
VVVVVVDD Nanotubes 159 
RADARADA Nanofibers 159 
LELELKLKLELELKLK Nanovesicles 169 
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The advantage of customizable length, permutation and combination of residues, and sequence 
repeats confers a range of different properties like charge, hydrophobicity and aromaticity that 
are highly appealing for their application and utility for development of functional 
bionanomaterials such as diphenylalanine peptide nanowires to template metal ions and peptide 
amphiphile conjugated to hydrophobic drug candidates for targeted delivery in cancer therapy. 
  
1.7.4   Self-assembly of helical coiled coil forming peptides 
The α-helix is the major secondary structure element in proteins170. The clockwise oriented 
loosely coiled spring-like structure is held stably together by a network of hydrogen bonds 
across the coil, with a hydrophobic core. The α-helical coiled coil represents the largest 
assembled motifs in proteins, made up of two, three or four right-handed amphipathic α-helices 
wrapped around in a left-handed super-coiled fashion with a continuous in-contact hydrophobic 
surface171,172. The distinct feature of the coiled-coil assembly is the heptad repeat sequence 
denoted by (abcdefg)n, where positions “a” and “d” is occupied by hydrophobic amino acid 
residues forming the hydrophobic core and other positions occupied by hydrophilic or charged 
residues. The overall structure of the α-helical coiled-coil is stabilized by hydrophobic 
interactions along with electrostatic interactions and salt bridges arising from charged amino 
acid residues placed in position e and g in the heptad repeat of the neighboring helices172 
(Figure 1.12).  
 
Another hierarchical structure formed by the coiling of α-helices are the helical bundles. 
Helical coiled-coil bundles are hierarchical organizations of coiled coils, wherein two or more 
coiled-coils are packed with a sterically close-packed hydrophobic core173.  
 




Figure 1.12: Schematic of the α-helix coiled coil: Showing the organization of the heptad motif 
and the assembly of the helix coil into coiled coil. Reproduced with permission from Kohn et 
al. (1997)172. 
 
1.7.5   Current sources of self-assembling helical type peptides 
Tirell & co-workers were the first to exploit the coiled-coil assembly by designing 
polyelectrolyte blocks rich in alanine, glycine, proline and glutamine, flanked by dimeric 
coiled-coil sequences that self-assembled into pH-responsive hydrogels174. Kojima et al. 
introduced the first single component α-helix based self-assembling peptide in 1997. The α3-
peptide with the sequence “LETLAKA” self-assembled into extended fibrils that were 5-10 
nm thick175.  
 
Kajava & co-workers utilized this design strategy to produce peptide sequences with heptad 
repeats in multiples of seven, which resulted in staggered ended coiled coils that self-assembled 
into fibers176. Conticello et al. further explored this design to produce versatile self-assembling 
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fiber (SAF) type peptide systems based on the single 42-residue leucine zipper-based helix 
motif177. Woolfson & co-workers designed many peptide sequences termed magic wand 
peptides that self-assemble into fibrous materials178 and added to the increasing set of SAF 
peptide sequences.   
 
Kopecek et al. further modified the design strategy by introducing a His-tag fused to the coiled 
coil peptide sequence that was metal coordinated linked to a synthetic polymer. This peptide-
polymer complex self-assembled into fibrous biomaterial179. Another noteworthy design is the 
GCN4 peptide inspired from the yeast transcription factor GCN4 that assembles into extended 
fibers with a tetrameric coiled-coil core triggered by concentration180. Other important designs 
inspired from natural systems that make up the library of the helical coiled-coil forming 
peptides are highlighted in table 1.3. 
 
Table 1.3: Current sources of helical coiled coil forming peptides 
Source Model Assembly References 
 












(GPO)n Triple helix 
183,184 










tetrameric and pentameric 
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1.8   Design source for novel self-assembling peptides 
The various design strategies and sources discussed above have led to the development of 
peptide sequences that can be triggered to self-assemble into a range of different 
nanostructures. Furthermore, the knowledge gained from the understanding of the self-
assembly process of different isolated peptide sequences has led to the development of 
sequences that can be tailored to meet the demands of specific applications including 3D cell 
culture, bio-mineralization, scaffolds for tissue repair, nanocircuitry, and delivery vehicles for 
bioactive molecules. The different sequences designed to date largely belong to the limited set 
of biological design sources highlighted above. Therefore, the need of new design sources for 
novel peptide sequences that can self-assemble in a regulated manner is thus warranted. 
 
Proteins usually function as homo-oligomers. Extensive study of oligomeric protein systems 
have shown oligomerization to be dependent on the concentration(s), the dissociation 
constant(s) (Kd)
187 and change in the physiological environment, such as pH, ionic strength, 
and temperature188. Such subtle equilibria existing between monomer and oligomer forms is 
brought about by the protein-protein interfaces that appear to be evolutionarily optimized to 
regulate self-assembly189,190,191. Analysis of the protein interfaces reveals regions of close 
contacts that provide the necessary structural versatility for multiple complementary non-
covalent interactions (section 1.2). The tendency of these interface motifs to interact with each 
other specifically as a homopolymer makes them attractive to explore for the design of self-
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1.9   Significance and aims of the research  
Self-assembling materials are widely explored for fabrication of nanodevices for different 
applications in bio-nanotechnology such as biosensing. templating minerals/metal ions and 
polymers for producing conductive nanotubes or nanowires124. Producing a building block that 
can self-assemble into stable nanostructures of defined morphology presents many challenges. 
Furthermore, sequences that can be utilized as components for bio-nanodevices such as 
bioactuators and biosensors require specific properties. Biologically inspired systems such as 
peptide sequences offer unique properties and features from the self-assembly perspective92,192. 
The different peptide sequence design strategies reported have allowed the creation of 
molecular biomaterials with better control over their dimensions and patterns of assembly94. 
The design sources for such sequences are however limited to the amyloidogenic motifs within 
proteins and other biologically inspired designs highlighted in the above sections. To design 
new self-assembling peptide sequences it is important to identify new design sources which 
requires understanding the natural self-assembly process of the biomolecular building blocks. 
Figure 1.13 shows the difference between the amyloidogenic assembly and the natural self-
assembly in oligomer protein systems. 
 
The different ways in which protein-protein interface motifs interact and arrange themselves 
in hierarchical structures provides a useful starting point to screen for sources of self-
assembling peptide sequences. Protein-protein interfaces are evolutionary fine-tuned to allow 
self-assembly of protein units in a precise and controlled manner. Thus, protein interface 
sequences in complementary noncovalent close-contacts offer a key feature for the design of 
peptide sequences that self-assemble in isolation. Simple protein-protein interfaces of homo-
oligomeric proteins that consist of a short stretch of complementary interacting sequences, were 
thus explored. 




Figure 1.13: Cartoon model showing the difference between the amyloidogenic assembly of 
peptide sequence inspired from transthyretin protein89 (A) and the natural self-assembly of 
oligomer protein system bovine Prx3 (PDB: 1ZYE) (B). The simple β-continuous protein-
protein interface used to design inspire peptide sequence is shown in square box. 
 
In this research work two different type of protein-protein interfaces were investigated for the 
design of self-assembling peptide sequences: the β-continuous protein interface and the helical 
coiled-coil interface.  
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The aims of the research experiments for this thesis work were: 
(I) To examine protein β-continuous interface across different classes of protein 
homomers for the design of β-sheet forming self-assembling peptides and the 
characterization of the self-assembly through biophysical techniques. 
(II) To investigate the role of the histidine residue in the assembly of peroxiredoxin 3 
derived β-interface peptide through single residue mutation as well as to explore the 
parent peroxiredoxin 3 protein β-interface through site-specific mutagenesis of a 
histidine residue. 
(III) To produce higher order assembly of human peroxiredoxin 3 (hPrx3) dodecamer 
toroids using β-sheet peptide templating and characterize the self-assembly through 
biophysical techniques. 
(IV) To examine the coiled-coil interface of the intermediate filament forming keratin 
protein of ovine origin for the design of responsive α-helical coiled coil self-
assembling peptides and characterization of the self-assembly.  
 
1.10   Thesis overview 
 
Chapter 1 gives an introduction to molecular self-assembly, the current sources self-assembling 
peptide sequences and techniques used to characterize such assembly. The chapter also 
introduces new source to design self-assembling peptide tectons.  
 
Chapter 2 presents the materials utilized and experimental procedures performed throughout 
the research work.  
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Chapter 3 presents the strategy for the design of β-sheet forming self-assembling peptide 
sequences. The chapter discusses the self-assembly of the different peptide sequences designed 
and the characterization of the assemblies using different biophysical methods. 
 
Chapter 4 details the design of variant peptide sequences and characterization of the resulting 
self-assembly. The chapter also discusses the different site-directed muteins of peroxiredoxin 
3 protein and the induced change in the self-assembly of the oligomeric state.  
 
Chapter 5 presents a strategy to generate higher order assembly of peroxiredoxin 3 toroid 
shaped oligomer into microscale assemblies and also discusses methods to control the 
hierarchical organization of the protein toroids into hierarchical assemblies. 
 
Chapter 6 outlines the design strategy and introduces a new source for the design of α-helical 
coiled-coil forming peptide sequences. The chapter also discusses methods to achieve control 
over the hierarchical organization of coiled coils into extended nanostructures.  
 
Chapter 7 discusses and summarizes the major findings in this research work and directions for 
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2   Chapter two 
 
Materials and methods 
 
2.1   Material 
 
2.1.1   Chemicals and reagents 
Unless otherwise stated all chemicals, reagents, and solvents were obtained from Sigma-
Aldrich, Invitrogen, BDH Laboratory supplies or Merck, and are of analytical grade. Precast, 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and molecular 
weight protein standards were obtained from Invitrogen iLife technologies. Media for 
chromatography analysis was supplied as pre-packed columns from GE Life Sciences 
(Auckland, New Zealand). Milli-Q water supplied in-house by advance A10 water purification 
system (Merck, Millipore). 
 
2.1.2   Peptides 
Peptide sequences were custom manufactured and supplied by Mimotopes Pty Ltd (Sydney, 
Australia) as acetate salts with a purity of > 95% as tested by matrix-assisted laser desorption 
ionization (MALDI) mass spectrometry by the provider. The peptide acetate salts were 
obtained as lyophilized powders and stored at -20°C. Some peptide variants as stated in 
appendix II were supplied by Prof. Justin Hodgkiss (Victoria University), Wellington, New 








Table 2.1: Peptide sequences studied 
Peptide Composition Source protein 
1 Ac-IKHLSVN-NH2 
 
Bovine peroxiredoxin 3 (Bt Prx3) 
 
2 Ac-MHIRLSFN-NH2 

















O. aeries cuticular keratin type II 
7 Ac-CEINTYRGLLDSEDC-NH2 O. aeries cuticular keratin type I 
 
2.1.3   Plasmids 
The pET plasmid vector system was used for protein expression1. This vector has been reported 
to give high protein expression yields and to be sensitive to selective protease cleavage. The 
pET-151/D-TOPO plasmid vector and pET22b plasmid vector system2,3 contained the pBR322 
origin of replication (ORI), the lac operator that allows induction of expression by addition of 
isopropyl β-D-1 thiogalactopyranoside (IPTG) (section 2.5.2) and the amp gene for resistance 
to ampicillin. The pET151/D-TOPO vector used for expression of human peroxiredoxin 3 
(hPrx3) wild type and selective muteins, contained the N-terminal 6*Histidine tag, TEV 
cleavage site and the bla gene for ampicillin resistance and expression.  
 
2.1.4   Bacterial strains 
Different E. coli strains as detailed in table 2.2 were used during the research for plasmid 
propagation, cloning and protein expression4.  
 
 




Table 2.2 Bacterial strains used for cloning and expression of protein 
Bacterial strain Description 
XL1-Blue (Stratagene) 
Genotype: recA1, endA1, gyrA96, thi-1, hsdR17, supE44, 
relA1, lac [F´ proAB lacIq Z∆M15 Tn10 (Tetr )] 
Rosetta “DE3” (Novogen) 
 
Genotype – F- ompT hsdSB[B-mB-] gal dcm [DE3] pRARE 
[CamR]) 
BL21 “DE3” (Stratagene) 
 
Genotype: F– ompT, hsdS(rB– mB–), dcm+, TetR, galλ(DE3), 
endA, Hte [argU proL CamR] [argU ileY leuW Strep/Specr]) 
 
Competent cells of each of the strains used were either purchased from Invitrogen Life 
Technologies (U.S.A) or made in-house (section 2.4.4.1). All the microbial work was carried 
out under aseptic conditions in a laminar flow hood or with an updraft generated by a flame. 
 
XL1-Blue and DH5α cells were used for propagation of plasmid vectors. For expression of 
hPrx3 and mutant proteins, the E. coli BL21 DE3 Rosetta cells were used. The cells contain the 
gene for T7 RNA polymerase, required for expression from the pET plasmid vector, and are 
competent for high protein expression yield.  
 
The cells contained the gene for resistance to chloramphenicol, to allow checking for non-
specific bacterial growth in the media. The BL21 (DE3) codon plus cells were used for 
expression of rTEV protein as they contained the RILP plasmid, allowing expression of rare 
codons, necessary for high-level expression of protein1,5,6. 
 
2.1.5   Sequences of protein investigated 
The sequences of hPrx3 wild-type protein, an hPrx3 protein containing N-terminal 6*His tag 
and hPrx3 homodimer protein-β interface muteins are detailed in table 2.3 and 2.4. 
 
 































Note: 1) The highlighted sequence in black corresponds to the mitochondrial localization 
sequence at the N-terminal.  
          2) ^ is a truncated form of the protein with the mitochondrial localization sequence 
replaced with the peptide tag containing the six consecutive histidine residues 
(6*His). 
 




































Note: The highlighted residue in black corresponds to the mutated residue.  




2.1.6   Growth media 
For propagation of plasmids and growth and protein expression from bacterial cells, the growth 
media detailed in table 2.5 were used. The media were sterilized by autoclaving and stored at 
room temperature before use7. 
 
Table 2.5: Composition of media used for growth of bacterial cultures 
Medium Composition 
LB medium 








Bacto-tryptone (20 mg/mL), yeast extract (5 mg/mL), NaCl (0.58 g/L), KCl 




Bacto-tryptone (10 g/L), yeast extract (5 g/L), (NH4)2SO4 (3.3 g/L), 
KH2PO4 (7.1 g/L), glucose (0.5 g/L), α-lactose (2.0 g/L), MgSO4 (0.15 g/L)  
 
2.1.7   Antibiotics and additives 
Antibiotics were used to select the transformed bacterial strains containing the recombinant 
plasmids with the desired gene of interest. The plasmid vectors used in the research contained 
the gene for ampicillin or kanamycin resistance. The pLysS plasmid in E. coli BL21 bacterial 
expression strain contained a gene for chloramphenicol resistance8. The antibiotics were 
prepared as stock solutions: ampicillin and kanamycin in water and chloramphenicol in ethanol 
and stored in aliquots of 1 mL at -20°C until used (Table 2.6). 
 









Sigma-Aldrich 100 mg/mL 100 µg/mL 
Chloramphenicol (Chl) 
 
Merck-Millipore 30 mg/mL 30 µg/mL 




Additive: Isopropyl β-D-1 thiogalactopyranoside (IPTG) was used to induce protein expression 
in bacterial expression systems from the vectors carrying the lac gene, which include the pET 
plasmid vector9. A stock solution of IPTG at a concentration of 400 mM in deionized water 
was added to the media at a 1:1000 dilution to give a working concentration of 0.4 mM. 
 
2.2   Buffers and solutions 
 
2.2.1   Solutions for CD spectroscopy and SAXS 
Table 2.7: Solvents used for C.D. spectroscopy and SAXS analysis 
 
Solvent Make Recipe 
Methanol Merck 
Different percentages of 






Trifluoroacetic acid (TFA) 
 
Acetic acid 
100 mM Imidazole BDH Analytical chemicals 
0.68 mg imidazole 
dissolved in 50 mL Milli-Q 
water, pH adjusted to 8.5 
and volume adjusted to 100 
mL 
Note: Milli-Q water used in the analysis was supplied from Milli-Q water purification system 
(Merck-Millipore). 
 
2.2.2   Buffers and solutions for plasmid extraction 
Table 2.8: Buffers used for extraction of plasmid DNA from bacterial cells  
Process Buffer Composition 
 Buffer S1 50 mM Tris-HCl, 10 mM EDTA, 100 µg/mL RNase A, 
pH 8.0 
Buffer S2 200 mM sodium hydroxide (NaOH), 1% sodium 
dodecyl sulfate (SDS) 
Buffer S3 4.2 M guanidinium hydrochloride (GuHCl), 900 mM 
potassium acetate, pH 4.80 
Wash buffer  10 mM Tris-HCl, 80% ethanol, pH 7.50 
Tris-EDTA (TE) 
buffer 

























2.2.3   Buffers and solutions for protein purification 
Extraction of protein from bacterial expression systems and further purification used 
specialized buffers that are known to fit for storage of biomolecules such as proteins. The buffer 
solutions and reagents used in the extraction and purification of hPrx3 protein were adapted 
from the previously established method by Phillips et al.10 
 
Table 2.9: Buffer solutions used for protein extraction and purification  
Process Buffer Composition 
  
Lysis buffer (B1) 
 
 
Stripping buffer (B2) 
 
 
Recharge buffer (B3)  
 
Loading buffer (B4) 
 
 
Elution buffer (B5) 
 
 
Storage solution (B6) 
 
20 mM Hepes,  150 mM NaCl, 30 mM imidazole pH 
8.0 
 
20 mM sodium phosphate, 0.5 mM NaCl, 50 mM 
EDTA, pH 7.40 
 
0.1 M nickel sulfate 
 
20 mM Hepes, 150 mM NaCl, 30 mM imidazole, pH 
8.0 
 
20 mM Hepes, 150 mM NaCl, 500 mM imidazole, pH 
8.0 
 










20 mM Hepes, 150 mM NaCl, pH 8.0 
 
20 mM Hepes, 150 mM NaCl, pH 8.0 
 
  
Loading buffer (B9) 
 
 




20 mM Hepes, 150 mM NaCl, 30 mM imidazole, pH 
8.0 
 
20 mM Hepes, 150 mM NaCl, pH 8.0 



































































































2.2.4   Buffers and solutions for SDS-PAGE 
MES running buffer: A 20X stock solution was supplied by Invitrogen Life Technologies 
U.S.A. A 1:20 dilution was performed to make a 1X working concentration of the buffer that 
was used for gel electrophoresis. 
 
Sample loading buffer: For1 mL of 2X sample loading buffer, 500 μL of sample loading buffer 
was diluted with 500 μL of Milli-Q water. The protein was diluted 1:1 with the sample loading 
dye sample before running on the gel. 
 
2.2.5   Buffers and solutions for rTEV protease purification 
The recombinant tobacco etch virus (rTEV) protease enzyme was used to cleave the 6*His-tag 
present at the N-terminus end of the recombinant protein. The buffers used for the extraction 
and purification of the rTEV protease are listed in the table below. 
 
Table 2.10: Buffer solutions used for rTEV extraction and purification  
Process Buffer Composition 
  
Lysis buffer  
 
 





20 mM sodium phosphate, 500 mM NaCl, 30 mM 
Imidazole pH 8.0 
 
20 mM sodium phosphate, 500 mM NaCl, 500 mM 
Imidazole, pH 8.0 
 




2.2.6   Buffers for peptide and protein mixing studies 
Sodium citrate buffer: 20 mM sodium citrate, 150 mM NaCl, pH 4.0 


















   
















Sodium borate buffer: 20 mM sodium borate, 150 mM NaCl, pH 9.0 
Sodium phosphate buffer:  20 mM sodium phosphate, 150 mM NaCl; pH 7.4 
Tris-Cl buffer: 20 mM Tris-HCl, 150 mM sodium chloride; pH 7.4 
Hepes buffer: 20 mM Hepes, 150 mM sodium chloride; pH 8.0 
PBS buffer: 10 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, 140mM NaCl pH 8.0 
Note: For reducing conditions the buffers were prepared containing 3 mM TCEP. 
 
2.2.7   Buffers and solutions for redox study of peptides 
Sodium citrate buffer: 50 mM sodium citrate, 150 mM sodium chloride, pH 4.0 
MES buffer: 50 mM MES, 150 mM sodium chloride, pH 5.0 
Tris-Cl buffer: 20 mM Tris-HCl, 150 mM sodium chloride, pH 7.60  
Sodium borate buffer: 50 mM sodium borate, 150 mM sodium chloride, pH 9.0 
 
The above mentioned buffers were prepared with the addition of 100 mM hydrogen peroxide 
(H2O2) to study the self-assembly of the peptides under induced oxidizing conditions. Studies 
on the peptide sequences under reducing conditions were performed in the above-described 
buffers contained with 10 mM TCEP in the buffer. 
 
2.2.8   Solution for ThT fluorescence assay  
A stock solution of 500 μM Thioflavin-T (ThT) was used for ThT binding assays. To prepare 
the stock solution, 8.0 mg of ThT (abcam®, Cambridge (M.A.), U.S.A) was weighed and 
dissolved in 5 mL of solvent (Milli-Q water or 100 mM imidazole or 150 mM NaCl solution 
or Hepes pH 8.0 buffer). The stock solution was diluted to a working concentration of 50 μM. 
Unless otherwise stated, a 1:1 dilution of the peptide sample with 50 μM ThT was performed 
to obtain a desired concentration of the peptide and working ThT concentration of 25 µM.  




2.2.9   Solution for TEM  
Uranyl acetate (SPI-Chem™, U.S.A) was used as a negative staining dye for transmission 
electron microscopy (TEM) analysis. To prepare a 2% working solution of uranyl acetate: 20 
mg of uranyl acetate was dissolved in 10 mL of Milli-Q water and filtered through a 0.22 µm 
filter. The uranyl acetate solution was stored at 4°C in a small glass bottle covered with 
aluminum foil. Uranyl acetate is a radioactive and photosensitive staining agent. Therefore 
appropriate care was taken while making, storing and using the sample11. 
 
2.2.10   Buffers and solutions for mass spectrometry  
Analysis solution: 30 mg ferulic acid dissolved in 0.5 mL 2-propanol and 0.5 mL of 0.5% 
triflouroacetic acid (TFA).  
 
2.3   Chromatography instrument, column, and media 
Chromatographic procedures were performed on the AKTA Explorer system (GE Life 
Sciences). Hi-Trap chelating columns (1 mL, GE Lifesciences) and His-Trap columns (5 mL, 
GE Life Sciences) were used for purification of recombinant proteins by IMAC recharged with 
a metal ion (section 2.5.5.4). For size exclusion chromatography, Superdex HiLoadTM 16/600 












2.4   Molecular Biology 
 
2.4.1   Commercial plasmids  
Plasmids (section 2.1.3) containing customized gene sequences and the corresponding primers 
were designed using the site-directed mutagenesis tool available from GenScript Inc., New 
Jersey (U.S.A.). The designed plasmid expression vector with gene sequences shown in table 
2.2 were then provided by Epoch Life Science Inc., Texas (U.S.A).  
2.4.2   DNA sequencing 
The accuracy of the mutagenesis was confirmed by the Sanger sequencing method12. The 
analysis was carried out at the School of Biological Sciences, University of Canterbury (N.Z.) 
using an Applied Biosystems 3130xl genetic analyzer. 
2.4.3   DNA concentration 
DNA yield was determined by measurement of U.V. absorbance at 260 nm wavelength13. The 
DNA concentration was determined using a Thermo Fischer Scientific Inc. Nanodrop 
spectrophotometer, with a built-in automated function, to calculate the concentration of the 
DNA present in the sample using the equation 2.1. 
                                             Concentration =   (A * εl/b)                                        equation 2.1 
 
                                   Concentration of DNA =   (A260/Ɛ260)*1                               equation 2.2 
 
The calculation of the DNA concentration was achieved by a modified Beer-Lambert equation, 
where c is the concentration in ng/μL, A is the absorbance in AU, ε is the wavelength-
dependent extinction coefficient in ng-cm/μL, b is the path length in cm.  




For calculation, A260 is the absorption at 260 nm in absorbance units (AU), Ɛ260 is the 
wavelength-dependent extinction coefficient at 260 nm (~ 50 ng/cm/µL) 1 cm was the path 
length (0.1 cm in the NanoDrop 2000)14. As the molarity of polymers such as DNA does not 
depend on the length, mass per unit length was employed for the calculation.  
 
2.4.4   Competent cells  
  
2.4.4.1   Making chemically competent cells 
A frozen glycerol stock of chemically competent cells was freshly plated onto an LB + agar 
plate using a flame sterilized nichrome wire. The plate was incubated overnight at 37°C. A 
single colony of bacterial cells was used to inoculate a 10 mL LB starter culture, incubated 
overnight at 37°C, shaking at 170 rpm. 2 mL of the overnight grown culture was used to 
inoculate further a 200 mL flask culture of LB, incubated at 37°C, shaking at 170 rpm. Cells 
were harvested at OD600 ~1 AU, by centrifuging at 6,500 rpm for 15 minutes (centrifuge 
maintained at 4°C) and suspended in 40 mL volume of 0.1 M calcium chloride (CaCl2). The 
cells were divided into 100 µL aliquots, flash-frozen and stored at -80°C15,16. 
 
2.4.4.2   Transformation of chemically competent cells  
A fresh aliquot of chemically competent cells was taken from -80°C storage and thawed gently 
on the ice. The plasmid DNA sample was also thawed gently, and 1 µL of the plasmid DNA 
was added to the competent cells, gently mixed using the pipette tip. The transformation mix 
was incubated on ice for 15 minutes and then subjected to heat shock by incubating at 42°C for 
45 seconds. Following the incubation, the mix was immediately placed on ice for 2 minutes to 
cool down. 100 µL of pre-warmed (~ 37°C) super optimal broth (SOB) media was added to 
the mix and then incubated at 37°C for 60 minutes, shaking at 160 rpm to regenerate the cells. 




The cells were then centrifuged at 6,500 rpm for 15 minutes and the supernatant removed. The 
cells were further suspended in 100 µL LB media and plated onto freshly prepared LB + agar 
plates containing selective antibiotics (section 2.1.7) and incubated at 37°C for 16 hours. Plates 
containing colonies of successfully transformed cells were stored at 4°C before use (expiry 
period is one week)17. 
 
2.4.5   Bacterial cell culture  
The desired strain of bacterial cells was streaked onto a freshly prepared LB + agar plate 
containing the appropriate antibiotics (section 2.1.7) using a sterilized nichrome wire. The 
plated bacterial cells were incubated at 37°C for 16 hours. A single colony of the bacterial 
strain was used to inoculate a fresh 10 mL starter culture containing appropriate antibiotics, 
incubated overnight at 37°C shaking at 160 rpm17. The overnight grown starter culture was 
subsequently used to inoculate larger scale cultures (section 2.5.3). 
 
2.4.6   Preparation of glycerol stocks  
Glycerol stocks were used for long term storage of bacterial strains and cells transformed with 
recombinant plasmids containing the gene of interest for protein expression. 10 mL of starter 
culture was prepared as described in section 2.4.5 and 2 mL of this culture was used to inoculate 
a 200 mL flask culture of sterile LB. The culture was incubated at 37°C for 4 hours, to allow 
growth and taken off incubation once the OD600 reached 0.6 AU. The cultured cells were cooled 
down to room temperature, and 700 μL of the culture was added to a 2 mL cryovial containing 
300 μL of 50% pre-autoclaved glycerol (final concentration of glycerol in the stock was 15%). 
Triplicate aliquots were vortexed and flash frozen by suspending the cryovial in liquid nitrogen 
and stored at -80°C18.  
 




2.5   Production of recombinant protein  
 
2.5.1 Transformation and protein expression 
The commercially available BL21(DE3) strain of E. coli cells was co-transformed with pET 
151-d-Topo plasmid vector9 (Epoch Lifesciences, U.S.A.) containing the gene encoding hPrx3 
and with the pRARE plasmid19. Chemically competent E. coli BL21 (DE3) bacterial cells were 
thawed on ice and aliquots of 2 µL each of i) the pET-151-d-Topo plasmid containing the hPrx3 
gene and ii) the pRARE plasmid were added. The transformation was performed as described 
in section 2.4.4.2. Glycerol stocks of the transformed cells were flash frozen using liquid 
nitrogen and stored at -80°C. The glycerol stock was used to inoculate expression cultures 
(section 2.5.2). 
 
2.5.2   Small-scale expression of protein  
To determine best conditions for expression of the recombinant protein: optimum incubation 
time, induction by isopropyl β-D-1-thiogalatopyranoside (IPTG) and temperature of growth, 
small-scale expression was trialed. Two different types of induction methods: IPTG mediated 
induction20 and auto-induction21, were used for the expression of recombinant proteins. 
 
2.5.2.1   IPTG-induced expression of protein  
A frozen glycerol stock of transformed cells (section 2.5.1) was freshly plated onto an LB + 
agar plate using a flame sterilized nichrome wire. The plate was incubated overnight at 37°C. 
A single colony of transformed cells grown on an LB + agar plate was used to inoculate 10 mL 
LB starter culture containing appropriate antibiotics. Suspension cultures were grown in 50 mL 
volume conical flasks to an OD600 between 0.4 to 0.6 AU. IPTG was added at 0.1 mM or 0.2 
mM or 0.4 mM concentration22.  




To examine the effect of temperature on protein expression, the cultures were subsequently 
incubated at 26°C or 37°C, with shaking at 170 rpm. 500 µL of the culture were taken at 
different time points and centrifuged at 12,000 rpm for 5 minutes to obtain a cell pellet; the 
supernatant was discarded. The cells were suspended in 100 µL of SDS-PAGE buffer and 
sonicated to lyse the cells (70% amplitude, 3*5 minutes). The lysed cells were centrifuged 
again at 12,000 rpm for 5 minutes, and the supernatant separated. 10 µL of supernatant and 10 
µL cell pellet suspended in SDS-PAGE buffer was analyzed by SDS-PAGE gel electrophoresis 
to assess protein expression (section 2.6.2). 
 
2.5.2.2   Protein expression by autoinduction 
A single colony of transformed cells was used to inoculate 10 mL of autoinduction media 
(section 2.1.6) and grown at 26°C and 37°C with shaking at 170 rpm21. Samples collected at 
different time points were analyzed as described in the above section. 
 
2.5.3   Scale-up of protein expression 
For expression of recombinant protein at a larger scale, LB + agar plates containing appropriate 
antibiotics were streaked with transformed cells and incubated overnight at 37°C. A single 
colony was picked to inoculate a 10 mL starter culture (with antibiotics) and incubated 
overnight with shaking at 170 rpm. The overnight grown culture was further used to inoculate 
flask cultures. 
 
2.5.4   Protein expression by IPTG induction 
The overnight grown starter culture was used to inoculate 200-500 mL of LB culture in a 2 L 
baffled flask containing an appropriate concentration of antibiotics. The flask culture was 
incubated at 37°C shaking at 170 rpm until the OD600 reached 0.4-0.6 AU.  




To induce protein expression, the culture was brought to room temperature and induced with 
0.4 mM IPTG. The induced culture was transferred to 26°C and grown overnight shaking at 
170 rpm. Further cells were harvested by centrifugation at 6000 rpm for 15 minutes and re-
suspended in 20 mL of lysis buffer. The cell suspension was directly used for extraction and 
purification of the protein or flash frozen using liquid nitrogen and stored at -80°C before use. 
 
2.5.5   Purification of recombinant protein 
 
2.5.5.1   Protein extraction by sonication 
Lysis of cells was carried out using a sonicator 3000 (Misonix) equipped with a microprobe 
for low volume samples (1-5 mL) and a standard probe for larger volume (30 mL). A cell 
suspension was prepared by suspending the cell pellet in lysis buffer in a 50 mL plastic beaker. 
The beaker was placed in an ice slurry to prevent excessive heating of the sample. The cells 
were sonicated at 70% amplitude with a pulse rate of 2 seconds and 5 seconds off, six times 
for a total of 30 minutes. 
 
2.5.5.2   Protein extraction by high-pressure homogenization 
Cell lysis was achieved by passing the cell suspension through a valve and by applying a high 
pressure that causes disruption of cells by shear stress23. A 50 mL cell suspension was lysed by 
passing it through a Microfluidics M-110P cell disruptor at 17,000 psi maintained at 4°C. The 
cell suspension was passed through the homogenizer three times to achieve complete lysis. The 
lysed cells were centrifuged to separate the cell debris at 12,000 rpm for 30 minutes maintained 
at 4°C. The supernatant containing the soluble recombinant protein was subjected to SDS-
PAGE gel electrophoresis to assess protein expression (section 2.6.2). 
 




2.5.5.3   Concentration of protein 
Protein samples were concentrated to the desired volume using centrifugal concentrators. 
Vivaspin® centrifugal concentrators (Sartorius Stedim Biotech) with a molecular weight cut-
off (MWCO) of one-third of the molecular weight of the protein were selected. The Vivaspin® 
concentrator has two chambers: (i) sample chamber (top part) and (ii) flow through the collect 
chamber (bottom part). The protein sample was loaded into the top sample chamber and 
centrifuged at 4000 rpm and 4°C until the desired volume was obtained. 0.5 mL volume 
Vivaspin® centrifugal concentrators were used for small sample volumes. 
 
2.5.5.4   Immobilized metal affinity chromatography (IMAC) 
IMAC was used to purify the 6*His tagged recombinant protein using a pre-packed column 
(section 2.3). The clarified lysate was passed through a 0.45 µm filter and a 0.22 µm filter. The 
filtered lysate was applied to the 5 mL His-Trap column pre-equilibrated with 10 column 
volumes (CV) of lysis buffer (section 2.2.3). The column was washed with 5 column volumes 
of the lysis buffer to remove any unbound protein. The tagged protein was eluted from the 
column by applying a gradient of 100% IMAC elution buffer over 20 minutes. Both the steps 
of tagged recombinant protein binding and elution were carried out using the AKTA Explorer 
system (GE Lifesciences) maintained at 4°C and operated at 1 mL/min flow rate. The eluted 
protein was collected as 1 mL fractions and assessed by SDS-PAGE gel electrophoresis 
(section 2.6.2). Fractions that contained the tagged protein were pooled and stored at 4°C before 
use.  
 
2.5.5.5   Size exclusion chromatography (SEC) 
The pooled protein fractions were concentrated to ~ 2 mL (concentration of ~ 40 mg/mL) using 
5 mL centricon tubes of 10 kDa molecular weight cut off (section 2.5.5.3).  




The concentrated protein sample was filtered through a 0.22 µm syringe filter and loaded onto 
a Superdex 200 16/60 column, pre-equilibrated with 2 CVs of buffer B7 (section 2.2.3) attached 
to the AKTA FPLC Explorer system (GE Lifesciences). The chromatographic separation was 
performed at 4°C with the column operated at a flow rate of 0.5 mL/min using the elution 
buffer B8 (section 2.2.3) and size separated protein samples collected as 1 mL fractions on a 
96 well sample plate using the auto-sampler attached to the AKTA system. The protein 
fractions were identified by UV absorbance at 280 nm and assessed by SDS-PAGE gel 
electrophoresis (section 2.6.2). 
 
2.5.5.6   Storage of purified protein 
Protein samples assessed by UV absorbance at 280 nm and SDS-PAGE gel electrophoresis 
were pooled and concentrated to 10 mg/mL. 200 µL aliquots in 2 mL cryovials with glycerol 
(15%) were flash frozen using liquid nitrogen and stored at -80 °C. 
 
2.5.6   Removal of N-terminus 6*His-tag  
 
2.5.6.1   Expression and purification of tobacco etch virus protease  
rTEV protease was expressed in electrocompetent E.coli BL21 (DE3) and purified using a 
protocol based on the methods developed by Blommel & Fox24.  
 
2.5.6.2   rTEV assisted cleavage of His-tag protein 
An aliquot of rTEV protease sample was taken from -80°C storage and thawed at room 
temperature. The recombinant hPrx3 protein expressed using the pET151-d-Topo vector 
contained a 26 residue linker peptide containing the “ENLYFQG” sequence (rTEV cleavage 
site) at the N-terminus end of the protein.  




A ratio of 1 µg rTEV to 20 µg recombinant protein was used to cleave the 6*His-tag from the 
hPrx3 protein, incubated at 4°C for 12 hours. Samples were collected at T0, T6 and T12 hours 
and checked by SDS-PAGE gel electrophoresis for cleavage of the tag.  
 
2.5.6.3   Purification of cleaved protein  
The incubated sample mix (rTEV + protein) was loaded onto a gravity column containing a 2.5 
mL bed volume of Cu2+ His-pure matrix (Sigma-Aldrich). The sample was mixed well with 
the column beads suspended in loading buffer B9 (section 2.2.3) using a pipette and allowed 
to sit for half an hour to allow the cleavage of 6*His-tag. The cleaved hPrx3 protein was 
purified using elution buffer B10 (section 2.2.3) by gravity chromatography. The elution step 
was performed a couple of times to recover most of the cleaved protein from the column matrix. 
The column matrix was further washed with high salt buffer B5 (section 2.2.3) to elute bound 
His-tag.  
 
Samples of eluted protein, high salt buffer wash, and matrix beads were assessed by SDS-
PAGE gel electrophoresis (section 2.6.2) for the efficacy of cleavage. The cleaved protein 
sample was concentrated to a volume of 2 mL and further passed through a 5 mL HisTrap™ 
column (GE Life Sciences) to remove any uncleaved tagged protein and cleaved tag. The 
HisTrap™ purified protein was collected and loaded onto a HiPrep™ 26/10 desalting column 
attached to the AKTA Explorer FPLC system and collected as 1 mL fractions. The fractions 
were assessed by SDS-PAGE gel electrophoresis and pooled together. The pooled protein 
sample was brought to a concentration of 1 mg/mL, and 200 μL aliquots of the protein were 
flash frozen in cryovials containing glycerol (15%)25.  
 
 




2.5.7   Buffer exchange 
 
2.5.7.1   Buffer exchange by dialysis membrane 
Protein samples were exchanged into desired solution conditions by transferring the protein 
sample into a dialysis tubing of 10,000 Da (MWCO). The tubing was placed in a beaker 
containing the required buffer solution with a typical sample volume to dialysis solution 
volume ratio of 1:2000. Dialysis was carried out by gently swirling the sample in the dialysis 
buffer to increase the rate of exchange and maintained at 4°C. The dialysis process was 
typically repeated to achieve a complete exchange. 
 
2.5.7.2   Buffer exchange by dialysis device 
To perform the buffer exchange of protein samples at lower volumes (< 1 mL) and minimize 
loss of sample, Slide-A-Lyzer™ MINI dialysis devices (Thermo Fisher Scientific) with an 
MWCO of 7000 kDa were used. A sample volume of 100-500 μL was pipetted into the dialysis 
cup and capped. The sample was submerged into the dialysis buffer at 4°C, regularly topped 
up and gently swirled to increase the dialysis exchange rate.  
 
2.5.8   Preparation of peptide acetate solutions 
Peptide acetate solutions were prepared by dissolving a precisely weighed amount of 
lyophilized peptide acetate powder in Milli-Q water/solvent/buffer solutions w/w (section 
2.2.1, 2.2.6 and 2.2.7). The peptide acetate solutions were vortexed for 20 to 30 seconds to mix 








2.5.9   Mixing of hPrx3 protein with peptide acetates 
The mixing of Prx3 peptide acetate with hPrx3 protein was carried out in Hepes, NaCl, TCEP, 
pH 8.0 buffer (section 2.2.6) unless otherwise stated. The hPrx3 protein stored at -80°C was 
thawed at room temperature and buffer exchanged by dialysis into the buffer overnight (section 
2.5.7.2). The peptide acetates were prepared in the buffer as described in section 2.5.8 at 
different concentrations and equilibrated at 4°C for 24 hours before mixing unless otherwise 
stated. Calculated volume of peptide acetate solution was added to the hPrx3 protein sample 
such that the required final ratio of peptide acetate to protein is achieved (Table 2.11).  
 
Table 2.11: Ratio of peptide-protein mixes 
Ratio 
(peptide to hPrx3  
protein toroid) 
Peptide concentration in 
mix 
Molar concentration of 
peptide in mix 
15000:1 5.0 mg/mL 4.9 mM 
7500:1 2.5 mg/mL 2.4 mM 
3000:1 1.0 mg/mL 1.0 mM 
1500:1 0.50 mg/mL 0.5 mM 
500:1 0.17 mg/mL 0.17 mM 
50:1 17 µg/mL 17 µM 
1:1 0.34 µg/mL 0.33µM 
1/50:1 6.8 ng/mL 6.6 nM 
 
Note: The protein concentration was kept same at 0.1 mg/mL (0.33 µM) for all the conditions. 
 
2.5.10   Oxidation and reduction of peptide acetates 
The lyophilized peptide acetates were prepared in Milli-Q water or appropriate buffer solutions 
(section 2.2.7) and incubated for 24 hours or more at room temperature. To study the peptide 
sequences under oxidizing conditions: 10 mM peptide acetate in buffer was prepared, and 11 
µL of 30% hydrogen peroxide (H2O2) was added to the peptide acetate solution (989 µL 
water/buffer + 11 µL of H2O2). To study the effect of reducing conditions, on peptide self-
assembly, the oxidized peptide acetate solutions were dialyzed into a buffer containing 10 mM 




TCEP solution overnight. Control samples were prepared to dissolve the peptide acetate in 
water/buffer without any reducing agent or oxidizing agent. Control samples for reducing 
conditions were prepared with peptide acetate in water/buffer containing 10 mM TCEP. All 
the samples were equilibrated at room temperature for over 24 hours before analysis unless 
otherwise stated. 
 
2.6   Biophysical characterization  
 
2.6.1   Determination of protein concentration  
Purified protein samples were analyzed for UV absorbance at 280 nm using a Thermo Fischer 
Nanodrop 2000. For calculation of protein concentration, the Nanodrop 2000 was blanked with 
the hPrx3 storage buffer and 2 µL of the protein sample was placed on the sample tip and the 
absorbance at 280 nm of the sample recorded26. The theoretical extinction coefficient of the 
protein calculated from the amino acid sequence of the protein using the Expasy online 
bioinformatics server27 was used for the calculation of the concentration using equation 2.3. 
 
                             Concentration of protein (mg/mL) = (A280 / ε280)) * 1              equation 2.3 
 
Where, A280 is the absorption of the protein sample at 280 nm in AU, ε280 is the extinction 
coefficient of the protein at 280 nm, and 1 is the path length (1 mm in the case of Nanodrop 
2000).  
 
2.6.2   SDS-PAGE analysis 
Denaturation of the sample was carried out by the addition of 10 µL of loading dye containing 
SDS to 10 µL of the protein sample, and the mixture was heated at 95°C for 5 minutes.  




For reducing SDS-PAGE gels, the sample loading dye was prepared with 5% β-
mercaptoethanol or TCEP where indicated. A 10 or 15 well precast Bolt® 4-12% gel cassette 
((Invitrogen Life Technologies) was assembled on the Bolt gel electrophoresis system 
(Invitrogen Life Technologies). 3 µL of Novex pre-stained molecular weight protein standard 
(Invitrogen Life Technologies) was loaded as the marker, and 5 µL of the denaturation mix 
was loaded into the sample wells.  
 
The gel was run in 1 X MES buffer made from a premade 20 X buffer concentrate (Invitrogen 
Life Technologies) at a constant voltage of 165 V for 35 minutes. After completion of the 
electrophoresis run, the gel was removed from the cassette and washed with distilled water. 
The gel was stained with Coomassie simply blue stain (made in-house) using a three-step 
process: (i) the gel was placed in distilled water and microwave heated for 20 s to remove SDS 
present in the running buffer, (ii) stain was added to the gel and microwave heated for 20 s and 
then kept on a rocking table shaking at 50 rpm for 1 hour to allow optimum staining and (iii) 
gel was destained submerged in distilled water for 1 hour, kept on a rocking table. The gel was 
imaged on the BioRad Gel Doc XR+ system using the Image Lab™ software. 
 
2.6.3   SEC coupled with in-line static light scattering (SEC-SLS) 
The protein sample purified through the analytical SEC column was passed through the in-line 
SLS system that detects the light scattered and measures the concentration of each fraction. To 
perform SEC-SLS analysis of protein samples, the Superdex 200 GL 10/300 column (GE 
Lifesciences) was connected to the Viscotek 302-040 Triple Detector DPC/SEC systems (ATA 
Scientific-Malvern Instruments Ltd.). Protein samples of known concentration were filtered 
through a 0.22 µm syringe filter with a 150 µL sample pipetted into an HPLC grade glass vial.  




100 µL of the protein sample was injected into the analytical SEC column pre-equilibrated with 
3 CVs of running buffer, operated at a flow rate of 0.5 mL/min and maintained at room 
temperature. Bovine serum albumin (BSA) was run along with the protein samples as a 
reference standard at the beginning and end of each sample sequence. The estimation of 
molecular weight distributions of the protein samples was done by calculation of the absolute 
molecular weight, radius of hydration and size distributions from the refractive index (RI), 
intrinsic viscosity and right angle light scattering (RALS) measurements against the reference 
standard BSA (Sigma) of molecular weight 66.4 kDa. The weight average molecular weight 
was calculated by the equation:  
                                                           M = K’. (LS)                                                 equation 2.4 
                                                                         (RI)  
 
Where K’ is a constant is calculated from the equation:  
                                                           K’ =       KRI                                                   equation 2.5 
                                                                   KLS (dn/dc) 
 
KRI and KLS are instrumentation calibration constants, LS is the light scattering signal, RI is the 
refractive index signal and dn/dc is the refractive index increment (0.186 mL/g for globular 
proteins)28. 
 
2.6.4   Circular dichroism spectroscopy 
Far-UV circular dichroism (CD) spectra were collected with a Jasco J-815 spectrometer using 
a 1.0 cm quartz cell at room temperature. Micromolar solutions for spectroscopic analysis were 
prepared by diluting the peptide stock solution (1 mg/mL) to a working concentration of 0.008 
mg/mL. Stock solutions were prepared by dissolving 1 mg of the lyophilized peptide powder 
into 1.0 mL of Milli-Q of appropriate diluent (water or buffer or solvent) and equilibrated 
overnight before analysis. Spectroscopic blanks were Milli-Q water or buffer or solvent 
(section 2.2.1) used to prepare the peptide acetate solutions.  




The samples were degassed to remove any air bubbles by placing them in a desiccator with 
vacuum applied for 5 minutes. All spectra were baseline corrected to remove effects attributed 
to scattering from aggregated particles. For protein analysis, stock solutions of protein samples 
were diluted to a working concentration of 0.1 mg/mL using the appropriate buffer before 
analysis. 
 
2.6.5   Cross polarized light microscopy 
Optimal microscopy experiments were carried out at room temperature (~ 20°C). Thin 
preparations of the peptide acetates in water prepared mounted on top of a glass slide and a 
coverslip placed to fix the peptide sample in place, carefully avoiding build-up of air bubbles. 
The sample slide was mounted on the Leica DM2700 P upright polarization microscope. The 
two polarizers were oriented at right angles to each other to achieve cross-polarization (± 45°). 
The preparations were imaged using the inline Leica EC3 high-speed digital color camera 
attached to the microscope and Leica laser microdissection (LMD) software29. 
 
2.6.6   ThT binding assay 
ThT fluorescence assay was used to analyze the presence of extended β-sheet assemblies for 
the peptide dissolved in aqueous solutions30. Peptide samples were dissolved in an aqueous 
solution of ThT so that the final concentrations in each sample were 25 μM ThT and 0.25-30 
mg/mL of peptide acetate. The peptide acetate solutions were prepared by dilution in 
water/buffer from a stock solution of 60-100 mg/mL and left to equilibrate at 4°C 24 hour 
unless otherwise stated. Fluorescence intensity was recorded for 100 μL aliquots placed into 
sample well plates using a Molecular Devices SpectraMax M5 fluorimeter equipped with a 
plate reader. Samples were excited at 440 nm, and fluorescence intensity was recorded at 482 
nm, using a 25 μM ThT solution in water/buffer as a blank.  




The fluorescence intensity values reported were average of three recordings obtained for 
triplicate sample preparations. The error bars displayed in the ThT binding plots were obtained 
from the standard deviation between three measurements of the sample. 
 
2.6.7   Turbidity assay 
Peptide samples prepared in solvents (section 2.2.1, 2.2.6 and 2.2.7) were analyzed at 500 nm 
post equilibration for 24 hours at 4°C. Absorbance measurements were performed at 500 nm 
for 100 μL aliquots placed into sample well plates using a Molecular Devices SpectraMax M5 
fluorimeter equipped with a plate reader.  
 
2.6.8   Transmission electron microscopy (TEM)  
Aqueous peptide solutions (15 µL drops) were adsorbed on carbon-coated Formvar 200-mesh 
copper grids (ProSciTech, Australia), successively deposited on water (3 times) and 2% uranyl 
acetate solution for one minute each. Excess liquid was removed using filter paper, and the grid 
was left to air dry for a few hours before imaging. The grids were examined using an FEI 
Morgagni 268D transmission electron microscope operating at 80 kV, with magnifications up 
to 180k. Micrographs were captured with a SIS/Olympus megapixel III digital camera mounted 
on a phosphor screen. ImageJ version 1.3 was used to analyze the TEM micrographs and 
perform measurements on the nanostructures imaged31. To reduce high and low frequency 
noise components and enhance the difference between the background and sample, a 2 nm to 
20 nm band-pass filter was applied to the raw micrographs. Measurement of the extended 
nanostructures was done using the analyze tool: the scale on the micrograph was set using the 
set scale tool to the nanometer. The measurement was performed using the measure tool by 
drawing the line across the length and width of the nanostructure32.  
 




2.6.9   Small angle X-ray scattering (SAXS) 
Small angle X-ray scattering was carried out at the Australian Synchrotron Radiation Facility 
(AS, Clayton, Australia) on the SAXS/WAXS beamline operated at 12 KeV using sample 
detector distances of 0.5 to 1 m depending on the experiments. Samples of the peptide acetate 
were prepared in solvents (Table 1.1) at 5% and 10% concentration (w/w) at room temperature. 
The samples were then transferred into 1.2-1.3 mm glass capillaries (Mark-Röhrchen für 
röntgenographische Aufnahmen) supplied by Capillary Tube Supplied Ltd. Cornwall (U.K.).  
 
Calculated amounts of the sample were pipetted at the top of the capillary and centrifuged at 
4000 rpm for 2 minutes to get the sample to the bottom of the capillary tube. The top of the 
capillary was sealed by applying hot melted wax and subsequent air drying. The sample 
capillaries were introduced into a capillary holder accommodating 20 capillaries. The 
diffraction patterns were recorded for a reciprocal spacing q (Å-1) from 0.02 to 2.1 Å-1 using a 
Dectris-Pilatus detector (1 M, 170 mm x 170 mm, effective pixel size, 172 µm x 172 µm) and 
recorded via a CCD (chip charged-coupled device). The momentum transfer q = 4π(sinθ/λ), 
where 2θ was the scattering angle and λ, the monochromatic X-ray beam wavelength of 0.15 
nm was used33.  
 
The scattering profile of the solvent and buffer was recorded and used for background 
subtraction. Data reduction and subtraction were performed using the ScatterBrain software 









2.6.10   Fourier transform infrared spectroscopy (FTIR)  
Attenuated total reflectance (ATR) Fourier transform infrared spectra were collected at the 
Australian Synchrotron infrared microspectroscopy beamline, Melbourne (AS, Clayton, 
Australia). The vibrations of the molecular bonds resulting from absorption of infrared 
radiation passed through the sample were recorded as a spectrum that represents absorption as 
a function of wavenumbers35,36. For analysis of peptide secondary structure conformation: the 
amide I vibrations37,38 were analyzed for β-sheet content39. 10% (w/w) samples of the peptide 
acetates in water and a small pellet of KBr standard (used for background subtraction) were 
placed between two diamond windows of a micro compression cell (Thermo Fisher Scientific, 
Waltham, MA, USA). The samples were measured at 4 cm-1 resolution using a Bruker V80v 
FT-IR spectrometer combined with a Hyperion 2000 focal plane array IR microscope fitted 
with a liquid nitrogen cooled narrow band mercury cadmium telluride (MCT) detector. Data 
was collected in transmission mode with a microscope aperture defined measurement area of 
5 µm x 5 µm on the sample in the mid-infrared spectral range between 4000-700 cm-1.  
 
The sample spectra obtained from an average of 64 scans and water signal was removed by 
subtraction of pure water spectrum. The Bruker OPUS 7.2 software was used for the spectral 
analysis and calculation of the second derivative using a 9 to 15 point Savitzky-Golay filter. 
 
2.6.11   Dynamic light scattering (DLS) 
DLS measurements were performed on a Malvern Zetasizer Nano Ne Laser operated at 173° 
backscatter. The Zetasizer software version 3.0 from Malvern was used to collect and analyze 
the data. Five hundred µL of sample were measured in a disposable single use polystyrene half-
micro cuvettes (Thermo Fischer Scientific) with a path length of 10 mm, at a controlled 
temperature of 25°C.  




For three replicates of the sample, 10 runs of 10 s each were performed with three repetitions. 
The intensity size distribution, Z-average diameter and polydispersity index (PDI) were 
obtained from the autocorrelation function using the “protein analysis mode” for both peptides 
and peptide-protein mix. The error bars displayed in the DLS graph were obtained from the 
standard deviation between three measurements of the sample and data presented as % intensity 
vs. size distribution histogram40.  
 
2.6.12   Analytical ultracentrifugation (AUC) 
AUC analysis was performed using a Beckman Optima XL-A analytical ultracentrifuge. 
Sample volumes of 380 µL were loaded onto the analytical ultracentrifuge cells with a six-
channel carbon-filled epon centerpieces, to give a column height of 1.83 mm. The samples 
were first centrifuged at 5000 rpm in a Beckman Optima XL-A analytical ultracentrifuge using 
a Beckman An60-Ti analytical rotor. Solute distributions were recorded using absorption optics 
at a wavelength of 280 nm. When the sedimentation equilibrium was reached, the rotor speed 
was increased to 30,000 rpm and rotor temperature maintained at 5°C. The buffer viscosity and 
frictional ratios were calculated using the Sednterp software41.  
 
Sample preparation: Samples of hPrx3 protein WT and muteins stored at -80°C were thawed 
at room temperature. The protein sample was dialyzed into Hepes, NaCl, pH 8.0 buffer with 
TCEP overnight at 4°C (section 2.5.7.2). The protein sample was centrifuged at 5000 rpm for 
5 minutes and subsequently filtered through a 0.22 µ filter. The filtered samples were subjected 
to AUC described above. The protein-peptide mix prepared as described in section 2.5.9. The 
samples were centrifuged at 5000 rpm for 2-3 minutes before loading onto AUC cells.  
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3   Chapter three 
 
Self-assembly of peptides derived from protein-β interfaces 
 
3.1   Introduction 
Biomolecular building blocks such as peptides are promising as molecular tectons assembling 
into a range of different nanostructures in solution. Their small size and chemical diversity 
make them highly desirable for designing nanopatterns for different applications such as 
bioelectronics, biosensors, and medical technology1. The design of stable peptide tectons is 
challenging. Choosing a natural source for designing self-assembling sequences gives the 
advantage that some properties of the parent molecule can be retained.  
 
Peptides were designed based on protein interfaces in an attempt to create peptide tectons that 
retained some of the useful self-assembling properties of the natural interface. Proteins have a 
natural ability to self-assemble into hierarchical complexes as part of their function2. Many 
such complexes can associate and dissociate in a reversible manner in response to a biological 
trigger3. Such assembly of proteins is driven through protein-protein interfaces that can interact 
with each other in a reversible manner4. High-resolution crystal structures of such protein 
interfaces show interface sequences in noncovalent close contacts. It was thus hypothesized 
that the corresponding isolated protein interface sequences could serve as a source of peptide 









3.2   Design models for peptide tectons 
Peptide tectons are simple, short sequences that can spontaneously self-assemble into well-
ordered nanoscale structures5. The different peptide sequences known to self-assemble to date 
belong to a limited group of biologically inspired sequences, as described in chapter one. New 
sources of design will thus widen the library of self-assembling sequences and provide for 
specific downstream applications in bionanotechnology. To explore the protein-protein 
interface sequences as a design source for novel self-assembling tectons, simple protein homo-
interfaces were chosen. The simple β-continuous protein interface is reported to be present in 
more than 10% of solved protein homo-oligomers4,6. Such interfaces exhibit two identical β-
strands from the two interacting protein units arranged in an anti-parallel manner in 
noncovalent close contact.  
 
A survey of more than eight hundred entries in the protein data bank (PDB) for protein 
homomers performed by Dr. Céline Valéry (R.M.I.T University; Victoria, Australia) was 
downsized to 20 structures based on the following unbiased criteria: (i) selection of native 
homo-oligomers with β-continuous interfaces, excluding structures with ligands and co-
factors, to limit complexity of the set of interactions involved; (ii) excluding fragmented and 
complex interfaces, that were comprised of multiple interacting motifs; (iii) selection of only 
one representative interface from the families of proteins with high sequence similarity, to 
ensure sequence variety and a valid test of the hypothesis.  
 
Statistical analysis performed by Dr. Valéry on the set of structures using the PDBe PISA 
online tool (EMBL) for selection of final sequences generated details of protein-protein 
interfaces (Figure 3.1).  
 





Figure 3.1: Models of protein homo-oligomers: Crystal structures (X-ray crystallography) for 
A, B, and C and solution structure (NMR) for D. Red region highlights the interface contacts 
identified by the PISA software. (A) Bovine peroxiredoxin 3 (Prx3) homo-dodecamer (PDB: 
1ZYE) (zoomed into the homodimer interface); (B) Bovine β-lactoglobulin (β-Lac) homodimer 
(PDB: 2Q39); (C) M. tuberculosis diaminopimelate decarboxylase (DAPDC) homo-tetramer 
(PDB: 2O0T) (zoomed into the tetramer interface); (D) E. coli UmuD’ homodimer (PDB: 
1I4V). 
 
Analysis of protein interface sequences showed that 90% of the sequences contained eleven or 
fewer residues, with 80% of them having at least one aromatic amino acid residue, almost all 
having 30% hydrophobic residues and 15% charged residues. 




3.3   Peptide sequences investigated for self-assembly 
The final set of selected peptide sequences were 7-8 residues long and corresponded to the β-
continuous interface of the following protein homo-oligomers: (i) the bovine Prx3 homodimer 
within the dodecamer toroid7; (ii) the bovine β-Lac homodimer8,9; (iii) M. tuberculosis DAPDC 
homotetramer10; (iv) the E.coli UmuD' protein homodimer11. All the corresponding protein 
oligomers have been identified in solution, except for the M. tuberculosis DAPDC tetramer 
that is reported only in the crystal structure12.The peptide sequences were capped at both ends: 
the N-terminus acetylated and the C-terminus amidated, to conserve the overall charge of the 
interface sequence. These peptides or similar sequences have not been earlier studied for self-
assembly under any conditions, except for a β-Lac motif similar to the β-Lac peptide that was 
reported to self-assemble under reducing conditions in the presence of urea13. Table 3.1 
presents the different design sources, corresponding β-interface sequences and their properties 
as calculated using the peptide property calculator {http://pepcalc.com/ (Innovogen, Sweden)}. 
 












































3.4   Characterization of peptide sequences in solution  
Inspection of the peptide sequences using the peptide property calculator {http://pepcalc.com/ 
(Innovogen, Sweden)} showed that all of the four sequences have approximately 40% of 
residues that are hydrophobic. The distribution of hydrophobic residues and polar or charged 
residues within the peptide sequence highlighted their amphipathic nature that is consistent in 
all four peptide sequences. Amphipathic peptide sequences composed of alternating polar and 
non-polar residues show a strong tendency to self-assemble into extended amyloid-like 
fibrils14,15. 
 
The peptides were synthesized as a freeze-dried powder (acetate salts) to > 95% purity as 
judged by MALDI-TOF (Mimotopes Ltd., Sydney, Australia). Peptide acetate solutions were 
prepared by dissolving the lyophilized powder in Milli Q water (w/w) and incubated at 4°C for 
24 hours (Section 2.5.8). The peptide acetates were soluble in water at dilute concentrations in 
the 0.25-2.5 mg/mL range for peptide 1 and peptide 2, ≥ 10 mg/mL for peptide 3 and ≥ 20 
mg/mL for peptide 4. The pH of the peptide acetate samples recorded was ~ 5.0. Peptide 
acetates prepared in non-polar solvents: HFIP, TFA, and methanol at room temperature, 
however, were clear solutions with no residual particulate matter. This suggested that upon 
exposure to hydrophilic environments, the hydrophobic effects favor the burying of peptide 
surface to minimize solvent exposed surface area and drive peptide aggregation. This 
mechanism of self-assembly has been previously described for amphipathic β-sheet forming 
peptides and short peptides with a substantial number of hydrophobic residues in the 
sequence14,16.  
 
Turbidity assays were performed to assess the extent of peptide aggregation in solution. Peptide 
acetates incubated in water and polar solvents in the 10-40 mg/mL range were examined at 500 




nm (section 2.6.7). Peptide acetates in water exhibited an increase in turbidity of the peptide 
solution, which can be attributed to the peptides self-assembled in solution17,18. No such change 
was, however, observed for the peptide acetates dissolved in HFIP or TFA or methanol.  
 
Specific dyes such as ThT that show enhanced fluorescence on binding to amyloid-like 
assemblies provide a reliable way to test for confirmation and estimation of the specific 
assembly of peptides into extended β-sheet based structures19. Furthermore, ThT is soluble in 
water and many physiological buffers and does not interact with molten globule, unfolded 
states and amorphous aggregates of protein20,21. Thus, ThT binding assays provided a reliable 
way for detection and estimation of self-assembly of the peptides in solution. Samples of 
peptide acetates in water prepared at concentrations of 10-50 mg/mL mixed with ThT dye 
exhibited strong ThT binding (section 2.6.6), which suggested the presence of extended β-sheet 
based structures consistent in all the four cases (Figure 3.2).  
 
For peptide acetate samples prepared by direct mixing of lyophilized peptide acetate powder 
with undiluted HFIP or TFA or methanol, no substantial ThT binding was observed. 
Conversely, peptide acetates prepared in dilute methanol solution (5%, 10% and 15% methanol 
in water) exhibited ThT binding, though to a lower extent than that observed for peptide 
acetates in water.  
 





Figure 3.2: ThT binding assays by dilution for peptide acetates: Fluorescence intensity values 
recorded immediately after dilution for Prx3 peptide, β-Lac and UmuD’ peptides is fitted to 
the least squared linear function y = B + Ax + Ax2 and the ThT data for DAPDC peptide is 
fitted to the sigmoid growth function y=B + (A + B)/(1 + e(x-x0)/dx)).The error bars correspond 
to the standard deviation between triplicate sample preparations. 
 
Samples of the peptide acetates were examined by transmission electron microscopy (TEM) to 
confirm fibril formation (section 2.6.8). TEM of negatively stained specimens allows 
visualization of extended assemblies such as amyloid-like fibrils at a high resolution in the 
dried state22. To enhance the resolution and contrast of the image for better quality, samples of 
the peptide acetates were centrifuged to pellet the peptide aggregates and subsequently treated 
with 3% glutaraldehyde23,24. TEM of peptide acetates in water adsorbed onto EM grids 
immediately after dilution revealed ordered nanostructures consistent for all four peptides 
(Figure 3.3).  





Figure 3.3: Representative TEM micrographs of peptide acetates in water:(A) Prx3 peptide in 
water at 40 mg/mL, (B) β-Lac peptide in water at 40 mg/mL, (C) DAPDC peptide in water at 
60 mg/mL, (D) UmuD’ peptide in water at 100 mg/mL. TEM micrographs correspond to the 
peptide acetate samples prepared immediately after dilution. (Scale bar is 200 nm) 
 
For, peptide acetate samples prepared in 100% HFIP or TFA or methanol, no such extended 
assemblies were observed. These results suggested that the self-assembly of the peptide into 
extended ordered nanostructures is favored under hydrophilic conditions. It is important to note 
that the hierarchical structure of the peptide assemblies is stabilized by a large number of 
noncovalent intermolecular interactions as well as intermolecular peptide-solvent contacts. 
Also, the major driving force behind folding of proteins and peptides is posited to result from 
hydrophobic effect or hydrophobic free energy25. Earlier de novo designs of self-assembling 
β-sheet forming peptide sequences highlight that residues such as isoleucine (I), tyrosine (Y), 




tryptophan (W), valine (V) and threonine (T) are good β-sheet formers providing the necessary 
set of hydrophobic interactions alongside the backbone hydrogen bonding26,27.  
 
Aromatic amino acid residues in short peptide sequences are known to be involved in aromatic 
stacking through π-π interactions. Short peptide sequences comprised of 5-7 residues 
containing a single phenylalanine residue self-assembled into amyloid fibrils, similar to those 
formed by full-length polypeptides28,29. Replacement of the phenylalanine residue in the 
peptide sequence severely impacted the ability of the peptide to self-assemble30.  
 
Interestingly, all four peptide sequences investigated for self-assembly here have at least one 
isoleucine residue; valine was present in two out of four peptides, and threonine was present in 
one out of four peptide sequences. Both β-Lac peptide and the DAPDC peptide contained one 
phenylalanine residue. The presence of specific residues that promote the β-sheet formation 
and peptide aggregation explains the intrinsic ability of the designed peptide sequences to self-
assemble in solution.  
 
3.5   Characterization of peptide self-assembly in solution  
Peptide acetates were soluble in the organic solvent (HFIP), acid (TFA) and polar solvent 
methanol + water mix and at low concentrations in water. Concentrated peptide acetate 
solutions at 10 mg/mL for Prx3 peptide and β-Lac peptide, 20 mg/mL for DAPDC peptide and 
40 mg/mL for UmuD’ peptide prepared in deionized water were found to gel if stored at 4°C 
over 24 hours. Above 5% w/w (50 mg/mL) for Prx3 peptide and β-Lac peptide, and above 15% 
w/w (150 mg/mL) for DAPDC peptide and UmuD’ peptide, the peptide acetate in water formed 
highly viscous hydrogels (Figure 3.4).  
 





Figure 3.4: Concentrated peptide acetate salts in water: Prx3 peptide and β-Lac peptide at 60 
mg/mL (A and B) and DAPDC peptide & UmuD’ peptide at 200 mg/mL (C and D) equilibrated 
for 24 hours at 4°C. The picture shows viscous hydrogels formed by self-assembly of peptide 
acetates in water. Prx3 peptide and β-Lac peptide formed highly turbid hydrogels that suggest 
an extensive network of fibrillar assemblies. 
 
Gelation is usually associated with water confinement by fibrillar objects that reticulate the 
media17. Turbidity is an indicator of aggregation, more specifically in the case of peptides a 
representative of the molecular-associated states as observed upon fibrillation in amyloid 
fibril31 and in the natural self-assembly of type I collagen18. Macroscopic fibrillar assemblies 
of self-assembling β-sheet type peptides show liquid crystallinity under cross polarizers32. 
Therefore, peptide acetates in water in the 20-200 mg/mL range were examined by light 
microscopy. All four peptide sequences exhibited birefringence under cross-polarizers with 
clear liquid crystalline textures (Figure 3.5). 





Figure 3.5: Birefringence of peptide hydrogels observed under polarized light with the cross-
polarizers at (± 45°). Optical textures of square columnar phase observed for Prx3 peptide at 
20 mg/mL and hexagonal columnar phases observed for the β-Lac peptide (20 mg/mL), 
DAPDC peptide and UmuD’ peptide at 200 mg/mL in water conditioned between two glass 
slides. The arrows point to one of the highest points of curvature of the specific textures. 
 
The liquid crystallinity of biological molecules is dependent on their arrangement in a repetitive 
manner aligned over a long distance, which brings about the elasticity and mechanical strength. 
Liquid crystals have been earlier reported for reversibly self-assembling peptides33,34 and this 
makes them different to amyloid fibrils which are insoluble precipitates. The formation of 
liquid crystal phases by peptide sequences prone to fibrillate is found to be dependent on the 
concentration of the peptide, fibril length, pH, and temperature35,36.  




To study the structural organization of the peptide sequences that led to gelation, the peptide 
acetates in water at dilute concentration were analyzed for secondary structure conformation. 
Circular dichroism of peptide acetate samples in water equilibrated for over 24 hours exhibited 
a minimum around 215-220 nm, suggestive of a β-sheet conformation3 in each case (Figure 
3.6).  
 
Figure 3.6: Far UV circular dichroism spectra of peptide acetates in water at 0.008 mg/mL: 
(A) Prx3 peptide; (B) β-Lac peptide; (C) DAPDC peptide; (D) UmuD’ peptide. The peptide 
acetate in water samples was equilibrated for 24 hours at 4°C and degassed before analysis. 
 
3.6   ThT binding assays  
ThT is a benzothiazole dye known to exhibit enhanced fluorescence intensity in the red region 
of the visible spectrum (~ 482 nm) upon binding to β-sheet assemblies38. Peptide acetates in 
water in the 20-100 mg/mL range examined immediately after preparation and at 24 hours after 
equilibration at 4°C, exhibited strong ThT binding (Figure 3.7). This suggested that the 
macroscopic assembly of the peptides in solution were extended β-sheet based structures.  





Figure 3.7: ThT binding assays by dilution for peptide acetates in water at 10 mg/mL recorded 
immediately after dilution and for samples equilibrated for 24 hours 4°C. The error bars 
correspond to the standard deviation between triplicate sample preparations. 
 
ThT binding assays performed by dilution of the peptides from an initially concentrated sample 
(24 hours old) showed that extended β-sheet structures dissociate upon dilution as indicated by 
the decrease in ThT fluorescence intensity. ThT binding curves were obtained by plotting the 
derivative (dt/dc) calculated as the ThT fluorescence intensity per mg of peptide in solution 
versus peptide acetate concentration (mg mL-1). Two out of the four peptide acetates, the Prx3 
peptide, and the β-Lac peptide exhibited a linear derivative curve suggestive of a single state 
that corresponded to the self-assembled extended β-sheet form of the peptides. The sigmoid 
growth type derivative curve obtained for the DAPDC peptide and UmuD’ peptide, however, 
was suggestive of a two-state self-assembly process with the presence of a critical 
concentration of assembly (Figure 3.8).  





Figure 3.8: ThT binding assays by dilution for peptide acetates: Fluorescence intensity values 
recorded 24 hours after dilution for samples equilibrated for 24 hours. The derivative of Prx3 
peptide and β-Lac peptide fitted to linear function y = Ax +B. The derivative of DAPDC peptide 
and UmuD’ peptide fitted to sigmoid growth function y=B + (A + B)/(1 + e(x-x0)/dx)). The error 
bars correspond to the standard deviation between triplicate sample preparations. 
 
In the case of DAPDC peptide, the peptide acetate in water at > 20 mg/mL, showed large 
variation in ThT binding measurement, hence was not included in the results. This could be 
attributed to the increase in macroscopic viscosity of the peptide acetate solution resulting from 




the increase in peptide self-assembly into large extended β-sheet structures at high 
concentration. At concentrations < 15 mg/mL for DAPDC peptide, the steep decline in ThT 
binding suggested a state of transition between the self-assembled β-sheet state to the smaller 
prefibrillar aggregates39.  
 
3.7   TEM characterization of peptide assembly 
To study the morphology of the β-sheet rich peptide assemblies in solution, peptide acetates in 
water in the 40-200 mg/mL range were observed under transmission electron microscope 
(Section 2.6.8). TEM of negatively stained EM grids of the peptides, revealed that all four 
peptides self-assembled into nanostructures with extended morphology: nanotapes for Prx3 
peptide, bundles of nanofibrils for β-Lac peptide and individual fibrils for DAPDC peptide and 
UmuD’ peptide (Figure 3.9). 
 
Figure 3.9: Representative TEM micrographs of (A) Prx3 peptide in water at 40 mg/mL, (B) 
β-Lac peptide in water at 40 mg/mL, (C) DAPDC peptide in water at 200 mg/mL, (D) UmuD’ 
peptide in water at 100 mg/mL equilibrated for 24 hours. (Scale bar is 200 nm) 




Measurement of nanostructures performed using ImageJ software showed that the extended 
nanotape like assembly of Prx3 peptide was 8-40 nm wide and of varied lengths between 0.8 
to 2 µm (Figure 3.10). 
 
Figure 3.10: TEM micrographs of Prx3 peptide in water at 40 mg/mL (A). The white arrows 
point to the different peptide fibril polymorphs. Histogram showing the distribution of fibril 
width (B) collected from 308 particles respectively. (Scale bar is 100 nm) 
 
The broad distribution of nanotape width observed suggested that the Prx3 peptide self-
assembled into polymorphic nanotapes. Most of the nanostructures spanned across the imaged 
cross-sectional area of the EM micrograph, which suggested that the observed nanostructures 
were much larger in length than the estimated values. Polymorphism has been previously 
described for amyloid fibrils40,41 and amyloid-like fibrils formed by β-sheet type peptides42.  




Bundles of nanofibrils of β-Lac peptide were on an average 2 µm in length. (Figure 3.9 B). 
DAPDC peptide fibrils were between 0.6-1.5 µm in length (Figure 3.9 C) however, fibrils of 
UmuD’ peptide were much smaller, with a length distribution between 0.2-1.0 µm. Fibrils with 
a length larger than 1 µm were uncommon with only a few seen spanning across the imaged 
micrograph cross-sectional area (Figure 3.9 D). The peptide fibrils for both DAPDC peptide 
and UmuD’ peptide were 4-10 nm in width. The distribution of width observed in the case of 
the peptides can be explained by the intertwining of fibrils that form a thick bundle of fibrils.  
 
3.8   Characterization of peptide self-assembly at alkaline pH 
Amino acid residues such as histidine contain ionizable imidazole side chain group with a pKa 
of 6.0. To investigate the effect of a change in the protonated state of the histidine side chain 
in the self-assembly of the peptides, they were studied at alkaline pH. CD spectra of peptide 
acetates dissolved in imidazole buffer at pH 8.5 were found to be similar to those observed for 
peptide acetates in water at ~ pH 5.0 with the characteristic minimum around 215-230 nm 
(Figure 3.11). 
 
The circular dichroism spectra of the peptide acetates observed were in agreement with the 
different studies published on peptide sequences that self-assemble into β-sheets. Also, 
theoretical studies on the optical properties of α-helices and β-sheets observed in solution have 
shown that the negative minimum that is consistent with an n to π* transition is observed for 
β-sheets in the 215-230 nm wavelength range43. The result thus suggested that change in the 
protonated state of histidine as a function of pH does not have a substantial effect on the 
secondary structure conformation of the peptide sequences in solution. 
 





Figure 3.11: Overlaid CD spectra of peptide acetates :(A) Prx3 peptide; (B) β-Lac peptide; 
(C) DAPDC peptide; (D) UmuD’ peptide in water (pH 5.0) and in 100 mM imidazole (pH 8.5) 
at 0.008 mg/mL. The peptide acetate samples were equilibrated for 24 hours at 4°C and 
degassed before analysis. 
 
TEM analysis of peptide acetates in imidazole pH 8.5 in the 20-100 mg/mL range revealed 
self-assembled peptide nanostructures similar to those observed for the peptides in water 
(Figure 3.12 and 3.13 panel 1). Dilute samples of the peptide acetate in imidazole at 1.0 mg/mL 
for Prx3 peptide and β-Lac peptide, 10 mg/mL for DAPDC peptide and 20 mg/mL for UmuD’ 
peptide revealed nanostructures of much smaller dimensions, consistent with the peptide 
acetate in water samples (Figure 3.12 and 3.13 panel 2). 





Figure 3.12: TEM micrographs of peptide acetates Prx3 and β-Lac in 100 mM imidazole pH 
8.5 (A,C) and in water (B,D) equilibrated for 24 hours. Numbers correspond to peptide 
concentration at 20 mg/mL (1), 1 mg/mL (2) and 0.01 mg/mL (3). (Scale bar is 200 nm) 
 
At the most diluted state; 0.01 mg/mL for Prx3 peptide and β-Lac peptide, 1 mg/mL for 
DAPDC peptide and UmuD’ peptide in imidazole buffer, no such extended nanostructures 
were observed (Figure 3.12 and 3.13 panel 3). This suggested the dissociation of extended 
nanostructures upon dilution, consistent with ThT binding assays.  
 





Figure 3.13: TEM micrographs of peptide acetates DAPDC and UmuD’ in 100 mM imidazole 
pH 8.5 (A,C) and in water (B,D) equilibrated for 24 hours. Numbers correspond to peptide 
concentrations  at 50 mg/mL (1), 10 mg/mL (2), 1 mg/mL (3) for DAPDC peptide and 100 
mg/mL (1), 20 mg/mL (2) and 1 mg/mL (3) for UmuD’ peptide. (Scale bar is 200 nm). 
 
3.9   Small angle X-ray scattering of peptides  
The molecular architecture within the extended nanostructures formed by peptides in solution 
was examined by SAXS. Concentrated sample of the peptide acetates in water in the 100-200 
mg/mL range was analyzed at the SAXS beamline at the Australian Synchrotron Facility 
(Section 2.6.9). The scattering profile obtained by plotting the log of the SAXS intensity (A.U.) 
versus the q value (Å-1) exhibited a distinct peak at 1.3 Å-1 consistent for all the peptides (Figure 
3.14).  





Figure 3.14: SAXS patterns recorded at room temperature for peptide acetate in water: (1) 
Prx3 peptide; (2) β-peptide; (3) DAPDC peptide; (4) UmuD’ peptide. The dashed red line 
shows the reflection at 1.3 Å-1 visible for all the peptide sequences. 
 
The presence of Braggs reflection at q = 1.3 Å-1 equates to the real space distance of ~ 4.8 Å  
(d = 2π/q), which corresponds to the characteristic β-sheet intra-strand distance44. This 
suggested that the peptide self-assembled in solution to form extended β-sheet based 
assemblies. The high intensity of the peak indicated that this distance corresponded to the 
repetitive distance in the extended intermolecular network of β-sheets.  




X-ray scattering studies on short peptides designed from motifs within proteins associated with 
amyloidosis, show characteristics meridional reflections at q value = 1.3 Å-1 and correspond to 
the hydrogen bonding distance in the β-sheet45,46. The lesser defined reflections observed at low 
angles > 0.5 Å-1 was attributed to the diffused scattering of the samples. Such SAXS patterns have been 
previously described in the case of the fibril forming neuropeptide somatostatin-1447 and are thought to 
arise from the anisotropic form factor of fibrillar nanostructures perpendicular to the fibril axis48. 
Overall, the SAXS data showed that the peptide sequences self-assembled in solution into extended β-
sheet based nanostructures that are similar in their molecular organization.  
 
3.10   Discussion 
The use of peptide tectons to produce molecular biomaterials with specific properties that allow 
control over self-assembly is central to bionanotechnology. Different self-assembling peptide 
sequences designed to date have largely focused on a limited set of sequences of biological 
origin. This research work aimed to introduce a new design source of peptide sequences that 
self-assemble in solution.  
 
Peptide sequences, were designed from simple protein-β interfaces of four different classes of 
protein homo-oligomers and investigated for self-assembly. All the peptide sequences in water 
formed birefringent hydrogels, with distinct liquid crystalline textures. The gelation of peptide 
acetate solutions was consistent with higher order assembly of the peptides. Birefringence 
observed for the peptide hydrogels was suggestive of the nematic phase of the liquid crystalline 
assemblies. The nematic liquid crystal phase is characteristic of molecules with a definitive 
order or pattern49,50. Electron microscopy revealed that all peptide sequences self-assembled 
spontaneously in solution into nanostructures with elongated morphologies. Such elongated 
nanostructures fall within the range of different morphologies described previously for β-sheet 
type self-assembling peptides51.  




EM further showed that the extended nanostructures formed by Prx3 peptide exhibited 
polymorphism. Polymorphism is reported to be an inherent property of amyloid fibrils 40,41,52, 
with such differences thought to arise due to the different ways of association and packing 
mode of building block units51. In a recently published work, MAS NMR coupled with cryo-
EM reconstruction showed that the polymorphic fibrils formed by peptide sequences derived 
from transthyretin protein comprised of β-sheets organized as two, three or four sheets laterally 
associated through terminal side-chain interactions in the extended nanoribbon architecture42. 
This can explain the type of distribution of nanotape width measured for the Prx3 peptide.  
 
The intertwining of peptide nanoribbons and nanofibrils observed in the case of Prx3 peptide 
and DAPDC peptide could be attributed to the twisting of the protofilament to minimize 
exposure of hydrophobic patches, as earlier described for fibrillization of amyloid Aβ peptide53, 
α-synuclein54 and insulin55. The periodicity of intertwining observed in the extended peptide 
nanostructures can be explained by the balance between the mechanical forces dominated by 
the elasticity of the protofilament and the electrostatic interactions arising from the distribution 
of hydrophobic and charge residues53.  
 
The four peptide sequences in water under dilute concentration exhibited the expected 
propensity for β-sheet secondary structure conformation37. For concentrated peptide hydrogels, 
the distinct Braggs reflection centered on q value = 1.3 Å-1 consistent in all peptide acetates 








The extended β-sheet networks in all the four cases were found to dissociate upon dilution as 
suggested by the ThT binding assays for dilute peptide acetate in water solutions. Derivative 
of ThT fluorescence intensity to peptide acetate was used to predict the self-assembly models 
ThT derivative Furthermore, absence of a linear distribution parallel to the x-axis for the ThT 
derivative plots suggested that the decrease in ThT fluorescence intensity is not an effect of 
dilution but due to the dissociation of the peptide β-sheet structures. Reversibility of assembly 
has been previously described for some peptide sequences47,58,59. In the case of UmuD’ peptide, 
the β-sheet assemblies estimated by ThT binding assays were found to be much smaller in 
length compared to the other three peptides as shown by TEM. The ThT assay further suggested 
a higher critical assembly concentration for the DAPDC peptide compared to the other 
peptides.  
 
Interestingly, the ThT results correlated well with the type of oligomer interface from which 
the peptides were designed. The Prx3 peptide, the β-Lac peptide and the UmuD’ peptide 
correspond to the homodimer interface of the protein, with the Kd of the homodimer interface 
reported to be in the micromolar range for both Prx360 and β-Lac61, and in picomolar range for 
E. coli UmuD’protein62. It is important to note that in the high-resolution NMR structure of the 
UmuD’ homodimer, hydrophobic pockets can be seen present near the protein homodimer β-
interface. The hydrophobic interactions along with steric effects arising from neighboring 
residues along the interface favor the formation of the protein homodimer at a much lower 
concentration in solution11. In the isolated form (UmuD’ peptide), however the peptide 
sequence is not able to reproduce the full properties of the interface motif, which explains the 
relatively higher critical assembly concentration observed for the UmuD’ peptide.  
 




The DAPDC peptide corresponds to the homotetramer interface of M. tuberculosis DAPDC 
protein that is still under debate, though posited to exist at very high concentrations within the 
protein crystal10. The, Kd of the interface is still disputed but thought to be in the micromolar 
range12, which explains the higher critical assembly concentration observed for the DAPDC 
peptide. The results shown here supports the connection that the derived peptide sequences are 
tectons with intrinsic assembly properties derived from the native parent interfaces.  
  
This work introduces a new design source for peptide tectons and adds to the current library of 
self-assembling β-sheet type peptide sequences. Such peptides inspired from naturally 
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4   Chapter Four 
 
Alteration of Prx3 protein-β interface peptide by sequence modification  
 
4.1   Introduction 
Self-assembling peptides have shown much promise as molecular tectons for different 
applications in bionanotechnology such as metal templating, biomineralization, biosensing, 
drug amphiphile for targeted drug delivery and for fabrication of nanodevices. For many of 
these applications, tuning, and control of the self-assembly process is highly desirable. Subtle 
sequence changes such as peptide net charge variation1,2 or change in 
hydrophobicity/aromaticity3 and varied sequence pattern4 have been shown to affect the self-
assembly properties of peptide sequences.  
 
Many studies have pointed out the significance of solution pH and hence the net charge 
distributions on the self-assembly of varied peptide sequences. Caplan et al. (2000) showed 
that the oligopeptide KFE12 self-assembled into extended β-sheets only upon neutralization of 
excess charge. The author reported that the self-assembly of the peptide occurred when the 
intermolecular electrostatic repulsive forces were below van der Waals attractive forces5. In a 
subsequent work, the author showed that rational alteration of charged residues and the number 
of repeat units in the oligopeptide can be used to trigger the peptide to self-assemble under 
physiological salt concentration and pH6. In another study, Lopez et al. (2002) reported that 
the hexapeptides: KTVIIE, STVIIE and KTVIIT self-assembled into fibrillar structures only 
when the net charge on the peptide is ± 17. Aromatic residues have been known to direct 
amyloid fibril formation in many amyloid inspired peptide sequences through π-stacking and 
aromatic hydrophobic interactions8.  




Different studies published by Gazit & co-workers have highlighted the central role of aromatic 
interactions in the self-assembly of short peptide sequences designed from different 
amyloidogenic proteins9,10. An important example is a hexapeptide -NFGSVQFV- and the 
shorter peptide –NFGSV-, derived from human hormone medin that self-assembled into 
amyloid-like fibrils. Alteration of the phenylalanine residue in the peptide sequences impaired 
the ability of the peptide to self-assemble11. Other examples include the diphenylalanine repeat 
(FF) peptide and phenylalanine oligopeptides inspired from Aβ1-42 associated with Alzheimer’s 
disease self-assembled into a range of structures including nanofibrils, nanowires, and 
nanotubes12,13,14.  
 
Interestingly, there are also self-assembling peptide sequences that are tolerant to subtle 
changes. Examples include the cyclic octapeptide Lanreotide, a synthetic analog of natural 
somatostatin hormone, which is tolerant to modification of lysine to D-lysine and mutation of 
aromatic residues15. In another work, Armstrong et al. (2011) showed that variation of 
phenylalanine residues at position 19 and 20 in the amyloid fibril forming Aβ1-42 that is thought 
be important for self-assembly with leucine or isoleucine rather enhanced amyloid fibril 
formation16. Despite numerous examples that show that small variation in peptide sequence or 
change in the chemistry of the peptide effect peptide self-assembly, it is difficult to predict the 
impact of the change or mutation. Therefore, it is important to consider each peptide sequence 
and the effect of the change on a case by case basis.  
 
4.2   Design strategy for alteration of Prx3 protein-β interface peptide  
From previous studies, it was understood that short peptide sequences designed from protein 
β-interfaces self-assembled into extended amyloid fibril-like structures17. The assembly of such 
peptide sequences was stable over the pH range 5.0 to 8.0 (Chapter 3, Section 3.7).  




In the specific case of Prx3 peptide, designed from the homodimer interface within the bovine 
Prx3 dodecamer18, the histidine residue at the interface was found to be in close contact with 
serine and asparagine residue. Figure 4.1A shows the 3.3 Å resolution crystal structure of the 
bovine Prx3 dodecamer and the homodimer β-continuous interface. Measurement of bonding 
distance performed using pymol (www.pymol.edu) showed that the histidine residue at 
position 136 to be within hydrogen bonding distance to the neighboring serine residue (position 
138) on the same β-strand and valine (position 139) and asparagine residues (position 140) on 
the complementary β-strand (Table 4.1 and Figure 4.1A).  
 
Sequence alignment focused at the homodimer interface of 2-Cys peroxiredoxin 3 from eleven 
different species revealed that the histidine residue at position 136 in the crystal structure of 
bovine Prx3 (PDB 1ZYE) at the interface sequence is highly conserved. Aside from the 
histidine, the three hydrogen bonding partners: valine, asparagine, and serine residues were 
also conserved in all the species except for S. cerevisiae. Figure 4.2 B shows the sequence 
alignment generated using the Uniprot database and the ESPript sequence alignment software 
(http://espript.ibcp.fr).  
 
Table 4.1: Location and bonding distance between histidine and hydrogen bonding partners 
Location Distance between residues 
β9 strand H136 to S138 (3.1 Å ) 
N140 to H136 (2.5 Å ) 
V139 to H136 (3.6 Å) 
β9- β9’ strand 
β9- β9’ strand 
β9’ strand H136 to S138 (3.0 Å ) 
β9’- β9 strand N140 to H136 (2.6 Å ) 
β9’- β9 strand V139 to H136 (3.5 Å) 






Figure 4.1: Crystal structure and sequence alignment of peroxiredoxin 3: (A) cartoon model 
of the ring-shaped dodecamer toriod of bovine Prx3 (PDB:1ZYE). The inset shows the 
placement of the asparagine (N), serine (S) and histidine (H) residues within the homodimer 
protein-β interface and the hydrogen bonding distances are highlighted by black dotted line. 
(B) Sequence alignment of Prx3 from eleven different species (position:135-145) produced 
using Uniprot database and ESpript software, showing the region of high consensus. The black 
dotted box highlights the β-continuous interface sequence. 




The highly conserved positions of the histidine, serine and asparagine residues in the sequence 
making up the protein-protein homodimer interface suggested that they were necessary 
interactions at the interface. Therefore, it was posited that these interactions could be necessary 
for the self-assembly of the isolated peptide sequence derived from the interface (Prx3 peptide). 
 
It is noteworthy that protonation of histidine residue as a function of pH is reported to be 
involved in the self-assembly process of different peptide and protein assemblies19,20,21,22. 
Histidine protonation due to pH change is described in the context of biomolecular switching 
in viral fusion proteins that facilitate the attachment of the virus particle to the host cell 
membrane23. More specifically, the interaction of the proximal histidine residue with hydrogen 
bonding partners such as aspartate and asparagine have been previously described in 
peroxidases and is concerned with important structural differences between non-animal (plant 
type) and animal heme peroxidases and dehydrogenases24,25,26. Carpena et al. (2009) showed 
that the imidazole side chain of histidine can exist in the negatively charged imidazolate form 
which is involved in hydrogen bonding with nearby asparagine and arginine residues in the 
high resolution (2.8 Å) crystal structure of human myeloperoxidase glycoform (hMPOm)24.  
 
In the case of peptides, hydrogen bonding between neighboring histidine and serine residues 
have been noted for peptide sequences that self-assembled into extended β-sheet based 
structures. In a recently published work, Valery et al. (2015) showed that the decapeptide 
triptorelin under alkaline conditions pH > 7.8 adopted a globular conformation in which the 
histidine residue in the peptide is involved in hydrogen bonding to the nearby serine residue 
and also involved in histidine-aromatic interactions. However, under acidic pH, such 
interactions are not present, and the peptide adopted an extended conformation and self-
assembled into bundles of small twisted nanotubes27.  




These studies suggested that protonation and deprotonation of histidine residue is important for 
maintaining the higher order quaternary structure of peptide and protein assemblies. Thus, it 
was hypothesized that change of histidine residue in the Prx3 peptide sequence to a 
hydrophobic residue would limit the probable side chain hydrogen bonding interactions and 
therefore affect the ability of the isolated peptide sequence to self-assemble. 
 
4.3   Variant Prx3 peptide sequences investigated 
To study the effect of a specific sequence change on the self-assembly of the Prx3 peptide, 
hydrophobic variations to the histidine residue were investigated. The histidine residue, at 
position 3 in the Prx3 peptide sequence was replaced with the hydrophobic alanine (A) residue. 
Variation of histidine residue to aromatic tyrosine (Y), and phenylalanine (F) tryptophan (W) 
was performed to study the replacement of imidazole ring side chain with aromatic ring side 
chain. The final set of peptide sequences were seven residues long that corresponded to the β-
continuous homodimer interface within the bovine Prx3 dodecamer18 with variation of 
histidine residue at position 3.  
 
The peptide sequences were capped at both ends: N-terminus acetylated and C-terminus 
amidated, to keep the overall charge on the peptide constant and comparability to the wild type 
peptide. The synthesized variant peptide sequences were obtained from Mimotopes Ltd. 
(Sydney, Australia) as a white lyophilized powder with purity > 95% confirmed by mass 
spectrometry and HPLC as provided by the manufacturer. Table 4.2 shows the parent peptide 
and variant peptide sequences explored in this work and their properties as calculated using the 
peptide property calculator {http://pepcalc.com/ (Innovogen, Sweden)}. The variant peptide 
sequences were named based on the variant residue introduced in place of histidine.  
 



















Ac-IKHLSVN-NH2 9.13 4/3 2.0 0 
H3A Ac-IKALSVN-NH2 9.02 4/3 1.0 0 
H3Y Ac-IKYLSVN-NH2 8.65 4/3 1.0 1 
H3W Ac-IKWLSVN-NH2 9.02 4/3 1.0 1 
H3F Ac-IKFLSVN-NH2 9.02 4/3 1.0 1 
 
4.4   Characterization of variant peptide self-assembly in solution 
From previous results, as described in chapter three (Section 3.4), it was understood that the 
parent peptide is soluble in organic solvents and, in water at low concentrations. Also, the 
peptide sequence self-assembled into extended nanostructures under hydrophobic conditions. 
Therefore, the variant peptide sequences were examined for solubility in organic solvents 
(HFIP, DMSO, and methanol), methanol in water mixes and water. Peptide acetate samples 
prepared as described in chapter two (Section 2.5.8), were found to be soluble in 100% HFIP, 
DMSO, and methanol in the 10 to 100 mg/mL range, similar to the parent peptide sequence.  
 
For peptide acetates dissolved in methanol-water mix at 50%, 25%, 10%, and 5% methanol 
concentration the variant peptide acetates H3A and H3F were found to be less soluble in 25% 
methanol solution at concentration ≥ 5 mg/mL. Peptide acetates H3Y and H3W were, however, 
soluble with no visible change in solution appearance in 5% methanol solution up to 20 mg/mL. 
All the peptide acetates exhibited poor water solubility at dilute concentrations, similar to the 
parent Prx3 peptide, which suggested that the self-assembly of the peptides is favored under 
hydrophilic conditions.  




Peptide acetate samples prepared at higher concentrations of 50 mg/mL for H3A and H3W and 
at 100 mg/mL for H3Y and H3F peptide variants formed turbid hydrogels over time at room 




Figure 4.2: Peptide acetate in water mixes of variant peptides: (A) H3A and (B) H2F at 50 
mg/mL and (C) H3W and (D) H3Y at 100 mg/mL equilibrated for 24 hours at 4°C. The picture 
shows viscous hydrogels formed by self-assembly of variant peptide acetates that suggest an 
extensive network of fibrillar assemblies. 
 
The results suggested that variant peptide sequences behave similarly to the parent peptide 
sequence in solution. It is important to note that solution environment and concentration of 
interacting molecules in solution can affect the subtle equilibrium between the non-assembled 
monomer state and the self-assembled aggregate state. This is explained by the Le Chatelier’s 
principle of general reaction of association, which states that the association and dissociation 
of molecules is a response triggered by the changes in the external solution environment 28,29,30. 
Pressure effects arising from the interaction between water molecules and the exposed 
hydrophilic groups of amino acid residues affect this equilibrium and drive self-assembly31,32.  




Turbid hydrogels analyzed by cross-polarized light microscopy exhibited birefringence, with 
liquid crystalline textures observed for all the four variant peptide acetates in water in the 50 
to 150 mg/mL range (Figure 4.3).  
 
 
Figure 4.3: Birefringence of variant peptide hydrogels observed under polarized light with the 
cross-polarizers at (± 45°). Optical textures of square columnar phase were observed for the 
peptide acetates in water at 50 mg/mL for H3A (A) and H3F (B), 100 mg/mL for H3W and 150 
mg/mL for H3Y, conditioned between two glass slides. The arrows point to one of the highest 
points of curvature of the specific textures. 
 
Birefringence under cross-polarizers is reflective of extended well-ordered assemblies 
consistent with that observed for amyloid-like fibrils33. The presence of liquid crystalline 
textures, consistent with the parent peptide (Chapter 3, Section 3.4) suggested that the variant 
peptide sequences self-assembled into large fibrillar structures in solution34,35. The variant 
peptide sequences exhibited a propensity for β-sheet secondary structure conformation 
consistent with the parent peptide, shown by the minimum at ~215 to 220 nm assigned to the 
β-sheet secondary structure36, for dilute peptide acetates in water analyzed by CD spectroscopy 
(Figure 4.4).  





Figure 4.4: Circular dichroism spectra of variant peptide acetates: (A) H3A and H3Y and (B) 
H3W and H3F in water at 0.01 mg/mL in the far U.V. range (190 - 260 nm).The peptide acetate 
in water samples was equilibrated for 24 hours 4°C and degassed before analysis. 
 
The result suggested that introduction of hydrophobic variation of histidine in the wild type 
Prx3 peptide sequence does not substantially alter the propensity of the peptide to exist in β-
sheet secondary structure conformation. 




4.5   ThT binding assays 
ThT binding assays on the parent Prx3 peptide showed that the peptide self-assembled in 
solution in a reversible manner, as described in chapter 3. Therefore, self-assembly of the 
variant peptides in solution was monitored using ThT fluorescence as a function of 
concentration and time duration. Peptide acetate samples for each of the four peptide variants 
and control parent Prx3 peptide prepared in water (w/w) were recorded at 24 hours after 
equilibration as described in chapter 2 (Section 2.5.6).  
 
All the four variant peptide sequences exhibited strong, though, to a lower extent compared to 
the parent peptide but consistent with the presence in each of the variant peptides of the ordered 
intermolecular β-sheet structures. ThT binding curves generated by plotting the derivative of 
ThT binding (dt/dc) versus peptide acetate concentration (mg mL-1), exhibited a linear 
derivative curve for the alanine variant H3A and the phenylalanine variant H3F, similar to the 
parent peptide. In the case of the aromatic variants H3W and H3Y, the peptide variants 
exhibited a sigmoid growth type derivative curve.  
 
These results suggested that the H3A and H3F variants exhibit a single state model of self-
assembly in which the self-assembled peptide β-sheets dominated in solution. The replacement 
of the histidine residue in the parent peptide sequence to the aromatic tryptophan or tyrosine 
residue, however, exhibit a two state self-assembly model. The model is consistent with the 
presence of a critical assembly concentration, a state of transition from prefibrillar oligomers 
to self-assembled β-sheet structures37 (Figure 4.5). The results suggest that the introduction of 
a tyrosine residue with an extra hydroxyl group compared to phenylalanine and the tryptophan 
residue with the large aromatic side chain results in the change of self-assembly equilibrium. 
 





Figure 4.5: ThT binding assays by dilution for Prx3 peptide (WT) and peptide variants. 
Fluorescence intensity values recorded 24 hours after dilution for samples equilibrated for 24 
hours. The derivative of Prx3 peptide, H3A variant and H3F peptide variant fitted to a linear 
function of y = Ax + B. The derivative of H3W peptide variant and H3Y peptide variant fitted 
to a sigmoid growth function of y=B + (A + B)/(1 + e(x-x0)/dx)).The error bars correspond to the 
standard deviation for triplicate sample preparations. 




This behavior of the variant peptide sequences can be explained by the Le Chatelier principle 
which states that a small change in the environment, such as temperature, pressure or solute 
molecules observes a resulting change in the subtle equilibrium between the monomer state 
and the self-assembled or aggregated state38,39. The solute effect on the equilibrium is due to 
the preferential solvation of each group exposed on the surface with respect to solvent and co-
solvent molecules29,30.  
 
4.6   Kinetics of peptide self-assembly in solution 
The kinetics of self-assembly of the variant peptide sequences in solution was examined by 
ThT binding: (i) at three different concentrations and (ii) at different time points. Peptide in 
acetate mixes prepared at 1 mg/mL, 5 mg/mL and 25 mg/mL were monitored for ThT binding 
immediately after dissolving in water and at subsequent time intervals over 48 hours for peptide 
solution samples stored at 4°C. The ThT fluorescence intensity fitted to a single exponential 
function is shown in figure 4.6. ThT binding recorded immediately after dissolving the peptides 
in water showed enhanced ThT fluorescence intensity for all four variant peptide acetates in 
water at 25 mg/mL, although to a lower extent compared to the parent Prx3 peptide.  
 
ThT binding recorded over a 48-hour time course for the peptide acetate solutions showed an 
increase in the ThT binding intensity over time for all four peptide variants consistent with the 
parent peptide. This suggested that the development of extended peptide β-sheet structures 
occurs over time and follows a kinetic profile that is effectively a single exponential40,41. The 
rapid self-assembly of the peptide acetates in water at higher concentration (25 mg/mL) into 
extended β-sheets that bind to ThT dye can be explained by the presence of β-sheet nuclei that 
affect the dynamic equilibrium between the peptide monomers and the self-assembled peptide 
β-sheet42.  





Figure 4.6: ThT binding assays for peptide acetates in water recorded at different time-points 
for samples equilibrated at 4°C at three different concentrations. The curves fitted to a single 
exponential function of y = A + B*e(-kx). The error bars correspond to the standard deviation 
for triplicate sample preparations. 




The substantial difference observed in ThT binding between peptide acetates at 25 mg/mL 
compared to peptide acetate solutions with a five-fold lower concentration of the peptide at 5 
mg/mL and 1 mg/mL respectively, suggested a nucleation-dependent assembly. This mode of 
self-assembly has been previously described for peptides and proteins that form amyloid 
fibrils43,44. 
 
The absence of any substantial ThT binding for dilute peptide acetate in water samples for the 
aromatic variants H3W and H3Y suggested a higher critical assembly concentration for the 
variant peptides. The results, obtained for the H3Y peptide variant are quite distinctive since 
H3F and H3Y are nearly identical with the only difference being the phenolic hydroxyl in the 
latter peptide. The H3Y peptide is less hydrophobic than the H3F peptide variant; this does 
seem to contribute to the difference in the rate of aggregation observed between the two peptide 
sequences. The difference in the aggregation of the lesser hydrophobic H3Y variant peptide is 
explained by the possibility of the hydroxyl group that is additional in the tyrosine amino acid 
to be involved in hydrogen bonding interactions with other residues. Also, this limits the 
specific directionality necessary for aromatic interactions, which is supported by negligible 
ThT binding observed for the H3Y peptide variant at dilute concentration in water.  
 
A similar observation is apparent for the specific variation of the histidine residue in the parent 
peptide to the aromatic tryptophan residue (H3W). This behavior of the variant peptide 
sequence can be attributed to the large aromatic side chain of the tryptophan residue that causes 
in steric hindrance, which is, however, overcome at higher concentration of the peptide acetate 
in water.  
 
 




Apparent rate constants for aggregation (kagg) were calculated from the best fit of the single 
exponential45,46, shown in figure 4.7. The kagg values calculated for the peptide variants at the 
highest concentration (25 mg/mL) were similar to the parent Prx3 peptide (0.20 ± 0.04), except 
for H3F peptide variant which has a twofold higher kagg values (0.47 ± 0.1). The larger kagg 
observed for the H3F variant can be explained by the increase in hydrophobicity of the peptide 
sequence which results in the burying of the phenylalanine side-chain away from the water 
molecules and the probable π-π interactions that stabilize the β-sheet10,12. 
 
 
Figure 4.7: Apparent rate constants of aggregation (kagg) for the peptide acetates in water at 
25 mg/mL, obtained from the best fit to the data shown in figure 4.6. Errors correspond to the 
standard errors of the means of three independent experiments. 
 
Subtle change in peptide chemistry though sequence modification can have varied effect in the 
self-assembly process. The results presented here, however, show that introduction of 
hydrophobic variation in the Prx3 peptide sequence through replacement of histidine residue 
does not substantially affect the self-assembly of the peptide into extended β-sheet based 
structures. 




Hydrophobicity of the peptide sequence is known to facilitate aggregation of the peptide into 
extended β-sheet structures47,48,49. Also, aromatic stacking of the peptide sequence through π-
π interactions, especially contributed by the phenylalanine is known to drive fibrillation of 
various peptide sequences50,51,52,53. The specific hydrophobic interactions and the possible 
aromatic stacking between the aromatic amino acid residues, therefore explains the self-
assembly of the variant peptide sequences consistent with the parent Prx3 peptide. The small 
difference observed in the aggregation kinetics for the variant peptide sequences can be 
attributed to the shift in the aggregation equilibrium due to sequence modification. This change 
in the dynamic equilibrium of self-assembly of the hydrophobic peptide variants is explained 
by the pressure effects resulting from preferential solvation and the possible burying of the 
hydrophobic residues with respect to water molecules31. Overall the results suggested that the 
self-assembly of peptide variants followed kinetics profile characteristic of cooperative 
processes54,55.  
 
4.7   TEM characterization of variant peptides 
To study the morphology of the β-sheet structures formed by the variant peptide sequences, 
negatively stained (uranyl acetate) grids of peptide acetates in water in the range 10-50 mg/mL 
were analyzed by TEM (Section 2.1.7). All four peptide variants self-assembled in solution to 
form nanostructures with extended morphology with bundles of nanotapes observed for H3A, 
individual nanofibrils and wide nanotapes for H3Y, individual nanofibrils for H3W, and H3F 
peptide variant consistent with the parent Prx3 peptide (Figure 4.8). The heterogeneous mix of 
peptide fibrils and wide peptide nanotapes observed for the variant peptide H3Y was suggestive 
of polymorphism. Polymorphism is known characteristic of amyloid fibrils41,56 and has also 
been described in the context of amyloid-like fibril assemblies formed by short peptide 
sequences57,58,59.  





Figure 4.8: Representative TEM micrographs variant peptide acetates: Prx3 peptide (A), H3A 
peptide (B), H3W (C), H3Y (D) and H3F (E) in water at 50 mg/mL equilibrated for 24 hours. 
(Scale bar is 200 nm) 




   
Figure 4.9: Representative TEM micrographs of H3Y peptide acetate in water at 15 mg/mL 
(A), 25 mg/mL (B), 50 mg/mL (C). The micrographs were taken after equilibration of the 
sample for 24 hours. The histograms shown the size distribution of the widths of the fibers 
observed in each case, collected from ≥ 300 particle measurements done using ImageJ. (Scale 
bar is 200 nm). 




Measurement of polymorphic nanotapes observed for H3Y variant peptide revealed peptide 
tapes with an average width of 50 nm at 50 mg/mL. Dilute peptide acetate solutions at 25 
mg/mL revealed narrow tapes with an average width of 20 nm and thin peptide fibrils observed 
at 10 mg/mL were on an average 10 nm wide (Figure 4.9). This type of size distribution of 
peptide nanotapes suggested the ability of the variant peptide sequence to self-assemble into 
extended fibrillar nanostructures of variable morphologies.  
 
The hallmark of many different peptide sequences that self-assemble into amyloid-like fibrils 
is the ability to self-assemble into fibrils of different morphologies. It is suggested that the 
structural polymorphism observed for the diverse self-assembling peptide sequences is due to 
the different packing of the peptide chains within the extended fibrillar structure56,57,60,61. Fibril 
polymorphism is reported to be controlled by growth conditions and also seed fibrils with a 
particular morphology that induces the formation of fibrils with same morphology in the 
sample62,63. In a recent atomic level resolution structure of transthyretin peptide fibrils, 
sideways stacking of β-sheets facilitated through terminal side-chain interactions resulted in a 
different number of β-sheets laterally arranged in the extended fibril architecture58,64. 
 
4.8   Small angle X-ray scattering of variant peptides 
 To study the repetitive molecular organization within the extended nanostructures observed 
for the parent peptide and the variant peptide sequences by TEM, samples of peptide acetates 
were analysed for SAXS patterns. Concentrated samples of the variant peptide acetates in water 
in the 50-200 mg/mL range and the parent peptide at 50 mg/mL in water and pH 8.0 imidazole 
buffer were analyzed at the SAXS beamline (section 2.6.9). The SAXS patterns of the variant 
peptide acetates in water showed the characteristic Bragg peak at q = 1.3 Å-1, consistently with 
the parent Prx3 peptide acetate in water and imidazole pH 8.0 buffer (Figure 4.10). 





Figure 4.10: SAXS patterns recorded at room temperature for peptide acetates in water & in 
pH 8.5 imidazole buffer for the Prx3 peptide (HisH and HisH2
+) and variant peptide acetates 
in water (F, Y, W, and A). The vertical dashed red line points out the reflection at 1.3 Å-1 visible 
for all the peptide sequences.  
 
 The Bragg’s peak observed for the wild type peptide and the variant peptide corresponds to 
the characteristic meridional reflection that arises from the spacing between the adjacent 
hydrogen bonded β-strands along the fibril axis. This type of SAXS pattern has been previously 
described for varied β-sheet type self-assembling peptides sequences and amyloid fibrils65,66,67.  




The lesser defined broad scattering observed at the small angles below 0.5 Å-1 for both wild 
type peptide, and variant peptides was attributed to diffused scattering of the samples. The 
well-defined reflections, however observed for the H3A peptide at smaller angles can be 
attributed to the formation of micro/nano-crystals in concentrated peptide acetate sample that 
contribute to more defined X-ray scattering. Such patterns have been previously described for 
fibrillizing peptide sequences and correspond to an equatorial reflection thought to arise from 
the anisotropic form factor of nanofibrils perpendicular to the fibril axis 54,68,69 
 
Overall the SAXS patterns showed that the molecular organization of the variant peptide 
sequences is similar to the parent Prx3 peptide, consistent with the repetitive organization of 
the β-sheets over long distances within the of the extended peptide nanostructures.  
 
4.9   Fourier transform infrared spectroscopy of variant peptides 
The arrangement of the peptide strands within the extended β-sheet assemblies of the peptide 
sequences was examined by FTIR microscopy at the Australian Synchrotron Facility (Section 
2.6.10).  
 
The FTIR spectrum recorded for concentrated peptide acetate in water (10% w/w) focused on 
the amide I vibrations (1600 – 1700 cm-1) which correspond to the vibrational stretching of the 
backbone carbonyl bonds70. The IR spectra obtained for the variant peptides and the parent 
peptide exhibited three well-defined infrared vibrations at ~1620 cm-1 , 1640 cm-1 , between 
1673 to 1685 cm-1 and lesser defined vibration around 1660 cm-1 (Figure 4.11). 
 
 





Figure 4.11: IR absorbance spectra for Prx3 peptide acetate in water & pH 8.5 imidazole 
buffer (HisH and HisH2
+) and variant peptide acetates in water (F, Y, W and A) recorded at 
room temperature. The black arrows show the distinct absorption peaks around 1620 cm-1, 
1640 cm-1 , 1650 cm-1 and 1680 cm-1 and the “*” points to the lesser defined peaks at 1640   
cm-1 and 1660 cm-1. 
 
The presence of the combination vibrations at ~1620 cm-1 and at 1673-1685 cm-1 was assigned 
to the antiparallel β-sheet secondary structure in accordance with the literature 70,71,72. The 
vibration around 1640 cm-1 was assigned to random conformations70,73,74,75. The fourth 
vibration around 1660 cm-1 was more pronounced for the aromatic peptide variants and 
assigned to a turn in thesecondary structure76,77. This combination was in agreement with the 
literature. The pair of vibrations observed around 1620cm-1 and 1680 cm-1 in each of the cases 
was consistent with the presence of antiparallel β-sheets, in the core cross-β architecture 
reported for the amyloid fibril fold78,79,80. Table 4.3 details the different vibrations observed for 
the parent Prx3 peptide and the peptide variants. 




Table 4.3: IRM amide I vibrations of the Prx3 peptide and variant peptides H3F, H3Y, H3A, 
and H3W. Wavenumbers taken from the 2nd derivatives of the IRM spectra and the 
















HisH2+ (WT) 1629 1651 1674 
H3Y 1625 1646 1676 
H3F 1623 1643 1682 
H3W 1627 1654 1678 
H3A 1620 1646 1675 
 
The small variation observed in the spectra between the control peptide Prx3 and peptide 
variants could be due to the small variation in the repetitive symmetries in the extended β-sheet 
assemblies77. The amide I vibrations here described are consistent with literature 81,82,83 and 
suggestive of the anti-parallel conformation of the peptide in each of the four cases. Altogether 
the IRM results demonstrated that the peptide variants adopt a well-defined antiparallel β-sheet 













4.10   Design of hPrx3 protein-β interface muteins 
Human peroxiredoxin 3 (hPrx3) belongs to the family of thioredoxin-dependent peroxidase 
enzymes that fix peroxides in the cells84 and exists as a stable dimer through the β-continuous 
interface85. This homodimer conformation is crucial for the organization of protein into the 
hierarchical toroid shaped structures including octamer86, decamer87, dodecamer18. The 
homodimer interface of the hPrx3 protein is symmetrical and contributed by two antiparallel 
β-strands (β9-β9’) in complementary non-covalent close contacts (Figure 4.1A). An important 
feature of the β-interface motif is the amphipathic nature with a solvent accessible hydrophilic 
face and a hydrophobic face. The complementary interactions along the interface motif 
contribute to the stable dimerization of the protein units.  
 
The histidine residue within the Prx3 peptide sequence derived from the homodimer interface 
of peroxiredoxin 3 protein was thought to be an important residue for self-assembly. The Prx3 
peptide corresponding to the homodimer β-continuous interface within the Prx3 dodecamer has 
been shown to reversibly self-assemble into extended β-sheet based nanotapes17. The assembly 
of the peptide into extended β-sheet nanostructures was resilient to specific hydrophobic 
variations of the histidine residue. This indicated that the backbone hydrogen bonds were well 
preserved within the extended β-sheet self-assembly of the parent peptide and variant peptide 
sequences.  
 
Short peptide strands have a larger degree of freedom to associate through backbone hydrogen 
bonding into extended β-sheets88 than the parent interface, where this freedom is restricted in 
the 3-dimensional native fold of the protein. Therefore to study the effect of the same variation 
at the homodimer interface in the parent protein, single residue mutants of hPrx3 protein were 
investigated.  




4.10.1   Expression and purification of hPrx3 muteins  
The hPrx3 protein that bears 93% sequence homology with bovine Prx3 and 100% sequence 
homology at the homodimer interface was used for this work. Hydrophobic muteins of hPrx3 
protein containing the specific mutation of the histidine residue at the homodimer interface 
were produced through site-directed mutagenesis. The protein muteins prepared as 
recombinant constructs comprised with the specific mutation of the histidine residue at the 
position 136 and the 6*His affinity peptide tag at the N-terminal end (Section 2.1.5).  
 
The wild type hPrx3 and protein muteins were expressed as N-terminus 6*His-tagged protein 
constructs in chemically competent E. coli BL21 DE3 Rosetta cells cloned with a pET-151-d-
Topo plasmid containing the gene for the hPrx3 protein89. Small scale flask cultures were 
trialed to ascertain the best conditions for a decent yield of protein, which were then used for 
large-scale expression of protein. A single colony of cells containing the specific hPrx3 WT 
and the mutein gene was used to inoculate a 10 mL starter culture grown overnight at 37°C. 
The starter culture was used to inoculate a 400 mL flask culture containing appropriate 
antibiotics grown at 37°C.  
 
Protein expression was achieved through IPTG induction (400 µM) after O.D.600 was reached 
(Section 2.5.2.1). The expressed protein was subsequently extracted by sonication (Section 
2.5.5.1) and purified by immobilized metal affinity chromatography (Section 2.5.5.4). 
Fractions with purified protein were judged by SDS-PAGE (Section 2.6.2), pooled and further 
subjected to preparative size exclusion chromatography (Section 2.5.5.5), as shown in Figure 
4.12A and B for wild type hPrx3. 





Figure 4.12: Purification of hPrx3: (A) Immobilized metal ion chromatography (IMAC) profile 
and SDS-PAGE gel of hPrx3 (WT). (B) The sample was run on a GE HiTrap IMAC FF column 
at a flow rate of 1.0 mL/min equilibrated with Hepes, imidazole pH 8.0 buffer.  
 
Note: Blue dashed lines represent the eluted fraction of the 6*His-tagged protein. Reducing 
SDS-PAGE gel shows the different steps of the purification process: TC; total cell lysate, S; 
soluble fraction, L; IMAC load, F; flow through, Eluted fractions (1,2,3 and 4). (B) Preparative 
SEC profile and reducing SDS-PAGE gel of eluted fraction II.  




The conditions of expression and purification of muteins were similar in each case to that of 
the wild-type hPrx3 protein to ensure uniformity and valid comparison between them (Figure 
4.13).  
 
Figure 4.13: Preparative SEC profiles of hPrx3 muteins. All the protein muteins were analyzed 
in HEPES pH 8.0 buffer on a Superdex 200 16/600 PG column at a flow rate of 1.0 mL/min. 
The Roman numbers indicate the four prominent protein species separated through 
chromatography. Dashed lines represent the dodecamer protein oligomer (6n)2 
90 and protein 
dimer (2n). 




The wild type 6*His hPrx3 protein eluted mostly as a single peak at 60 mL retention volume, 
which corresponded to the toroid shaped single ring form of the protein. The lesser defined 
earlier eluting shoulder peak at ~ 50 mL and the later eluting peak at 80 mL corresponded to 
the high molecular aggregate and the dimer form of the protein respectively. This type of 
distribution by size exclusion chromatography is usually encountered for the hPrx3 protein in 
solution91. The muteins eluted as a mixer of oligomeric species, with the peak at 80 mL 
corresponding to the dimer form of the protein that is pronounced for H136F and H136Y 
muteins. For the specific change of the histidine residue to the aromatic tryptophan residue 
with a larger double ring side chain, the homodimer interface within the hPrx3 dodecamer 
appeared to have been weakened, consistent with the presence of the monomer form of the 
protein in solution.  
 
The wild type hPrx3 is a typical 2-Cys peroxiredoxin with a peroxidative thiol (CP) residue and 
that an adjacent thiol cysteine (resolving cysteine CR). The central β-sheet within the protein is 
oriented to give rise to a stable parallel β-sheet organization. The exposed β9 motif of one 
protein monomer associated with the complementary β9’ motif of the other monomer protein 
to form a continuous β-sheet interface. The protein dimer locked through the B-interface, 
stabilized by the different non-covalent interactions across the β9- β9’motifs. The amino acid 
sequence of the interface motifs within protein oligomers are evolutionary fine-tuned to drive 
self-assembly of the protein monomer units in a regulated and controlled manner.  The results 
here show that introduction of a hydrophobic mutation at the homodimer interface (B-interface) 
of hPrx3 protein by replacement of histidine residue do not have a substantial effect on the 
dimerization of the protein. For the specific mutation of the histidine to tryptophan, the 
monomer form of the protein is present in higher amounts relative to the protein dimer however, 
the data does not reveal whether this is at the expense of the dimer formation. 




4.10.2   Solution state characterization of hPrx3 and dimer interface muteins  
Analytical size exclusion chromatography coupled with a static light scattering detector 
(Section 2.6.3) allowed estimation of molecular weights of the different protein oligomers in 
solution. The size exclusion purified wild type hPrx3 protein and interface muteins at 1 mg/mL 
(load concentration) was subjected to in-line static light scattering. The molecular weight 
estimation was performed using a BSA standard protein injected before the sample protein and 
at the end of the run. Figure 4.14 shows the SEC-SLS profiles of the wild type hPrx3 and 
muteins. 
 
The control wild-type hPrx3 protein showed mainly a single peak at retention time of ~12 
minutes, which was estimated to be of ~ 300 kDa (I) that corresponded to the dodecamer form 
of the protein (6n)2
91. The peak at a higher retention volume of ~ 18 mL was estimated to be of 
50 kDa (II) corresponding to the dimer form of the protein. This type of distribution of the 
oligomeric state of the His-tagged hPrx3 has been previously described and indicates the 
stabilization of the dodecamer form by the peptide loop sequence (His-tag)85. For the tagged 
hPrx3 protein, the dimer-dodecamer equilibrium seems to be biased, which explains the 
presence of the large population of dodecamer and a small population of dimers as observed 
here by SEC-SLS. 
 
For the aromatic muteins (H136F, H136Y, and H136W) the dimer form of the protein was 
found to dominate with the major peak observed at a retention time of ~18 minutes consistent 
with the wild-type protein. The alanine mutein H136A in contrast to the aromatic muteins 
showed a major peak at retention time of ~12 minutes that was consistent with the dodecamer 
form of the protein and three lesser defined peaks which were estimated to be of 110 kDa, 50 
kDa, and 25 kDa.  










Figure 4.14: SEC-SLS of hPrx3 and muteins in HEPES, NaCl pH 8.0 on a Superdex 200 10/300 
GL column at a flow rate of 0.5 mL/min. The Roman numbers indicate the four prominent 
protein species separated through chromatography. Dashed lines represent the HMW 
dodecamer ring form (6n)2 and dimer (2n). 
 
The Mw of the second peak in the analytical SEC-SLS of H136A mutein (Figure 4.14, B) was 
closest to the theoretical molecular weight of a tetramer as calculated from its amino acid 
sequence. Table 4.4 lists the Mw calculated for hPrx3 WT protein and muteins. 




Table 4.4: List of molecular weights (kDa) obtained for muteins in comparison of hPrx3 WT. 



















The column was pre-equilibrated with Hepes, NaCL pH 8.0 buffer 
A Superdex 200 GL 10/300 column was run at a flowrate of 0.5 mL/min. The Mw listed are 
taken at the midpoint of the eluted peak. 
 
The chromatogram of the protein mutein obtained at a loading concentration of 1 mg/mL was 
analyzed for the molar mass of the main protein conformation. The molar mass determined was 
found to be highest at the apex of the peak and fell off on the trailing.   
 
The SEC-SLS provided a good overview of the different oligomeric forms adopted by the 
hPrx3 muteins in solution. The different oligomeric forms identified for the hydrophobic 
muteins suggested that the specific sequence change of the histidine residue at the homodimer 
interface affects the monomer-dimer equilibrium that is more biased towards the dimer form. 




For the specific mutation of the histidine residue to the large aromatic tryptophan residue, the 
destabilization of the dimers, however, suggested that the homodimer protein-β interface is 
weakened. This results in the shift of the monomer-dimer equilibrium towards the monomer 
form of the protein.  
 
It should be noted that the dodecamer conformation is a stable quaternary assembly of the wild 
type hPrx3 protein dimers adopted in the tagged state of the recombinant protein. Therefore, 
the oligomeric forms of the hPrx3 muteins identified by SEC-SLS consistent in all the four 
muteins indicated that these oligomeric states are stable assemblies of the tagged recombinant 
muteins.  
 
4.10.3   Characterization of H136W and H136A muteins 
The static light scattering of size excluded protein muteins showed striking results for His-
tagged recombinant muteins H136A and H136W.  In the case of the aromatic mutein H136W 
the monomer form of the protein was prefered due to the weakend interactions across the dimer 
interface. The hydrophobic mutein H136A, however, was found to exist mainly as a 
dodecamer, though with presence in detectable amounts of the tetramer, dimer and monomer.  
 
To further investigate concentration dependence of the self-assembly of the protein, samples 
of the muteins at different concentrations were analyzed by SEC-SLS. Figure 4.15, shows the 
elution profile of H136W mutein at six different concentrations trialed. At lower 
concentrations, of the mutein at 1 mg/mL and below, the monomer form was more pronounced 
with a lower proportion of the dimer form. Above 1 mg/mL of mutein in solution, a distinct 
peak corresponding to the dodecamer form of the protein was present, which became more 
pronounced with concentration.  





Figure 4.15: SEC-SLS of H136W 6*His tagged mutein at different concentrations in HEPES, 
NaCl pH 8.0 buffer. The arrows indicate to the three prominent protein species separated 
through chromatography, the HMW dodecamer ring form (6n)2, dimer (2n) and monomer (n). 
 
To study the role of the N-terminal 6*His tag in the assembly of the mutein, a cleaved form of 
the protein with the tag removed was subjected to SEC-SLS (Figure 4.16).  





Figure 4.16: Comparative SEC-SLS of 6*His H136W and H136W (tag cleaved) in HEPES, 
NaCl pH 8.0 buffer. The arrows indicate to the three prominent protein species separated 
through chromatography, the HMW dodecamer ring form (6n)2, dimer (2n) and monomer (n). 
 
Comparison of the SEC-SLS profiles of tagged and untagged H136W muteins showed a 
striking difference, with the untagged form found to exist mainly as a monomer. This suggested 
that the specific mutation of the histidine to tryptophan weakens the β-continuous dimer 
interface. The absence of any substantial rise in the dimer peak but the presence of a dodecamer 




peak at a higher concentration of the mutein in solution was also suggestive of a monomer-
oligomer equilibrium that is biased towards the dimer. The presence of the dodecamer peak 
observed for H136W, can be explained by the association of mutein dimers assembled through 
the protein-β interface at higher concentration into dodecamer toroids. This behavior of the 
untagged mutein was consistent with the tagged form, where similar monomer to dimer 
equilibrium existed for different concentration of the protein in solution.  
 
The presence of a relatively large population of H136W dimers observed in the tagged state of 
the mutein suggested that the monomer-dimer equilibrium was biased, and the tagged state 
facilitated the association of the protein monomers into dimers. The peptide affinity tag (6*His) 
exists as a freely accessible N-terminus loop in the 3-dimensional folded form of the protein 
and near the β9 motif that makes up the β-continuous homodimer interface of hPrx3. This 
raised the possibility of the stabilization of the H136W monomers units into the dimer 
conformation in the tagged state through interactions arising from the larger surface area of 
association provided by the peptide tag. The role of the N-terminal tag in the stabilization of 
the higher order ring-shaped oligomer form of the Prx protein has been previously described 
85,92,91. 
 
At dilute concentrations of the cleaved H136W mutein in solution at 1 mg/mL, the monomer 
form of the protein was pronounced, with a relatively low proportion of the dimer. At twice 
this concentration of the mutein in solution, the presence of a distinct peak that corresponded 
to the dodecamer suggested a state of transition of monomers to dimer and the dimers further 
self-assembling into the higher order dodecamer.  




In the case of H136A mutein, the dodecamer form was more pronounced with the relatively 
lower amount of dimer, and very less monomer peak observed at all concentrations trialed 
(Figure 4.17).  
 
Figure 4.17: SEC-SLS of H136A 6*His tagged mutein at different concentrations in HEPES, 
NaCl pH 8.0. The arrows indicate to the four prominent protein species separated through 
chromatography, the HMW dodecamer ring form (6n)2, possible tetramer (4n), dimer (2n) and 
monomer (n). 




Above 1 mg/mL in solution, a detectable increase in the dimer peak to that of the monomer 
suggested a monomer to dimer transition, with a certain ratio of that dimer population self-
assembling into dodecamer and a small population of tetramers. This result suggested that the 
mutation of the histidine to a more hydrophobic alanine residue does not substantially affect 
the protein homodimer interface.  
 
It is important to note that the dodecamer oligomer form adopted by the hPrx3 protein under 
reducing condition, is facilitated by the partial unfolding of the protein structure and formation 
of the “Cp-loop”93. This partially unfolded structure is in dynamic equilibrium with the fully-
folded Prx and the Cp-loop acts as a switch between the dodecamer and dimer. In the mutated 
form, this dynamic equilibrium seems to be affected, which would explain the distribution of 
different oligomeric forms of the hPrx3 protein detected in the specific case of H136A.   
 
SEC-SLS of untagged H136A mutein showed that most of the protein existed in the higher 
order dodecamer form, with a relatively low amount of dimer present consistent with that 
observed for the tagged form (Figure 4.18).  





Figure 4.18: Comparative SEC-SLS of 6*His H136A and H136A (tag cleaved) in HEPES, 
NaCl pH 8.0 buffer. The arrows indicate the two prominent protein species separated through 
chromatography, the HMW dodecamer ring form (6n)2 and the dimer (2n). 
 
Analysis of the tagged and untagged form of the H136W mutein by AUC (Section 2.6.12) at 
three different concentration confirmed that the monomer form of the protein predominated in 
solution (Figure 4.19). This suggested that the introduction of the specific hydrophobic 
mutation in hPrx3 protein weakened the of the homodimer protein-β interface.  





Figure 4.19: AUC of H136W and H136A muteins in HEPES, NaCl pH 8.0 buffer. The arrows 
indicate the four prominent protein species sedimenting on centrifugation: n: monomer, 2n: 
dimer, 4n: tetramer and (6n)2: dodecamer.  




In the case of the H136A mutein, the AUC showed the presence of the different oligomer forms 
dimer, tetramer and dodecamer, along with some amount of monomer, consistent for the 
concentrations trailed. The results, thus show that for the mutation of the histidine residue to 
alanine does not substantially affect the homodimer protein-β interface with the monomer-
dimer equilibrium more biased towards the dimer form of the protein. The small population of 
the H136A mutein monomer form detected could correspond to the small population of non-
associated mutein monomers. The AUC also revealed that His-tag supported the formation of 
protein dimer in H136W mutein, however the tag does not appear to make a substantial 
difference for H136A mutein (Figure 4.18 and Figure 4.19). It is important to note that the N-
terminal region of the protein that contains the His-tag sequence is in close proximity to the 
homodimer interface in the 3-dimensional fold of the Prx3 protein18,85. This raises the 
possibility of specific side-chain interactions between the His-tag sequence and the dimer 
interface sequence which stabilizes the otherwise weakened protein-protein interface and favor 
dimer formation. The role of His-tag in stabilizing protein oligomer conformation has been 
previously described in Prx3 systems85,91,92. The variation of histidine to alanine (H136A) 
however, does not substantially alter the homodimer interface properties, which explains why 
no substantial difference is observed in the behavior of the tagged mutein and untagged mutein 
in solution. 
 
Comparison of the molar masses determined from the apex of the peak data to the theoretical 
Kd value reported for the wild-type protein generated equilibration constants of dissociation 
for dimer to monomer in the 2.0 µM to 4.0 µM range for the muteins. The equilibrium constants 
of dissociation for dimer to monomer was judged to be > 2-4 µM as complete dissociation of 
the dimer to monomer was not observed for the lowest concentration trailed in this work. 
 




4.11   Discussion 
The histidine residue in the isolated Prx3 peptide sequence was chosen to be varied as it was 
found to be highly conserved within the parent β-continuous homodimer interface in Prx3 
protein and within hydrogen bonding distance to neighboring serine and asparagine residues. 
Peptide variants designed with the histidine replaced with hydrophobic residues all formed 
birefringent hydrogels with liquid crystalline textures observed for all the four peptide acetates 
in water. The variant peptide sequences showed a propensity to exist as β-sheets at dilute 
concentration in solution36 similar to the wild-type peptide. This indicated that the specific 
variation of the histidine residue in the peptide does not alter backbone hydrogen bonding and 
thus β-sheet conformation is retained.  
 
ThT binding assays showed that all the variant peptide acetates in water associated with the 
amyloid-specific ThT dye in a reversible manner, though to a lower extent, but consistent with 
the parent peptide. The binding assays further showed that the Prx3 peptide sequence with a 
specific variation of the histidine to the aromatic tyrosine or tryptophan has higher critical 
assembly concentration. Peptide self-assembly studies as a function of time showed that the 
specific aromatic variations of the Prx3 peptide (H3W and H3Y) exhibited a two-state model 
of self-assembly consistent with the presence of a lag phase. Time course studies on amyloid 
fibril formation by proteins and peptides usually exhibit a lag or nucleation phase and growth 
phase which occurs rapidly with the addition of monomers and stationary phase that is 
predominated by mature fibrils94,95,96,97. The rate of self-assembly can be changed by the 
addition the nuclei or seeds that shorten the lag phase. The absence of any substantial lag phase 
at a higher concentration of the peptide acetate in water can be explained by the solute effects 
on the monomer-aggregate equilibrium.  
 




Apparent rate constants of aggregation revealed that the specific change in the sequence from 
histidine to phenylalanine resulted in faster assembly kinetics. The specific change in the 
peptide sequence to the more hydrophobic phenylalanine residue results in burying of the 
phenylalanine side-chains away from solvent molecules and the specific aromatic interactions 
between phenylalanine side-chains favour faster aggregation kinetics. Phenylalanine has been 
noted to be an important residue in driving amyloid assembly and frequently encountered in 
varied in amyloidogenic motifs reported to date50,51. Furthermore, peptides comprised of only 
two repeating phenylalanine residues have been shown to self-assemble into full length 
amyloid fibrils largely driven by aromatic interactions12,13. Diphenylalanine motifs are shortest 
self-assembling peptide motifs developed using the “reductionist approach” by Gazit & co-
workers50,51 and have been successfully used as “molds” for fabrication of metal nanowires. 
Furthermore, self-assembling diphenylalanine peptides can be grown on surfaces as vertical 
nanowires that act as attachment surface for 3D cell culture for development of biosensing 
devices14. Thus, peptide sequences containing phenylalanine residue provide a good starting 
point to build peptide based building blocks that can self-assemble into discrete nanostructures 
to be used a biomaterials. 
 
Thermodynamic studies on pressure and solute effects on the self-assembly of biomolecules in 
solution show that the association-dissociation equilibrium is affected by the change in the 
environment including pressure, temperature and number of solute molecules 98,38,99,39. Also, it 
has been noted that lyophilized peptide acetate sample shows the presence of amyloid 
nucleates97. This explains the substantial ThT fluorescence observed immediately after dilution 
of peptide acetate powder in water and for concentrated peptide acetate in water samples. The 
rise in the ThT fluorescence observed over time is consistent with the growth of the peptide 
fibrillar structures with the addition of peptide monomers96,97. 




TEM and SAXS corroborated evidence that all the designed variant peptide sequences self-
assembled into β-sheet based nanostructures with extended morphologies consistent with those 
described for the parent Prx3 peptide. SAXS patterns of the peptide sequences showed that the 
hydrophobic peptide variants have a similar β-sheet organization at the molecular level which 
is repetitive over long distances, consistent with the parent peptide. The molecular organization 
observed for the variant peptide sequences are similar to that observed for different peptide 
sequences that self-assembled into amyloid-like fibrils66,67,69,100. Some differences observed at 
the small angles can be correlated to the slight differences observed by TEM concerning the 
symmetries which is attributed to the different lamination of the β-sheets in the extended 
nanostructures. This difference in the symmetry of the β-sheets can be associated with the 
different morphologies observed for the variant peptides and furthermore to the polymorphism 
observed in the nanotapes formed by the variant peptide H3Y101,102. FTIR further confirmed 
that the backbone conformation of both wild-type Prx3 peptide and the hydrophobic variants 
was that of an antiparallel β-sheet type with the characteristic combinative vibrations77,78.  
 
A mutational approach used to explore the effect of variation of the histidine residue at the 
parent Prx3 homodimer interface changed the high order dodecamer assembly of the protein. 
However, the dimer form of the Prx3 protein was found to be largely stable across all the 
hydrophobic muteins studied with the only exception being the H136W mutein. The change in 
the monomer-dimer equilibrium observed in the case of hPrx3 mutein H136W can be attributed 
to the replacement of the imidazole side chain group by the bigger aromatic side chain. It is 
important to note that the β9-β9’ motif within the homodimer interface of the hPrx3 dodecamer 
has restricted movement. Thus, the weakening of the interface can be attributed to the localized 
steric hindrance caused due to the introduction of the tryptophan residue having a large 
aromatic side chain group. This, eventually destabilizes the interface and can explain the 




predominance of monomer species observed in solution for the H136W mutein. The behavior 
of the parent mutein was found to be in contrast to the corresponding isolated peptide variant 
sequence H3W that self-assembled into extended β-sheet based nanostructures. This suggested 
that the isolated peptide sequence interacts in a different way to the parent interface. In the 
isolated form, the smaller size and length of the sequence offers a higher degree of flexibility 
and freedom to associate into β-sheets, overcoming the steric hindrance due to the large 
aromatic group. Within the 3-dimensional fold of the Prx3 protein this flexibility of the β-motif 
is restricted, and the steric effects due to the large aromatic tryptophan residue limit the 
association of the protein monomers. 
 
Overall, the results showed that the peptide sequence corresponding to the homodimer protein-
β interface of Prx3 protein is stable to the specific hydrophobic variation of the histidine 
residue. Of the different peptide sequences studied the H3F peptide was the most aggregation 
prone. The different muteins studied designed with the corresponding variation of the histidine 
residue all behaved similarly except the H136W where the monomer form was preferred. The 
results thus support the variant peptide sequences as molecular tectons with self-assembling 
properties stemming from the parent protein-β interface. The results shown here augur well 
with those observed with proteins and peptide sequences that self-assemble into amyloid-like 
fibrils and showcase peptide sequence derived from protein interface as stable molecular 
tectons. Such stable self-assembling peptide tectons show potential to be used as building 









4.12   References 
1. Jun, S., Hong, Y., Imamura, H., Ha, B. Y., Bechhoefer, J. & Chen, P. (2004). Self-
Assembly of the Ionic Peptide EAK16: The effect of charge distributions on self-
assembly. Biophysical Journal 87, 1249-1259. 
2. Jeon, J. & Shell, M S. (2012). Charge effects on the fibril-forming peptide KTVIIE: a 
two-dimensional replica exchange simulation study. Biophysical Journal 102, 1952-
1960. 
3. Zhao, X., Pan, F. & Lu, J. R. (2008). Recent development of peptide self-assembly. 
Progress in Natural Science 18, 653-660. 
4. Lee, N. R., Bowerman, C. J. & Nilsson, B. L. (2013). Effects of varied sequence pattern 
on the self-assembly of amphipathic peptides. Biomacromolecules 14, 3267-3277. 
5. Caplan, M. R., Moore, P. N., Zhang, S., Kamm, R. D. & Lauffenburger, D. A. (2000). 
Self-assembly of a β-sheet protein governed by relief of electrostatic repulsion relative 
to van der Waals attraction. Biomacromolecules 1, 627-631. 
6. Caplan, M. R., Schwartzfarb, E. M., Zhang, S., Kamm, R. D. & Lauffenburger, D. A. 
(2002). Control of self-assembling oligopeptide matrix formation through systematic 
variation of amino acid sequence. Biomaterials 23, 219-227. 
7. López de la Paz, M., Goldie, K., Zurdo, J., Lacroix, E., Dobson, C. M., Hoenger, A. & 
Serrano, L. (2002). De novo designed peptide-based amyloid fibrils. Proceedings of the 
National Academy of Sciences of the United States of America 99, 16052-16057. 
8. Hamley, I. W. (2007). Peptide fibrillization. Angewandte Chemie International Edition 
in English 46, 8128-8147. 
9. Gazit, E. (2005). Mechanisms of amyloid fibril self-assembly and inhibition. model 
short peptides as a key research tool. FEBS Journal 272, 5971-5978. 
10. Gazit, E. (2007). Self assembly of short aromatic peptides into amyloid fibrils and 
related nanostructures. Prion 1, 32-35. 
11. Reches, M. & Gazit, E. (2004). Amyloidogenic hexapeptide fragment of medin: 
homology to functional islet amyloid polypeptide fragments. Amyloid 11, 81-89. 
12. Tamamis, P., Adler-Abramovich, L., Reches, M., Marshall, K., Sikorski, P., Serpell, 
L., Gazit, E. & Archontis, G. (2009). Self-assembly of phenylalanine oligopeptides: 
insights from experiments and simulations. Biophysical Journal 96, 5020-5029. 




13. Maeda, I., Taniguchi, S., Watanabe, N., Inoue, A., Yamasaki, Y. & Nose, T. (2015). 
Design of phenylalanine-containing elastin-derived peptides exhibiting highly potent 
self-assembling capability. Protein and Peptide Letters 22, 934-939. 
14. Sasso, L., Vedarethinam, I., Emneus, J., Svendsen, W. E. & Castillo-Leon, J. (2012). 
Self-assembled diphenylalanine nanowires for cellular studies and sensor applications. 
Journal of Nanoscience and Nanotechnology 12, 3077-3083. 
15. Valéry, C., Pouget, E., Pandit, A., Verbavatz, J.-M., Bordes, L., Boisdé, I., Cherif-
Cheikh, R., Artzner, F. & Paternostre, M. (2008). Molecular origin of the self-assembly 
of lanreotide into nanotubes: a mutational approach. Biophysical Journal 94, 1782-
1795. 
16. Armstrong, A. H., Chen, J., McKoy, A. F. & Hecht, M. H. (2011). Mutations that 
replace aromatic side chains promote aggregation of the Alzheimer’s Aβ peptide. 
Biochemistry 50, 4058-4067. 
17. Valery, C., Pandey, R. & Gerrard, J. A. (2013). Protein β-interfaces as a generic source 
of native peptide tectons. Chemical Communications 49, 2825-2827. 
18. Cao, Z., Roszak, A. W., Gourlay, L. J., Lindsay, J. G. & Isaacs, N. W. (2005). Bovine 
mitochondrial peroxiredoxin III forms a two-ring catenane. Structure 13, 1661-1664. 
19. Hamley, I. W., Kirkham, S., Dehsorkhi, A., Castelletto, V., Adamcik, J., Mezzenga, R., 
Ruokolainen, J., Mazzuca, C., Gatto, E., Venanzi, M., Placidi, E., Bilalis, P. & Iatrou, 
H. (2014). Self-assembly of a model peptide incorporating a hexa-histidine sequence 
attached to an oligo-alanine sequence, and binding to gold NTA/nickel nanoparticles. 
Biomacromolecules 15, 3412-3420. 
20. Qin, Z.-l., Zheng, Y. & Kielian, M. (2009). Role of conserved histidine residues in the 
low-pH dependence of the semliki forest virus fusion protein. Journal of Virology 83, 
4670-4677. 
21. Tu, Z., Young, A., Murphy, C. & Liang, J. F. (2009). The pH sensitivity of histidine-
containing lytic peptides. Journal of peptide science 15, 790-795. 
22. Kalani, Mohamad R., Moradi, A., Moradi, M. & Tajkhorshid, E. (2013). Characterizing 
a histidine switch controlling pH-dependent conformational changes of the influenza 
virus hemagglutinin. Biophysical Journal 105, 993-1003. 
23. Mair, C. M., Meyer, T., Schneider, K., Huang, Q., Veit, M. & Herrmann, A. (2014). A 
histidine residue of the influenza virus hemagglutinin controls the pH dependence of 
the conformational change mediating membrane fusion. Journal of Virology 88, 13189-
13200. 




24. Carpena, X., Vidossich, P., Schroettner, K., Calisto, B. M., Banerjee, S., Stampler, J., 
Soudi, M., Furtmuller, P. G., Rovira, C., Fita, I. & Obinger, C. (2009). Essential role of 
proximal histidine-asparagine interaction in mammalian peroxidases. Journal of 
Biological Chemistry 284, 25929-25937. 
25. Passardi, F., Bakalovic, N., Teixeira, F. K., Margis-Pinheiro, M., Penel, C. & Dunand, 
C. (2007). Prokaryotic origins of the non-animal peroxidase superfamily and organelle-
mediated transmission to eukaryotes. Genomics 89, 567-479. 
26. Birktoft, J. J. & Banaszak, L. J. (1983). The presence of a histidine-aspartic acid pair in 
the active site of 2-hydroxyacid dehydrogenases: X-ray refinement of cytoplasmic 
malate dehydrogenase. Journal of Biological Chemistry 258, 472-482. 
27. Valéry, C., Deville-Foillard, S., Lefebvre, C., Taberner, N., Legrand, P., Meneau, F., 
Meriadec, C., Delvaux, C., Bizien, T., Kasotakis, E., Lopez-Iglesias, C., Gall, A., 
Bressanelli, S., Le Du, M.-H., Paternostre, M. & Artzner, F. (2015). Atomic view of 
the histidine environment stabilizing higher-pH conformations of pH-dependent 
proteins. Nature Communications 6, 7771-7778. 
28. Kirkwood, J. G. & Buff, F. P. (1951). The statistical mechanical theory of solutions. 
Journal of Chemical Physics 19, 774-777. 
29. Ben-Naim, A. (2006). Molecular theory of solutions. Oxford University Press. 
30. Ben-Naim, A. (2012). Theoretical aspects of pressure and solute denaturation of 
proteins: A Kirkwood-buff-theory approach. Journal of Chemical Physics 137, 
235102-235108. 
31. Ben-Naim, A. (2011). Molecular theory of water and aqueous solutions: The role of 
water in protein folding, self-assembly and molecular recognition. World Scientific. 
32. Ben-Naim, A. (2006). On the driving forces for protein-protein association. Journal of 
Chemical Physics 125, 024901-024910. 
33. Jarrett, J. T. & Lansbury, P. T., Jr. (1993). Seeding "one-dimensional crystallization" 
of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-
1058. 
34. Bolisetty, S., Adamcik, J. & Mezzenga, R. (2011). Snapshots of fibrillation and 








35. Pomerantz, W. C., Yuwono, V. M., Pizzey, C. L., Hartgerink, J. D., Abbott, N. L. & 
Gellman, S. H. (2008). Nanofibers and lyotropic liquid crystals from a class of self-
assembling β-peptides. Angewandte Chemie International Edition in English 47, 1241-
1244. 
36. Greenfield, N. J. (2006). Using circular dichroism spectra to estimate protein secondary 
structure. Nature Protocols 1, 2876-2890. 
37. Knapman, T. W., Aggeli, A. & Ashcroft, A. E. (2008). Critical concentrations of β-
sheet peptide self-assembly quantified directly by nanoelectrospray ionization mass 
spectrometry. Rapid Communications in Mass Spectrometry 22, 1611-1614. 
38. Pierce, V., Kang, M., Aburi, M., Weerasinghe, S. & Smith, P. E. (2008). Recent 
Applications of Kirkwood–Buff theory to biological systems. Cell Biochemistry and 
Biophysics 50, 1-22. 
39. Gee, M. B. & Smith, P. E. (2009). Kirkwood–Buff theory of molecular and protein 
association, aggregation, and cellular crowding. Journal of Chemical Physics 131, 
165101-165111. 
40. Campioni, S., Mossuto, M. F., Torrassa, S., Calloni, G., de Laureto, P. P., Relini, A., 
Fontana, A. & Chiti, F. (2008). Conformational properties of the aggregation precursor 
state of HypF-N. Journal of Molecular Biology 379, 554-567. 
41. Kodali, R. & Wetzel, R. (2007). Polymorphism in the intermediates and products of 
amyloid assembly. Current Opinion in Structural Biology 17, 48-57. 
42. Otzen, D. E. (2013). Amyloid fibrils and prefibrillar aggregates: molecular and 
biological properties. John Wiley & sons. 
43. Xue, W. F., Homans, S. W. & Radford, S. E. (2008). Systematic analysis of nucleation-
dependent polymerization reveals new insights into the mechanism of amyloid self-
assembly. Proceedings of the National Academy of Sciences of the United States of 
America 105, 8926-31. 
44. Streets, A. M., Sourigues, Y., Kopito, R. R., Melki, R. & Quake, S. R. (2013). 
Simultaneous measurement of amyloid fibril formation by dynamic light scattering and 
fluorescence reveals complex aggregation kinetics. PLoS One 8, 1-10. 
45. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G. & Dobson, C. 
M. (2002). Kinetic partitioning of protein folding and aggregation. Nature Structural 
and Molecular Biology 9, 137-143. 
 




46. Hortschansky, P., Schroeckh, V., Christopeit, T., Zandomeneghi, G. & Fändrich, M. 
(2005). The aggregation kinetics of Alzheimer’s β-amyloid peptide is controlled by 
stochastic nucleation. Protein Science 14, 1753-1759. 
47. Calamai, M., Taddei, N., Stefani, M., Ramponi, G. & Chiti, F. (2003). Relative 
influence of hydrophobicity and net charge in the aggregation of two homologous 
proteins. Biochemistry 42, 15078-15083. 
48. Chiti, F., Stefani, M., Taddei, N., Ramponi, G. & Dobson, C. M. (2003). Rationalization 
of the effects of mutations on peptide and protein aggregation rates. Nature 424, 805-
808. 
49. DuBay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M. & Vendruscolo, M. 
(2004). Prediction of the absolute aggregation rates of amyloidogenic polypeptide 
chains. Journal of Molecular Biology 341, 1317-1326. 
50. Azriel, R. & Gazit, E. (2001). Analysis of the minimal amyloid-forming fragment of 
the islet amyloid polypeptide. An experimental support for the key role of the 
phenylalanine residue in amyloid formation. Journal of Biological Chemistry 276, 
34156-34161. 
51. Gazit, E. (2007). Self assembly of short aromatic peptides into amyloid fibrils and 
related nanostructures. Prion 1, 32-35. 
52. Makin, O. S., Atkins, E., Sikorski, P., Johansson, J. & Serpell, L. C. (2005). Molecular 
basis for amyloid fibril formation and stability. Proceedings of the National Academy 
of Sciences of the United States of America 102, 315-320. 
53. Chelli, R., Gervasio, F. L., Procacci, P. & Schettino, V. (2002). Stacking and T-shape 
competition in aromatic-aromatic amino acid interactions. Journal of the American 
Chemical Society 124, 6133-43. 
54. Javid, N., Roy, S., Zelzer, M., Yang, Z., Sefcik, J. & Ulijn, R. V. (2013). Cooperative 
self-assembly of peptide gelators and proteins. Biomacromolecules 14, 4368-4376. 
55. van der Zwaag, D., Pieters, P. A., Korevaar, P. A., Markvoort, A. J., Spiering, A. J. H., 
de Greef, T. F. A. & Meijer, E. W. (2015). Kinetic analysis as a tool to distinguish 
pathway complexity in molecular assembly: an unexpected outcome of structures in 
competition. Journal of the American Chemical Society 137, 12677-12688. 
56. Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W. M., Mattson, M. P. & Tycko, R. 
(2005). Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid 
fibrils. Science 307, 262-265. 




57. Verel, R., Tomka, I. T., Bertozzi, C., Cadalbert, R., Kammerer, R. A., Steinmetz, M. 
O. & Meier, B. H. (2008). Polymorphism in an Amyloid-Like Fibril-Forming Model 
Peptide. Angewandte Chemie International Edition in English 47, 5842-5845. 
58. Fitzpatrick, A. W. P., Debelouchina, G. T., Bayro, M. J., Clare, D. K., Caporini, M. A., 
Bajaj, V. S., Jaroniec, C. P., Wang, L., Ladizhansky, V., Müller, S. A., MacPhee, C. E., 
Waudby, C. A., Mott, H. R., De Simone, A., Knowles, T. P. J., Saibil, H. R., 
Vendruscolo, M., Orlova, E. V., Griffin, R. G. & Dobson, C. M. (2013). Atomic 
structure and hierarchical assembly of a cross-β amyloid fibril. Proceedings of the 
National Academy of Sciences of the United States of America 110, 5468-5473. 
59. Krasnoslobodtsev, A. V., Deckert-Gaudig, T., Zhang, Y., Deckert, V. & Lyubchenko, 
Y. L. (2016). Polymorphism of amyloid fibrils formed by a peptide from the yeast prion 
protein Sup35: AFM and tip-enhanced raman scattering studies. Ultramicroscopy 165, 
26-33. 
60. Paravastu, A. K., Petkova, A. T. & Tycko, R. (2006). Polymorphic fibril formation by 
residues 10–40 of the Alzheimer's β-amyloid peptide. Biophysical Journal 90, 4618-
4629. 
61. van der Wel, P. C. A., Lewandowski, J. R. & Griffin, R. G. (2007). Solid-state NMR 
study of amyloid nanocrystals and fibrils formed by the peptide GNNQQNY from yeast 
prion protein Sup35p. Journal of the American Chemical Society 129, 5117-5130. 
62. Antzutkin, O. N., Leapman, R. D., Balbach, J. J. & Tycko, R. (2002). Supramolecular 
structural constraints on Alzheimer's β-amyloid fibrils from electron microscopy and 
solid-state NMR. Biochemistry 41, 15436-15450. 
63. Petkova, A. T., Buntkowsky, G., Dyda, F., Leapman, R. D., Yau, W. M. & Tycko, R. 
(2004). Solid state NMR reveals a pH-dependent antiparallel β-Sheet registry in fibrils 
formed by a β-Amyloid peptide. Journal of Molecular Biology 335, 247-260. 
64. Fitzpatrick, A. W., Knowles, T. P., Waudby, C. A., Vendruscolo, M. & Dobson, C. M. 
(2011). Inversion of the balance between hydrophobic and hydrogen bonding 
interactions in protein folding and aggregation. PLoS Computional Biology 7, 1-10. 
65. Segman, S., Lee, M.-r., Vaiser, V., Gellman, S. H. & Rapaport, H. (2010). Highly stable 
pleated-sheet secondary structure in assemblies of amphiphilic α/β-peptides at the air–
water interface. Angewandte Chemie International Edition in English 49, 716-719. 
66. Serpell, L. C. (2000). Alzheimer’s amyloid fibrils: structure and assembly. Biochimica 
et Biophysica Acta: Molecular Basis of Disease 1502, 16-30. 




67. Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B. & Blake, C. C. 
(1997). Common core structure of amyloid fibrils by synchrotron X-ray diffraction. 
Journal of Molecular Biology 273, 729-739. 
68. Guinier, A. (1994). X-ray diffraction in crystals, imperfect crystals, and amorphous 
bodies. Dover. 
69. van Grondelle, W., Iglesias, C. L., Coll, E., Artzner, F., Paternostre, M., Lacombe, F., 
Cardus, M., Martinez, G., Montes, M., Cherif-Cheikh, R. & Valery, C. (2007). 
Spontaneous fibrillation of the native neuropeptide hormone Somatostatin-14. Journal 
of Structural Biology 160, 211-223. 
70. Haris, P. I. & Chapman, D. (1995). The conformational analysis of peptides using 
Fourier transform infrared spectroscopy. Biopolymers 37, 251-263. 
71. Susi, H. & Byler, D. M. (1987). Fourier transform infrared study of proteins with 
parallel β-chains. Archives of Biochemistry and Biophysics 258, 465-469. 
72. Stuart, B. H. & Ando, D. J. (1997). Biological applications of infrared spectroscopy. 
John Wiley & sons. 
73. Krimm, S. & Bandekar, J. (1986). Vibrational spectroscopy and conformation of 
peptides, polypeptides, and proteins. Advances in Protein Chemistry 38, 181-364. 
74. Bandekar, J. (1992). Amide modes and protein conformation. Biochimica et Biophysica 
Acta 1120, 123-143. 
75. Goormaghtigh, E., Cabiaux, V. & Ruysschaert, J.-M. (1994). Determination of Soluble 
and Membrane Protein Structure by Fourier Transform Infrared Spectroscopy. In 
Physicochemical Methods in the Study of Biomembranes. Springer science 23, 329-
362. 
76. Pelton, J. T. & McLean, L. R. (2000). Spectroscopic methods for analysis of protein 
secondary structure. Analytical Biochemistry 277, 167-176. 
77. Zandomeneghi, G., Krebs, M. R. H., McCammon, M. G. & Fändrich, M. (2004). FTIR 
reveals structural differences between native β-sheet proteins and amyloid fibrils. 
Protein Science 13, 3314-3321. 
78. Barth, A. (2007). Infrared spectroscopy of proteins. Biochimica et Biophysica Acta: 
Bioenergetics 1767, 1073-1101. 
79. van Grondelle, W., Lecomte, S., Lopez-Iglesias, C., Manero, J.-M., Cherif-Cheikh, R., 
Paternostre, M. & Valery, C. (2013). Lamination and spherulite-like compaction of a 
hormone's native amyloid-like nanofibrils: spectroscopic insights into key interactions. 
Faraday Discussions 166, 163-180. 




80. Stroud, J. C., Liu, C., Teng, P. K. & Eisenberg, D. (2012). Toxic fibrillar oligomers of 
amyloid-β have cross-β structure. Proceedings of the National Academy of Sciences of 
the United States of America 109, 7717-7722. 
81. Valery, C., Artzner, F., Robert, B., Gulick, T., Keller, G., Grabielle-Madelmont, C., 
Torres, M. L., Cherif-Cheikh, R. & Paternostre, M. (2004). Self-association process of 
a peptide in solution: from β-sheet filaments to large embedded nanotubes. Biophysical 
Journal 86, 2484-501. 
82. Kawasaki, T., Fujioka, J., Imai, T., Torigoe, K. & Tsukiyama, K. (2014). Mid-infrared 
free-electron laser tuned to the amide I band for converting insoluble amyloid-like 
protein fibrils into the soluble monomeric form. Lasers in Medical Science 29, 1701-
1707. 
83. Kawasaki, T., Yaji, T., Imai, T., Ohta, T. & Tsukiyama, K. (2014). Synchrotron-
infrared microscopy analysis of amyloid fibrils irradiated by mid-infrared free-electron 
laser. American Journal of Analytical Chemistry 5, 384-394. 
84. Hall, A., Karplus, P. A. & Poole, L. B. (2009). Typical 2-Cys peroxiredoxins: 
structures, mechanisms and functions. The FEBS Journal 276, 2469-2477. 
85. Barranco-Medina, S., Lázaro, J.-J. & Dietz, K.-J. (2009). The oligomeric conformation 
of peroxiredoxins links redox state to function. FEBS Letters 583, 1809-1816. 
86. Qiu, W., Dong, A., Pizarro, J. C., Botchkarsev, A., Min, J., Wernimont, A. K., Hills, 
T., Hui, R. & Artz, J. D. (2012). Crystal structures from the plasmodium 
peroxiredoxins: new insights into oligomerization and product binding. BMC Structural 
Biology 12, 1-18. 
87. Saccoccia, F., Di Micco, P., Boumis, G., Brunori, M., Koutris, I., Miele, A. E., Morea, 
V., Sriratana, P., Williams, D. L., Bellelli, A. & Angelucci, F. (2012). Moonlighting by 
different stressors: crystal structure of the chaperone species of a 2-Cys peroxiredoxin. 
Structure 20, 429-439. 
88. Matthes, D., Gapsys, V. & de Groot, B. L. (2012). Driving forces and structural 
determinants of steric zipper peptide oligomer formation elucidated by atomistic 
simulations. Journal of Molecular Biology 421, 390-416. 
89. Rosano, G. L. & Ceccarelli, E. A. (2014). Recombinant protein expression in E. coli: 
Advances and challenges. Frontiers in Microbiology 5, 1-17. 
90. Gazit, E. (2002). A possible role for pi-stacking in the self-assembly of amyloid fibrils. 
FASEB Journal 16, 77-83. 




91. Phillips, A. J., Littlejohn, J., Yewdall, N. A., Zhu, T., Valéry, C., Pearce, F. G., Mitra, 
A. K., Radjainia, M. & Gerrard, J. A. (2014). Peroxiredoxin is a versatile self-
assembling tecton for protein nanotechnology. Biomacromolecules 15, 1871-1881. 
92. Gretes, M. C. & Karplus, P. A. (2013). Observed octameric assembly of a plasmodium 
yoelii peroxiredoxin can be explained by the replacement of native “ball-and-socket” 
interacting residues by an affinity tag. Protein Science  22, 1445-1452. 
93. Wood, Z. A., Poole, L. B., Hantgan, R. R. & Karplus, P. A. (2002). Dimers to 
doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins. Biochemistry 
41, 5493-504. 
94. Naiki, H., Hashimoto, N., Suzuki, S., Kimura, H., Nakakuki, K. & Gejyo, F. (1997). 
Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro. 
Amyloid 4, 223-232. 
95. Serio, T. R., Cashikar, A. G., Kowal, A. S., Sawicki, G. J., Moslehi, J. J., Serpell, L., 
Arnsdorf, M. F. & Lindquist, S. L. (2000). Nucleated conformational conversion and 
the replication of conformational information by a prion determinant. Science 289, 
1317-1321. 
96. Lee, J., Culyba, E. K., Powers, E. T. & Kelly, J. W. (2011). Amyloid-β forms fibrils by 
nucleated conformational conversion of oligomers. Nature Chemical Biology 7, 602-
609. 
97. Naldi, M., Fiori, J., Pistolozzi, M., Drake, A. F., Bertucci, C., Wu, R., Mlynarczyk, K., 
Filipek, S., De Simone, A. & Andrisano, V. (2012). Amyloid β-peptide 25-35 self-
assembly and its inhibition: a model undecapeptide system to gain atomistic and 
secondary structure details of the Alzheimer's disease process and treatment. ACS 
Chemical Neuroscience 3, 952-962. 
98. Jiao, Y. & Smith, P. E. (2011). Fluctuation theory of molecular association and 
conformational equilibria. Journal of Chemical Physics 135, 014502-014513. 
99. Stites, W. E. (1997). Protein-protein interactions:  Interface structure, binding 
thermodynamics, and mutational analysis. Chemical Reviews 97, 1233-1250. 
100. Langkilde, A. E., Morris, K. L., Serpell, L. C., Svergun, D. I. & Vestergaard, B. (2015). 
The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction 
and electron microscopy. Acta Crystallography Section D: Biological Crystallography 
71, 882-895. 
 




101. Colletier, J.-P., Laganowsky, A., Landau, M., Zhao, M., Soriaga, A. B., Goldschmidt, 
L., Flot, D., Cascio, D., Sawaya, M. R. & Eisenberg, D. (2011). Molecular basis for 
amyloid-β polymorphism. Proceedings of the National Academy of Sciences of the 
United States of America 108, 16938-16943. 
102. Tycko, R. & Wickner, R. B. (2013). Molecular structures of amyloid and prion Fibrils: 
Consensus vs. Controversy. Accounts of Chemical Research 46, 1487-1496.1. 
 




5   Chapter Five 
 
Templating higher order nanotubular assembly of hPrx3 protein 
 
5.1   Introduction 
Orchestrating the assembly of biological building blocks into hierarchical structures that can 
be used for fabrication of specific patterns requires the design of stable building blocks that 
can be triggered to self-assemble. Molecular self-assembly provides a versatile pathway for 
production of nanoscale materials that can be used in bionanotechnology applications such as 
templating minerals for production of conductive materials and fabrication of nanodevices. 
Exploiting the chemistry of biological tectons through a bottom-up approach has been used to 
create well-ordered structures in the nano- and micro-scale dimension with specific properties 
that can be used to trigger self-assembly. The use of simple biological molecules as scaffolds 
and templates has allowed for the production of a large number of varied yet customized non-
biological structures. Important examples include DNA origami1,2 and RNA origami3,4 that 
have been successfully used to create a range of different nanoscale shapes and patterns. 
 
Proteins offer some major advantages over nucleic acids as biological tectons since the range 
of different 3-dimensional structures possible is vast and they offer a wide range of surface 
chemistry that can be tuned for functionalization5,6,7. However, such templating remains 
challenging due to a lack of stable tectons that can direct such assembly. Naturally occurring 
proteins can organize themselves stably into a range of different structures that serve a specific 
function such as, nanotubes of TMV coat protein that encapsulate the viral genome and aid in 
host infection8, bacterial pili that help in gene transfer, and flagella that allow for bacterial 
locomotion9, microtubules that are components of the cytoskeleton10, nanostacks of 2-cys 




peroxiredoxin that have holdase activity11. Such assembly of the protein units largely results 
from oligomerization of symmetric domains through complementary non-covalent 
interactions. Also, the highly complex and crowded environment in vivo provides the necessary 
entropic effects to guide specific assembly of proteins, as seen for proteins that self-assemble 
into filaments that are part of the cytoskeleton12, protein fibres13-19 and amyloid spherulites14. 
However, producing such stable architectures in the laboratory remains challenging as it is 
difficult to mimic the exact cellular environment and also, the experiments are carried out at 
dilute concentrations. 
 
Tailoring protein building blocks, through a range of different techniques, have provided an 
alternate route to produce multiprotein structures in vitro20. Design strategies currently reported 
have relied mainly on modification of natural domains and/or incorporation of specific 
secondary structure elements through genetic modification or through chemical linking7. 
Protein tectons with an ability to self-assemble into nanometric structures have provided an 
alternative for the rational design of recombinant constructs that can self-assemble in response 
to a trigger21. Also, they can be expressed in large quantities and offer the ease of site-directed 
modifications and some of them offer the advantage of thermal stability, such as the LSMα 
from Methanobacterium thermoautotrophicum22.  
 
Peptides that self-assemble into extended nanostructures in response to physiological trigger 
have proven to be excellent candidates for production of functional hybrid materials23. In 
another approach, mixing of macromolecules with small molecules has led to production of 
macroscopic structures from molecular self-assembly through cooperative behavior. An 
important example is the production of large membrane structures by mixing the 
polysaccharide hyaluronic acid with peptide amphiphiles24. Xu et al. (2013) showed that 




aggregates of amphiphilic peptides mixed with cytosol proteins bind to the protein in drastically 
different ways depending on the scale of peptide assemblies25. In more recent work, fibril-
forming peptide motifs were successfully exploited as nano-scaffolds to which different 
proteins can be linked to create functional biomaterials, such as nanofibers with enzymatic 
activity and nanofibers with antigenicity for enhanced immune response 26. Self-assembled 
peptide nanostructures as scaffolds present an attractive tool to template assembly of complex 
proteins due to ease of use, customization and control of assembly in vitro. This chapter 
discusses the strategy to generate well-ordered extended nanoscale architectures of hPrx3 
protein, templated through self-assembling peptide sequences.  
 
5.2   Peroxiredoxin a model self-assembling protein  
Peroxiredoxins (Prxs), a family of enzymes that fix free peroxide in the cells and protect them 
from oxidative damage, exist as obligate homodimers that further self-assemble into toroidal 
oligomers27. Some Prxs can be triggered to form a range of different supramolecular 
assemblies28, such as clusters29, cages30, interlocked rings31, toroidal stacks32-36 and short 
nanotubes37. The toroid form of the protein is a responsive assembly of the protein dimers 
triggered by reducing conditions27. The radial symmetry of the associated dimers gives rise to 
the toroidal face comprising of five or six repeating units of the protein dimer. The toroid-
shaped oligomer is a generic structure of peroxiredoxin proteins with varying ring sizes and 
provides a large surface area of contact including the cavity of the toroidal pore. Amongst the 
different peroxiredoxins characterized, the dodecamer toroid-shaped quaternary conformation 
adopted by the mammalian Prx3 protein is the largest, with an external and internal diameter 
of 14 nm and 7.5 nm respectively38,39,40 (Figure 5.1).  





Figure 5.1: Crystal structure and TEM of hPrx3: (A) Cartoon image of hPrx3 dodecamer 
(PDB 5JCG) showing the inner and outer diameter of the ring structure; (B) Cartoon image 
of hPrx3 toroidal stack observed in protein crystal at alkaline pH 41; (C) TEM image shown 
was taken after dialyzing cleaved hPrx3 in pH 8.0 reducing buffer. (Scale bar is 100 nm). 




This feature of the Prx ring has been exploited for the production of toroidal nanostacks of 
peroxiredoxin from S. mansoni functionalized with gold nanoparticles42. An interesting feature 
observed in Prxs is the ubiquitous self-assembly of the toroids into short nanostacks of upto 
500 nm in length under acidic conditions. A recent high-resolution cryo-EM structure of hPrx3 
toroidal stacks showed that the stacking of the toroids is facilitated through a network of 
hydrogen bonds between the surface exposed α2, α6 and β2 motifs that lock the toroids into 
the high molecular weight stacked architecture43,39. In a more recent study, it was revealed that 
short toroidal stacks of Prx3 can form under alkaline pH under the highly crowded environment 
within the protein crystal. In the crystal structure the toroidal stacks can be further seen laterally 
associated to each other41. The extended toroidal stacked assembly of Prx protein is posited to 
be a distinct assembly of the protein with holdase activity29,39.  
 
These properties of hPrx3 make it attractive as a protein tecton to be explored for production 
of non-biological supramolecular assemblies that could eventually find application as 
nanoscaffolds in bionanotechnology. As mentioned earlier, the Prx3 toroid provides a large 
number of surface exposed positively and negatively charged amino acid residues that can act 
as sites for attachment of linkers such as lysine to link polymers towards the creation of 
hybrid material. The hollow core of the protein toroids and extended nanotubes can be used 
as encapsulate molecules with a specific activity. Furthermore, the toroid conformation is 
redox sensitive, thus provides a suitable control for targeted delivery and release of 
therapeutic molecules in vitro and their application as drug delivery vehicles. Modification 
of surface chemistry of the toroid through the introduction of specific residues like cysteine 
can allow for the production of non-biological architectures structures with redox sensitivity. 
Furthermore, incorporation of unnatural amino acids (UAA) is another prospective 
application that can be used for to produce protein architectures bearing antibiotic activity. 




For example, the UAA phenylglycine a homolog of phenylalanine bearing aromatic 
properties and is found in different antibiotics such as Apalcillin and Mezlocillin. 
 
5.3   Strategy for templating higher order assembly of hPrx3 
Electrostatic surface potential analysis performed on the crystal structure of hPrx3 (PDB 5JCG) 
using pymol software (www.pymol.org) showed polar and charged residues richly distributed 
on the surface (Figure 5.2). The homo-dodecamer toroid of hPrx3 contains six repeating dimer 
units of the protein. The radial symmetry between the associated dimers generates a toroid 
shaped scaffold with four different surfaces. The four different facets of the toroid are easily 
accessible and provide a large surface area for the association of the ring with extended peptide 
nanostructures, and for the ring to ring association. Analysis of the protein sequence using the 
protein property calculator tool (Expasy and http://protcalc.sourceforge.net) revealed that 
under neutral to alkaline conditions the protein is highly charged with a theoretical net charge 
of -4 at pH 7 and a net charge of -8 at pH 8.  
 
 
Figure 5.2: An electrostatic surface potential model of hPrx3 (PDB 5JCG) generated at pH 
8.0, showing the distribution of charged residue. Positively charged residue are shown in color 
blue and negatively charged residues are shown in the color red. 




As described in the previous chapter, the peptide sequences studied were comprised of one or 
more charged amino acid residues and the overall net charge on the peptide sequence is +1 or 
-1 at near neutral pH. Also, the side chain group of the charged lysine residue (K), the hydroxyl 
group of the serine residue (S) and the carboxamide group of the asparagine residue (N) within 
the β-continuous homodimer interface of Prx3 protein are seen protruding outwards from the 
β-sheet surface (Figure 4.1). 
   
The self-assembled extended peptide fibrillar structures thus provide a large surface area of 
non-covalent contact points that is accessible to the hPrx3 toroids. It was therefore 
hypothesized that mixing the extended peptide nanostructures with hPrx3 protein toroids, 
would result in association of hPrx3 toroids with the peptide nanostructures in a specific 
manner to form extended peptide-protein assemblies.  
 
5.4 Production of hPrx3 protein nanotubes 
The hPrx3 protein was expressed and purified as described in chapter 4 (Section 4.10.1). The 
N-terminal 6*His-tag was cleaved from the fusion protein through site-specific cleavage by 
rTEV protease and further purified (Section 2.5.6.2 and 2.5.6.3). The purity of the product was 
judged by SDS-PAGE analysis and complete removal of 6*His-tag was confirmed by liquid 
chromatography coupled with mass spectrometry (Appendix 1, Figure A1). The mixing 
experiments were carried out in HEPES, NaCl buffer at pH 8.0 buffer containing TCEP 
(Section 2.2.6) as the protein is stable in the buffer and adopts the toroid shaped quaternary 
conformation. Also, the self-assembly of the peptide was found to unaffected in this condition 
(Figure 5.3 A). Unless otherwise stated, the peptide solution was prepared by dissolving the 
peptide acetate powder in pH 8.0 buffer above the critical assembly concentration, vortexed to 
mix and equilibrated for 24 hours at 4°C prior to mixing. 




5.4.1 Mixing Prx3 peptide with hPrx3 protein  
The tagged hPrx3 protein sample stored at -80°C was thawed at room temperature and dialyzed 
into pH 8.0 buffer containing TCEP overnight (Section 2.5.7.2) and concentrated to 10 mg/mL 
(Section 2.5.5.3). The peptide acetate was mixed with 6*His hPrx3 protein, as described in 
section 2.5.9. TEM analysis of the peptide-protein mix revealed extended nanotubular 
assemblies with hPrx3 toroids scaffolded onto peptide fibrils (Figure 5.3 B, C). Aside, from 
the extended nanotubular structures, some free Prx3 peptide fibrils and hPrx3 toroids were also 
observed on the EM grid which suggested a heterogeneous mix of nanotubes, fibrils, and free 
toroids.  
 
Figure 5.3: TEM showing the extended nanotubular assembly of 6*His hPrx3 templated by 
Prx3 peptide nanotapes. 




(A) Control sample of peptide acetate in buffer at 5 mg/mL.  
(B) Control sample of 6*His hPrx3 protein in buffer at 0.1 mg/mL.  
(C) Extended nanotubes formed upon mixing Prx3 peptide tapes to 6*His hPrx3 protein toroids 
(0.1 mg/mL) equilibrated for 24 hours at 4°C. 
(D) Zoomed EM micrograph produced using ImageJ by applying bandfass filter, shows the 
details of the protein toroids arranged into extended nanostacks and free peptide nanotape.  
Note: Experiments were conducted in 20 mM Hepes, 150 mM NaCl at pH 8.0. (Scale bar is 
100 nm) 
 
To examine the significance of the peptide tag in the nanotubular assembly of the hPrx3 protein, 
the experiments were repeated with the cleaved hPrx3. The presence of extended tubular 
structures of nano- and microscale lengths similar to those observed with tagged protein 
demonstrated that the specific assembly of the protein toroids with the peptide tapes was not 
6*His-tag dependent (Figure 5.4).  
 
TEM further revealed that the tubular nanostructures are extended with many of them spanning 
across the imaged cross-section of the EM grid. Measurements performed on the TEM 
micrographs using ImageJ software revealed that the nanotubular structures were 
heterogeneous in length, with an average overall length between 1 to 2 micrometers. The width 
of the extended nanotubes was measured as a distribution between 10 to 15 nm44. 





Figure 5.4: TEM showing the extended nanotubes of hPrx3 templated by Prx3 peptide 
nanotapes: (A) Extended nanotubular structures formed on mixing Prx3 peptide mixed with 
hPrx3 protein; (B) Zoomed EM micrograph produced using ImageJ; (C) Histogram showing 
the distribution of nanotube length and nanotube width (D) collected from 308 and 302 
particles respectively. (Scale bar is 100 nm) 
Note: The concentration of peptide is 5.0 mg/mL and protein concentration is 0.1 mg/mL 
(0.0003 mM) with a molar ratio is 15000 peptide molecules:1 protein toroid. Experiments were 
conducted in 20 mM Hepes, 150 mM NaCl, 3 mM TCEP at pH 8.0.  




To assess whether the assembly of hPrx3 protein with Prx3 peptide was specific, two types of 
strategies were undertaken: 
 
(i) Mixing Prx3 peptide with other toroid shaped proteins. 
(ii) Mixing other self-assembling peptide sequences with hPrx3 protein. 
 
5.4.2   Mixing Prx3 peptide with ApTpx and Lsmα 
To examine the interaction of the peptide tapes with other toroid shaped proteins, the 
experiment was repeated with a decamer peroxiredoxin derived from the thermophile 
Aeropyrum pernix (ApTpx)45 and the unrelated toroid shaped heptamer protein Lsmα from 
Methanobacterium thermoautotropicum22.  
 
Mixing experiments were performed in solution conditions most conducive for the protein: In 
Hepes pH 8.0 buffer for ApTpx and in PBS pH 8.0 for Lsmα (Section 2.2.6). The overall 
theoretical charge on protein in the experimental conditions is -4.5 (ApTpx) and -2.5 (Lsmα). 
No specific extended nanotubular assembly was observed on mixing the two unrelated proteins 
with the peptide tapes (Figure 5.5).  





Figure 5.5: TEM of Prx3 peptide nanotapes mixed with other toroidal proteins: EM 
micrograph of Prx3 peptide mixed with ApTpx decamer toroids (A) and peptide mixed with 
Methanobacterium thermoautotrophicum LSMα heptamer toroids (B). Control sample show 
mostly individual decamer toroids for both ApTpx (CI) and Methanobacterium 
thermoautotrophicum Lsmα (CII) at 0.1 mg/mL. The peptide acetate concentration in the 
sample mix is 5 mg/mL. (Scale bar is 100 nm) 




The solution conditions for the experiment were as follows: 
(A) Hepes buffer: 20 mM Hepes, 150 mM NaCl, 3 mM TCEP pH 8.0 
(B) PBS buffer: 10 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, 140mM NaCl pH 8.0 
The roman numerals show the control protein samples: (I) ApTpx in Hepes pH 8.0 buffer and 
(II) Lsmα in PBS pH 8.0 buffer. 
 
Control samples of protein in their respective buffers revealed mostly individual protein toroids 
in both the cases. Control peptide samples showed extended nanotapes like assemblies as 
observed in control pH 8.0 buffer. The results thus suggested that nanotubular assembly 
observed was specific to the Prx3 protein. 
 
5.4.3   Mixing different peptide tectons with hPrx3  
To investigate the significance of altering the peptide sequences on the peptide-protein 
assembly, the interaction of hPrx3 protein with self-assembling peptide sequences other than 
Prx3 peptide was studied. Peptide sequences described in chapter 3 (Section 3.3) were prepared 
in the experimental buffer above the critical concentration of assembly and mixed with the 
hPrx3 protein. The conditions of assembly observed with the Prx3 peptide were maintained for 
the series of peptide sequences investigated for the specificity of the interaction with the 
protein.  
 
TEM of the protein-peptide mixes revealed that all the peptide sequences trialed induced 
hierarchical micron-long tubular stacks of the hPrx3 protein, with dense bundles of nanotubes 
observed with β-Lac peptide mixed with protein, individual nanotubes along with some 
bundles of nanotubes with DAPDC peptide and mostly individual nanotubes with UmuD’ 
peptide (Figure 5.6). The results suggested the assembly is specific to hPrx3. 





Figure 5.6: TEM showing the nanotubular assembly of hPrx3 protein induced by different 
peptide sequences: (A) hPrx3 + β-Lac peptide; (B) hPrx3 + DAPDC peptide; (C) hPrx3 + 
UmuD’ peptide. Control peptide acetate samples in reducing pH 8.0 buffer show self-
assembled nanostructures: (I) β-Lac peptide (10 mg/mL); (II) DAPDC peptide (70 mg/mL); 
(III) UmuD’ peptide (100 mg/mL). Protein concentration is 0.1 mg/mL. (Scale bar is 100 nm) 




5.5   Production of decorated peptide tapes and protein nanosheets 
Variants of the Prx3 peptide as described in Chapter 4 mixed with the hPrx3 protein also 
induced extended tubular assembly of the protein toroids similar to that described for parent 
Prx3 peptide. In the case of H3Y variant containing the specific sequence change with the 
histidine residue replaced by tyrosine residue, mixed with protein toroids resulted in a non-
specific assembly, with peptide tapes decorated with protein toroids (Figure 5.7 B). 
 
As described in chapter 4 (Section 4.7), the H3Y peptide variant self-assembles into a 
heterogeneous mix of thin and wide extended peptide tapes. The polymorphic peptide tapes 
with varying widths present different type of scaffolds to which protein toroids can associate. 
In the case of thin peptide tapes, relatively smaller surface area is available to the protein toroids 
thus, the protein toroids associate laterally which result in nanotube assembly. The wider 
peptide tapes present a large surface area of contact that is available to the protein toroids. This 
explains the non-specific assembly of the toroids decorated onto the extended peptide tapes. 
Therefore, to examine the non-specific assembly of the toroids with the variant peptide, mixing 
studies were carried out at large molar excess of the peptide that favored wide tape like 
assembly.  
 
TEM of variant peptide-protein mix containing 150 fold higher concentration (w/v) of the 
peptide to protein revealed nanotubular structures, with protein toroids, found laterally 
associated to the extended peptide tapes (Figure 5.7 A). For the sample containing a 250 fold 
excess of the peptide mixed with the protein, TEM revealed peptide nanotapes decorated with 
protein rings (Figure 5.7 B). In the case of a peptide-protein mix prepared to contain 500 fold 
excess (w/v) of the peptide mixed with protein, the hPrx3 toroids were found to laminate on 
top of the wide extended peptide tapes forming protein nano-sheets (Figure 5.7 C).  





Figure 5.7: TEM of variant peptide acetate H3Y mixed with hPrx3 at different concentrations: 
(A) H3Y peptide mixed at 150 fold higher excess to protein show nanotubes and peptide fibrils; 
(B) H3Y peptide mixed at 250 fold higher excess to protein show decorated peptide tapes; (C) 
H3Y peptide at 500 fold higher excess to protein show protein nanosheets. (Scale bar is 100 
nm).  




Note: Control peptide acetate sample prepared in reducing pH 8.0 buffer show peptide 
nanostructures: (I) Nanofibrils at 15 mg/mL; (II) Nanotapes at 25 mg/mL; (III) Wide nanotapes 
at 50 mg/mL. (Scale bar is 200 nm) 
 
5.6   Factors affecting peptide-protein assembly 
In order to probe the factors that control the different modes of interaction of hPrx3 toroids 
with peptide tapes, different solution conditions, and concentrations of peptide were tested. 
Previous studies on hPrx3 protein showed that the ionic strength of the buffer influences the 
self-assembly of the protein toroids into nanostacks36. Furthermore, pH is known to play an 
important role in the stacking of the protein toroids into extended tubes with acidic pH favoring 
the assembly of multiple toroids35,42.  
 
5.6.1   Peptide-protein assembly at different pH conditions   
Solution conditions such as pH can have a substantial effect on the quaternary organization of 
proteins and peptides. In the case of hPrx3, the protein toroids are stable at acidic and alkaline 
pH conditions. Furthermore, acidic pH < 6.0 favors the assembly of multiple toroids into short 
nanotubes 36. Therefore, to study the effect of pH on the assembly of peptide tapes with protein 
toroids, the peptide-protein mixes were prepared in different pH buffers. As, the theoretical pI 
of hPrx3 is 6.8, a pH range of 4.0 to 9.0 was chosen. 
 
The self-assembly of hPrx3 toroids and the Prx3 peptide was found to be stable across the 4.0 
to 8.0 pH range (Figure 5.8 A, B). This was apparent from the extended nanotubular assembly 
observed for the peptide-protein mixes prepared in pH 8.0 buffer and dialyzed into pH 6.0 
buffer and pH 4.0 buffer overnight. In the case of a peptide-protein mix dialyzed into pH 9.0 
buffer, mostly short peptide nanotapes and aggregated protein were observed (Figure 5.8 C).  





Figure 5.8: TEM of the peptide-protein mix at different pH: Peptide-protein mix dialyzed into 
pH 4.0 buffer (A) and pH 6.0 buffer (B) that show extended nanotubes. (C) Peptide-protein mix 
in pH 9.0 buffer shows fewer peptide tapes. Peptide concentration in the mix is 5 mg/mL and 
protein concentration is 0.1 mg/mL. (For A,B and C, the scale bar is 100 nm and for I-VI the 
scale bar is 200 nm) 




The solution conditions for the experiment were as follows: 
(A) pH 4.0: 20 mM sodium citrate, 150 mM NaCl, 3 mM TCEP 
(B) pH 6.0: 20 mM MES, 150 mM NaCl, 3 mM TCEP pH 6.0,  
(C) pH 9.0: 20 mM sodium borate, 150 mM NaCl, 3 mM TCEP pH 9.0  
Control buffer: 20mM Hepes, 150 mM NaCl, 3 mM TCEP pH 8.0  
The roman numerals show the control peptide acetates dissolved in pH 4.0 buffer (I); peptide 
acetate in pH 6.0 buffer (II); peptide acetate in pH 9.0 buffer. The control protein samples are 
at pH 4.0 (II), pH 6.0 (IV) and pH 9.0 (VI). 
 
Measurements performed on imaged nanotubes for the peptide-protein mix under acidic pH 
were found to be larger in length than those formed by protein only in this condition. Control 
experiments performed with Prx3 peptide acetate in pH 4.0 buffer and pH 6.0 buffer showed 
mostly self-assembled peptide nanotapes consistent with those observed at pH 8.0. At pH 9.0, 
the peptide nanostructures were relatively shorter than those observed at pH 8.0 and acidic pH. 
These results also showed that the self-assembly of the Prx3 peptide was stable at pH 4.0. For 
protein only samples, the extended nanotubes of hPrx3 protein observed at acidic pH ≥ 6.0 was 
consistent with those reported earlier36.  
 
TEM of hPrx3 protein dialyzed into pH 9.0 buffer did not show any toroids, consistent with 
the SEC-SLS data showing the protein existed as a dimer (Figure 5.9). This result explained 
the absence of the nanotubular assembly for the protein-peptide mix at pH 9.0. 
 





Figure 5.9: The SEC-SLS trace of hPrx3 protein at 0.1mg/mL in reducing buffer pH 9.0, shows 
a single peak corresponding to the protein dimer. 
 
5.6.2   Peptide-protein assembly at high salt concentration   
Samples of peptide-protein mix dialyzed into a buffer with varying amounts of sodium chloride 
concentration suggested that the peptide-protein assembly is disrupted by the high 
concentration of salt in the buffer. TEM of peptide-protein mix dialyzed into the high salt buffer 
(reducing pH 8.0 buffer + 500 mM sodium chloride) overnight showed mostly free peptide 
fibrils, some toroids associated non-specifically to peptide fibrils, a few nanostacks and free 
protein toroids (Figure 5.10).  
 
The protein nanosheets produced using the H3Y peptide variant were also shown to 
disassemble in buffer with high salt concentration (Appendix 1, Figure A2). These results 
suggested that the assembly of hPrx3 toroids with Prx3 peptide and peptide variant H3Y is 
largely of electrostatic nature. 





Figure 5.10: TEM of the peptide-protein mix at high salt concentration: Peptide-protein in 
reducing pH 8.0 buffer with 150 mM NaCl dialyzed into high salt pH 8.0 buffer overnight, 
showing mostly free peptide fibrils, short nanotubes, and free protein toroids. The arrows point 
to the protein toroids associated with peptide-fibrils in a non-specific manner. (I) Peptide 
control sample at 5 mg/mL shows extended nanostructures and (II) Control protein sample 
concentration at 0.1 mg/mL shows mostly protein toroids. (Scale bar is 100 nm) 
 
5.6.3   Peptide-protein assembly at varying ratio of peptide to protein 
Peptide-protein mixes prepared at dilute concentration of the Prx3 peptide and H3Y peptide 
variant at 1 mg/mL in reducing pH 8.0 buffer equilibrated for 24 hours revealed mostly free 
toroids and some toroids laterally associated to the peptide fibril. However, negatively stained 
EM micrographs of peptide and protein mixes equilibrated over 48 hours revealed short 
toroidal stacks and protein toroids laterally associated to peptide tapes (Figure 5.11). As 
previously described in chapter 4, the peptide sequences under dilute conditions exhibit slow 
kinetics of self-assembly. Also, the extent of self-assembly of the peptide is much lesser, which 
explains the result for dilute peptide-protein mixes.  





Figure 5.11: TEM micrographs of hPrx3 protein toroids mixed with Prx3 peptide (A) and 
H3Y variant (B) in HEPES, NaCl buffer pH 8.0 equilibrated for 48 hours. Arrows show 
hPrx3 protein toroids laterally associated to extended peptide tapes. (Scale bar is 100 nm). 
 
The results highlighted that the formation of extended peptide nanostructures is necessary to 
template nanotubular assembly of hPrx3 protein toroids. To investigate the effect of the amount 
of peptide mixed with hPrx3 protein on the overall length of the nanotubular structures, the 
experiments were carried out at different concentrations of the peptide, keeping the protein 
concentration constant. Negatively stained TEM micrographs of the different Prx3 peptide and 
hPrx3 protein mixes showed an overall decrease in the size distribution of the nanotubes with 
a decrease in molar excess of peptide to protein (Figure 5.12).  





Figure 5.12: Representative TEM micrographs of Prx3 peptide mixed with hPrx3 protein at 
(0.1 mg/ml) in reducing pH 8.0 buffer at different ratios. The final peptide concentration in the 
peptide-protein mix is: (A) 5mg/mL, (B) 2.5 mg/mL, (C) 1 mg/mL, (D) 0.5 mg/mL, (E )0.17 
mg/mL, (F) 17 µg/mL, (G) 0.34 µg/mL (equimolar concentration to protein) and (H) 6.8 ng/mL 
(below equimolar concentration to protein). (Scale bar is 100 nm) 




Measurement of the nanotubular structures from different EM grids of the peptide-protein 
mixes performed using the ImageJ software, presented an overall decrease in nanotube length 
with decrease in the amount of peptide mixed with the protein (Figure 5.13). Thus, supporting 
the inference that varying the amount of peptide mixed with protein allowed some control on 
the overall length distribution of the nanotubular structures formed. The extended micron long 
nanotubular assembly of the hPrx3 protein described here have not been previously reported. 
 
Figure 5.13: Length distribution of nanotubes collected from ≥ 300 particle measurements 
performed using the ImageJ software. The ratios indicate the number of peptide molecules to 
protein for each of the peptide-protein mixes shown in Figure 5.12.  




The maximum length of nanotubes formed on mixing Prx3 peptide with hPrx3 toroids shows 
an overall decrease in the length of nanotubes relative to the amount of peptide concentration 
in solution. 
 
The peptide-protein mixes prepared with the dilute concentration of the peptide mixed with the 
protein showed mostly short nanostacks consistent with the presence of free toroids (Figure 
5.12 and Figure 5.13 panel F, G & H). These results indicated that at high concentrations of 
the peptide in solution (where extended peptide nanostructures are present) mixed with the 
protein produces extended nanotubular assembly. With the decrease in the amount of peptide 
mixed with protein in solution, the resultant nanotubular structures show a relative decrease in 
the overall size. Control samples of the peptide revealed mostly extended peptide nanotapes 
for the peptide acetate in buffer sample in the 5 mg/mL to 1 mg/mL range, though at a dilute 
concentration of 0.5 mg/mL mostly short peptide tapes were present. Below 0.5 mg/mL very 
few or no extended structures were observed on EM grid (Appendix 1, Figure A3). 
 
5.7   Solution state characterization of peptide-protein assembly 
To study the extended nanotubular assembly observed by TEM in solution, the peptide-protein 
mixes were studied as a function of the average hydrodynamic size by DLS46,47. DLS provides 
a fast and straightforward method for estimation of the mean size of nanostructures in 
solution48.  
 
Hydrodynamic size distribution by intensity was chosen as the method of analysis as the 
emphasis is on the species with the largest scattering intensity contributing to the overall result. 
DLS showed a decrease in the overall size of nanostructures in solution with the decrease of 
Prx3 peptide mixed with hPrx3 protein (Figure 5.14 A). 





Figure 5.14: DLS of protein-peptide mixes in reducing pH 8.0 buffer plotted as size distribution 
by intensity. (A) Prx3 peptide and hPrx3 protein mixes with different concentrations of peptide 
mixed with protein. The final concentration of the peptide in the mix is: 0.50 mg/mL (1500:1); 
0.17 mg/mL (500:1); 0.02 mg/mL (50:1) and protein control is hPrx3 at 0.1 mg/mL. (B) Peptide 
control samples: peptide acetate in reducing pH 8.0 buffer. The peptide-protein mix and 
control samples were incubated at 4°C for 24 hours prior to analysis. 
 
The intensity by size data for the peptide-protein mix containing higher fold excess of peptide 
mixed with protein (1500:1) revealed a polydisperse sample consistent with the presence of 
large species with an average size of ~1000 nm. DLS of the peptide-protein mix with lower 
fold excess of the peptide to protein (500:1), showed a decrease in the intensity by size which 




suggested the decrease in the number of large nanostructures in solution. For the peptide-
protein mix with a tenfold lower excess of the peptide mixed with protein in solution (50:1), 
intensity by size showed a decrease in the average size of large aggregates in solution.  
 
The substantial intensity observed at the lower end of the log scale at ~ 10 nm for all the 
peptide-protein mixes trialed consistent with the control protein sample was attributed to free 
protein toroids. For peptide only samples (Figure 5.14 B), a narrow distribution of intensity by 
size at ~ 1000 nm for the highest concentration of peptide in solution suggested mostly peptide 
nanostructures that moved in solution in a similar manner.  
 
To examine the molecular weight distribution of such nanostructures in solution, the peptide-
protein mixes were subjected to sedimentation velocity analytical ultracentrifugation. As Prx3 
peptide does not comprise of any aromatic amino acids, the relative absorbance in the peptide-
protein mixes is contributed solely by the protein.  
 
The plot of relative concentration vs sedimentation coefficient for the peptide-protein mixes 
revealed peak at ~ 8 S is consistent with the control protein sample though with lower relative 
absorbance (Figure 5.15). The result suggested that all the peptide-protein mixes observed of 
free protein toroids. The relative lower absorbance of the protein in solution for the peptide-
protein mixes examined suggested that there was less free protein in solution.  
 





Figure 5.15: Analytical ultracentrifugation of hPrx3 and Prx3 peptide + hPrx3 mixes in 
reducing pH 8.0 buffer. The final concentration of the peptide in the mix is: 0.50 mg/mL 
(1500:1); 0.17 mg/mL (500:1); 0.02 mg/mL (50:1) and protein control is hPrx3 at 0.1 mg/mL. 
The peptide-protein mix and control samples were incubated at 4°C for 24 hours prior to 
analysis. 
 
To assess the presence of extended nanotubular structures in peptide-protein mixes that may 
fall out of solution, the samples were analyzed by TEM. Negatively stained EM grids made 
from resuspended pellets of peptide-protein mixes containing Prx3 peptide at 1500 fold and 
500 fold molar excess to protein revealed mostly extended nanotubular structures (Figure 5.16 
A and B). A TEM of the peptide-protein mix containing the peptide at 50 fold molar excess to 
protein revealed a heterogeneous mix of short nanotubes and free toroids (Figure 5.16 C).  





Figure 5.16: TEM micrographs of pellets obtained post-centrifugation of peptide-protein 
mixes suspended in pH 8.0 buffer. (A) Peptide-protein mix at 1500:1; (B) Peptide-protein mix 
at 500:1; (C) Peptide-protein mix at 50:1. Protein concentration is 0.1 mg/mL. White arrows 
show the hPrx3 toroids laterally associated with extended peptide tapes. (Scale bar is 100 nm) 




The results suggested that the extended peptide nanostructures template hPrx3 protein toroids 
in solution and such large peptide-protein settle to the bottom of the tube, therefore not detected 
by AUC. For peptide-protein mix containing dilute amount of peptide mixed with protein, that 
contain few or no extended peptide nanostructures that can template protein toroids, only short 
toroidal stacks and free toroids are present. This result supports the inference that extended 
peptide nanostructures are necessary to template protein toroids in solution into extended 
nanotubes. 
 
5.8   Discussion  
In this work, self-assembling peptide sequence designed from the homodimer interface of Prx3 
protein was successfully used to template nanotubular assembly of hPrx3 protein toroids. 
Peroxiredoxin proteins are versatile self-assembling protein tectons that can self-assemble into 
a range of different nanostructure in response to a physiological trigger. The protein tecton has 
been successfully exploited for the production of hierarchical assemblies such as 
nanostacks36,38. However, production of extended nanotubular assemblies of peroxiredoxin 
protein reaching microscale dimensions is reported here for the first time.  
 
Peptide sequences that can self-assemble into extended nanostructures in solution49 were used 
to template the higher order assembly of hPrx3 protein into nanotubes and nanosheets. Self-
assembling peptides that form amyloid-like fibrils have been useful as scaffolds to link 
synthetic polymers50,51 and biological molecules52,24,25 to create nanostructures with 
functionality. The amphipathic peptide sequences described in chapter 3 and 4, all self-
assembled in solution into extended nanostructures. The exposed side chains of charged and 
polar amino acid residues making up the peptide sequence provide multiple contact points for 
a large number of electrostatic interactions and hydrogen bonding. Charged biomolecule like 




protein can interact and associate with such extended peptide structures to produce 
supramolecular complexes with distinct morphology.  
 
To test this hypothesis, the toroid shaped hPrx3 protein was chosen due to the large surface 
area of the dodecamer quaternary conformation that is richly distributed with charged amino 
acid residues in a symmetrical manner. The self-assembling Prx3 peptide mixed with hPrx3 
protein in buffer condition that favors the dodecamer conformation of the protein interestingly 
produced extended nanotubular structures of nano- and microscale lengths. The extended 
nanotubular assembly of hPrx3 protein with peptide nanotapes was consistent for both the 
tagged and untagged form of the protein. It is interesting that the N-terminal peptide tag 
attached to the protein to facilitate protein purification is known to favor the dodecamer 
oligomer form of the Prx3 protein in solution36,39. Also, recombinant constructs of 
peroxiredoxin containing the peptide tag have been shown to form short nanostacks templated 
through nickel functionalized gold nanoparticles41. However, the tag was not necessary for the 
specific extended nanotubular assembly of the hPrx3 protein with peptide nanotapes.  
 
Experiments performed by mixing the peptide nanotapes with different toroid shaped proteins, 
revealed that the assembly was specific to the hPrx3 protein. Experiments with different self-
assembling peptide sequences mixed with hPrx3 protein, however, resulted in extended 
nanotubular assembly in each case. The specific assembly of the protein toroids with the 
peptide can be explained by the large size of the dodecamer protein toroid which provides a 
large surface area of contact necessary for the assembly and its natural tendency to self-
assemble. This is well evidenced in the self-assembly of protein toroids into stacks under acidic 
pH11,36,38 and under crowded environments within the protein crystal40.  




As described in chapter 3 and chapter 4, the self-assembled peptide nanostructures dissociate 
upon dilution49, therefore mixing experiments performed with dilute peptide acetate solution 
mixed with protein toroids revealed nanotubes that were smaller. Furthermore, mixing studies 
carried out with very dilute peptide solution mixed with protein toroids revealed mostly short 
nanotubes, nanostacks and free toroids. This suggested that the extent of the nanotube assembly 
upon mixing peptide with protein is relative and dependent on the amount and the length of 
peptide nanostructures in solution.  
 
Solution characterization of peptide-protein mixes by DLS showed that the extended 
nanotubular assemblies were present in solution, though it was difficult to detect such 
supramolecular structures by AUC. Solution environment can have a substantial effect on 
molecular self-assembly processes, especially assembly of two different macromolecules 
through excluded volume effects, binding, and templating53,54,55. The absence of multiple peaks 
corresponding to differently sedimenting nanostacks and nanotubes for peptide-protein mixes 
examined by AUC suggested that under such dilute conditions the specific assembly is 
weakened. This can be attributed to the large solution partitioning that exists between the 
peptide aggregates and the protein toroids which hinder in molecular interactions necessary for 
the specific self-assembly. Protein toroids associated with the peptide nanostructures, however, 
quickly settle to the bottom of the solution and thus, not detected by AUC. This explains the 
low relative absorbance of free protein toroids for the peptide-protein mixes examined by AUC 
that corresponded to mostly free protein in solution.  
 
The extended nanotubular structures observed for dilute peptide-protein mixes by TEM can be 
explained by molecular crowding that occurs on air-drying of the samples mounted onto the 
EM grid. This crowding of molecules results in the protein toroids and the peptide nanotapes 




coming into close proximity which favors macromolecular associations that leads to templating 
of toroids onto peptide nanotapes. 
 
 Similarly, peptide-protein mixes with a large molar excess of peptide mixed with protein, 
presents a highly crowded environment with macromolecules in close contacts53. The higher 
number of diffusing molecules at higher concentration of peptide mixed with protein toroids 
results in more molecular collisions between the participating molecules leading to the 
increase in the tendency to form extended toroidal stacks. Also, it is important to note that at 
higher concentration in solution; the peptide forms viscous hydrogels comprised of self-
assembled extended peptide tapes. Therefore, mixing higher fold excess of peptide in solution 
with protein toroids results in the increase in macroscopic viscosity of the final solution mix 
due to macromolecular crowding56. This change in viscosity results in slow translational 
movement of the macromolecules and the entropic effects under such crowded environments 
favor macromolecular association. This type of self-assembly of macromolecules in solution 
has been previously described in the case of proteins17,57 and biopolymers58.  
 
Crystallization of proteins presents a similar crowded environment wherein protein units tend 
to self-assemble into hierarchical structures otherwise not observed in solution55,56,57,58,59,60. 
This explains why under highly concentrated conditions the protein toroids associated to the 
extended peptide nanostructures electrostatically, and the scaffolded toroids further lock with 
adjacent toroids through the R-interface38 to form the stable extended nanotubular structures. 
The different assembly of protein toroids observed with the variant peptide H3Y can be 
explained by the templating of toroids onto the wide peptide tapes through the different 
exposed surface of the protein toroid. 




The strategy described in this work proposes a single step process to template the assembly of 
hPrx3 protein into extended nanotubes and nanosheets in a controlled manner using self-
assembling peptide sequences. Furthermore, the findings of this work show an alternate route 
of the assembly of peroxiredoxin toroids into extended tubular assemblies as observed in 
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6   Chapter Six 
 
Self-assembly of helical coiled coil interface derived peptides  
 
6.1   Introduction 
Helical coiled coils are another important protein motif that has been explored for the design 
of self-assembling peptide tectons1. α-helical coiled coils are versatile protein-protein 
interactive domains that constitute nearly 3% of reported protein coding regions2. They were 
first identified in fibrous assemblies of proteins such as keratin, myosin, epidermin, fibrinogen 
and soft α-keratin (stratum corneum) and hard α-keratin (trichocytes)3,4. Helical coiled coils 
are comprised of two or more helices wrapped around each other. This structural motif plays 
an important role in cementing protein-protein interactions for oligomerization of proteins 
involved in diverse biological processes1. The hallmark of such helical coiled coils is the 
repetitive arrangement of seven residues designated “abcdefg” called the heptad motif5,6. 
Sequences designed from heptad motifs found in natural assemblies of different structural 
proteins such as collagen, albumin, gelatin, fibroin and the intermediate filament protein keratin 
have been investigated for development of biomaterials7,8. Permutations and combinations of 
native heptad motifs have allowed for production of peptide tectons that can be triggered to 
self-assemble into a range of different fibrous nanostructures1. 
Keratins show much promise for design of stable biomaterials due to their inherent property to 
self-assemble into mechanically durable, highly stable and tough fibrous structures that form 
the bulk of epidermal appendages such as hair, wool, horns, hooves and nails, as well as their 
natural abundance9. Keratins have been used to produce biomaterials that are biocompatible 
and biodegradable. Keratins from wool and human hair have specific cell binding motifs with 




the sequence LDV and EDS that support cellular attachment. Also, keratins are believed to 
regulate cellular functions and behavior11. These properties has allowed the use of keratin based 
materials for 3D cell culture and for tissue engineering applications. Self-assembled keratin 
films produced by mixing with glycerol and chitosan exhibit enhanced mechanical properties 
and have been successfully used to produce films with wound healing and antibacterial 
activity10. Another important example is the keratin-polyamide 6 (PA6) nanofibers produced 
by electrospinning of solution mixes containing different rations of keratin protein and 
polyamide 6 (PA6). Keratin-PA6 films and nanofibers have been used in variety of applications 
ranging from biomedical sciences, for active water filtration and as textile fibers. Keratin based 
hydrogels demonstrate neuroinductive ability and facilitate tissue regeneration in vitro through 
enhanced activity of Schwann cells, and have been very useful as biomaterials in regenerative 
medicine11,12. 
 
Mammalian keratins are versatile proteins produced in vertebrate epithelia that rapidly self-
assemble in a heteromeric manner into smooth and flexible filaments13,14,15,16 together with 
keratin associated proteins that are intermediate in diameter (~ 10 nm)17,18. Keratin IF proteins 
that make up the hard tissues such as hair and nail (“hard” keratins) and the keratin IF of various 
soft epithelia (“soft” keratin) are made of low sulfur polypeptides which are homologous: low 
molecular weight ( ~ 45 kDa) acidic type I and the higher molecular weight (~ 60 kDa) neutral 
to basic type II keratins19,20. Hard keratin IFs make up a large portion of the skin epidermis and 
all the dry weight in keratinized epidermis such as wool, hair, nail, claws, quills, horns and 
hooves21. Keratin fibers are associated with cortical cells comprised of longitudinally aligned 
intermediate filaments in the growth direction surrounded by cell matrix. Figure 6.1 shows a 
schematic of the keratin fiber19. 





Figure 6.1: Keratin intermediate filament organization: (A) Schematic diagram showing the 
structural organization of the intermediate filament protein keratin in the wool fiber ;(B) Model 
of IF protein structure showing the central helical coiled coil rod domain separated by linking 
segments and the coiled coil heterodimer complex formed from the self-assembly of type I and 
type II keratins; (C) TEM micrographs showing the morphology of keratin intermediate 
filaments. (Taken with permission from CSIRO22 and Hermann et al. 199923. 




Most subtypes of IF proteins self-assemble as a homopolymer, but keratin intermediate 
filaments that form wool fibers are distinct in that they assemble into an obligate 
heteropolymer. Self-assembly of hard α-keratins into IFs proceeds from dimerization of type I 
and type II keratins into a coiled coil heterodimer23. Oligomerization of coiled coil 
heterodimers gives rise to the second level of structural hierarchy the unit length filaments 
(ULFs) with width between 50–60 nm or 50–120 nm. Annealing of the ULFs leads to 
elongation into long extended filaments, which further undergo compaction along the lateral 
axis to give rise to ~10 nm wide mature intermediate filaments that make wool fibers23,24.  
New Zealand (NZ) is one of the largest producers of wool and NZ wool exports contribute 11% 
of the annual global wool production25. The value of the wool produced is dependent on the 
quality of the wool, which is in turn dependent on the quality of the individual fibers. To open 
up new, non-traditional, markets for NZ wool, wool basic components can be explored as 
potential sources of new biomaterials for a range of applications, including medical and 
material sciences. To do so, the basic structure and properties of intermediate filament proteins 
need to be understood at molecular level. In particular the self-assembly process leading to the 
formation of the 10 nm intermediate filaments (IFs) that act as basic building blocks in the 
hierarchical assembly of wool fibers16.  
This chapter discusses the design of peptide sequences from keratin proteins that are the main 
components of wool intermediate filaments and the basic self-assembling properties of chosen 








6.2   Keratin as source of peptide tectons 
Crystallographic studies focused on the central rod domain of the intermediate filament 
proteins18,26,27,28 revealed that specific motifs located in the C-terminal end of the helical rod 
domain are critical for the self-assembly of the heterodimers and subsequent filament 
assembly29. Such motifs show high consensus among different keratins across species as 
diverse as primitive fish and humans, which include the non-heptad sequence called “stutter” 
and the highly conserved so called consensus motifs: “LNDR” motif in coil 1A and 
“TYRKLLEGEE” motif in coil 2B16,27,30. These motifs are part of the coiled coil protein 
interface that is involved in the oligomerization of IF proteins.  
In the crystal structure of IF protein vimentin homodimer coil 2B and keratin heterodimer coil 
2B, the consensus motif sequence “TYRKLLEGEE” is found to be in complementary non-
covalent close contact27,31. Structural analysis of vimentin homodimer coil 2B (PDB 1GK6) 
and keratin K5-K14 heterodimer coil 2B (PDB 3TNU) for interface sequences by the PISA 
software revealed the consensus sequence motif as an interface motif. Inspection of the 
interface residues revealed two important interactions: a salt bridge between the glutamic acid 
residue and arginine residue and a hydrogen bond between the tyrosine residue and arginine 
residue (Figure 6.2). The salt bridge between the glutamic acid residue and the arginine residue 
within the consensus sequence motif is an essential interaction across the interface and 
conserved in both homopolymeric and heteropolymeric IFs32,33. The structural versatility of 
such interface motifs provides the necessary driving force for such oligomerization of proteins 
through sets of non-covalent interactions. Also, such motifs are evolutionary optimized to drive 
such self-assembly in a highly specific and controlled manner34. 





Figure 6.2: Atomic structure of coil 2B domain: Crystal structure of vimentin homodimer (A, 
PDB 1GK6) and human keratin K5/K14 heterodimer (B; PDB 3TNU). The molecular 
interactions occurring between the consensus sequence motif at coiled coil protein interface of 
the vimentin homodimer and K5-K14 heterodimer are highlighted15,32. 




Another important feature of the coil 2B of IF keratins is the rich distribution of cysteine 
residues, especially flanking the consensus sequence motif of IF keratins specific to the wool 
fiber35. Current understanding is that the disulfide bonding within keratin filaments is part of a 
major reorganization of the filaments from predominantly parallel bundles to crossed networks 
upregulated at early stages of terminal differentiation of epidermal cells32,36,37. Keratins 
extracted from the stratum corneum in the absence of reducing agents and in the presence of 
air rapidly disulfide cross-link into large aggregates unable to enter an SDS-PAGE gel36. In 
another study, mutant xenopus and mouse keratin designed with a cysteine residue introduced 
in the central rod domain formed disulfide linked keratin homodimers over time in the presence 
of air38. Sequence analysis of wool hard α-keratin type I and type II focused on the coiled coil 
2B region generated using T-coffee and ESpript (http://espript.ibcp.fr)39 revealed cysteine 
residue present flanking the consensus sequence motif “CEINTYRS/GLLE/DSEDC” (Figure 
6.3). The dense localization of cysteine residues near the highly conserved consensus sequence 
motif at the C-terminus within hard α-keratins of human hair and sheep wool makes them 
sensitive to redox change. 
 
In the specific case of wool hard α-keratins, the only heptad like sequence studied thus far 
looking at self-assembly is the consensus sequence motif “YRRLLEGEE”. This motif was 
identified as a key coil 2B motif that can self-assemble into tetramers on its own27,40. In an 
earlier study, Hatzfeld et al. showed that a synthetic peptide corresponding to the consensus 
sequence motif of human cytoskeletal keratin containing an N-terminal cysteine residue 
inhibits keratin filament assembly. However, any specific self-assembly of the peptide 
sequence on its own was not described41.  





Figure 6.3: Sequence alignment of C-terminus end of the coiled coil 2B region of the central 
rod domain of different type I and type II hard α-keratins from Ovis aeris. The black dashed 
box shows the location of the peptide sequence comprised of the consensus sequence motif 
designed from type I α-keratin (K31P1 and K31P2) and type II α-keratin (K81P1).  
 
To our knowledge, no other isolated wool peptide motif has been investigated as source of self-
assembling peptides. The influence of cysteine residues, despite their intrinsic role in 
intermediate filament cross-linking and responsiveness to redox conditions, has also not been 
previously evaluated in terms of influence and control of self-assembly. 
 
6.3   Peptide sequences investigated for self-assembly 
A UniProt wide search for cuticular α-keratins and keratin associated proteins in Ovis aeris 
species resulted in > 240 entries. The entries were narrowed down by focusing on: (i) type I 
and type II keratins, while excluding keratin associated proteins; (ii) the consensus motif 




sequence at the carboxy-terminal end of coil 2B in the central coiled coil rod domain and (iii) 
the region of consensus sequence motif flanked by cysteine residues.  
 
The final set of peptide sequences were composed of 11-15 residues corresponding to the 
consensus sequence motif from the C-terminus region of the 2B coil of O. aeris type I hard α-
keratin and O. aeris type II hard α-keratin. The peptide sequences were modified from the 
original sequence by addition of the cysteine residue at both the N-terminus and C-terminus 
and capped at both the ends: N-terminal acetylated and C-terminal amidated to conserve the 
overall charge of the sequence (Table 6.1).  
 
Table 6.1: Ovine keratin derived peptide sequences chosen as models 
Name Peptide Source pI 
Charge at 
neutral pH 
K31P1 Ac-CYRGLLDSEDC-NH2 Keratin 31 3.54 -2.1 
K81P1 Ac-CYRRLLEGEEC-NH2 Keratin 81 4.45 -1.1 
K31P2 Ac-CEINTYRGLLDSEDC-NH2 Keratin 31 3.43 -3.1 
Note: Figure 6.3 shows the location of the corresponding source peptide sequence within the 
type I and type II hard α-keratins. 
 
In the specific case of the K31P2 peptide derived from the C-terminus end of the coiled coil 
2B of type I hard α-keratin, it is noteworthy that the peptide sequence comprised of the 
consensus sequence motif flanked by cysteine residues is a naturally conserved sequence 
(Figure 6.3 A). The K31P2 peptide investigated in this work  differs from the previously 








6.4   Characterization of peptide self-assembly  
 
6.4.1   Solution characterization of peptide self-assembly 
The peptide sequences were obtained as a white colored lyophilized powder from Mimotopes 
Ltd. (Sydney, Australia). The purity of the peptides was > 95% as tested by the manufacturer. 
Initial studies on the peptide acetate dissolved in water and HFIP/TFA mixes showed good 
solubility. However studies with peptide acetate dissolved in water were not soluble at peptide 
concentrations > 10 mg/mL (w/v). The secondary structure of the peptide sequences in solution, 
was examined by circular dichroism spectra for dilute peptide acetates in water at 0.1 mg/mL. 
CD spectra for all the three peptide showed minima at ~ 222 nm and at ~ 208 nm (Figure 6.4). 
The presence of the double minima at the corresponding wavelengths for each of the peptides 
suggested a helix conformation of peptides in solution42. 
 
Figure 6.4: Far UV circular dichroism spectra of peptide acetates K31P1, K81P1 and K31P2 
in water at 0.1 mg/mL. The peptide acetate in water samples was equilibrated for 24 hours at 
4°C and degassed prior to analysis. 




6.4.2   TEM characterization of peptide self-assembly  
Lyophilized peptide acetates were dissolved in water in the 10–50 mg/mL (w/v) range. In the 
specific case epidermal keratins the assembly of keratins into extended intermediate filaments 
is known to occur at room temperature43. Thus, the experiments were carried out at room 
temperature and the peptide acetates were equilibrated in solution for at least 24 hours prior to 
analysis.  
 
Peptide K31P1 was found to be soluble in water at all the concentrations investigated, however, 
both peptide K81P1 and peptide K31P2 showed lower solubility in water. Furthermore, peptide 
acetates K81P1 and K31P2 in water at ≥ 10 mg/mL concentration, stored at 25°C (room 
temperature) for over 24 hours showed visible precipitates (Figure 6.5). This indicated a 
saturated peptide solution having large number of insoluble peptide aggregates. 
 
Figure 6.5: Peptide acetates in water (pH ~ 5.0) at 10 mg/mL equilibrated for 24 hours at 
25°C. 
 
Negatively stained micrographs of the peptide acetate in water samples for K31P1 and K81P1 
analyzed by TEM (Section 2.9.1) did not show any substantial difference between EM 
micrographs prepared immediately after dilution and 24 hours after equilibration at 25°C. It is 
important to note that the CD spectra showed that the peptides attained a helical conformation 




in water, however absence of any clear self-assembly by TEM suggested the peptide self-
assembled into short helical coiled-coil structures which were difficult to visualize by TEM. A 
similar concentrated sample of K31P2 peptide equilibrated over 24 hours however, self-
assembled into short tape like structures that appeared to be hierarchical structures self-
assembled from smaller rod shaped structures (Figure 6.6).  
 
Figure 6.6: Negatively stained micrographs of peptide acetates in water (pH ~ 5.0) at 10 
mg/mL (w/v) analyzed at 24 hours (A), T1 week (B) and T3 weeks (C) stored at 25°C . Arrows 
indicate to the short rod shaped fragments. (Scale bar is 200 nm) 
 
Peptide acetates prepared in water at 10 mg/mL monitored over three weeks stored at room 
temperature developed a turbid appearance suggesting the presence of extended assemblies. 
Such samples of peptide acetates analyzed by TEM showed mostly short rod like fragments 




and some longer tapes for the K31P1 peptide; and mostly extended tape like nanostructures for 
K81P1 peptide; extended filament like nanostructures and short rod shaped fragments for 
K31P2 peptide (Figure 6.6 C).  
 
The presence of a heterogeneous mix of short rod like fragments and extended filament 
structures in all the three cases suggested that the peptide first self-assembled into short rod 
like fragments that further assembled into extended filament like nanostructures. The 
development of such extended assemblies in solution over time explains the turbid appearance 
of the peptide acetate solutions. Further, the absence of such rod like fragments and tapes for 
K31P1 and K81P1 peptide acetate samples equilibrated for 24 hours and over 1 week suggested 
a slow assembly process for these peptide sequences. 
 
Measurements performed on the extended nanostructures observed by TEM for the peptide 
acetates using ImageJ software, revealed nanostructures of mostly 50 nm in length for K31P1 
peptide, 200 nm in length for K81P1 peptide and between 400 nm and 800 nm in length for 
K31P2 peptide (Figure 6.7). The width of such extended nanostructures in each of the three 
cases was found to be between 8-10 nm (Figure 6.8). Aside from the extended nanostructures, 
the smaller unraveled structures also observed in all the three cases were < 50 nm in length and 
between 5 nm and 7 nm in width. Such small structures have been previously described for IF 
proteins and are thought to correspond to the protofibrils13,14,44.  
 





Figure 6.7: Measurement of nanostructures of peptide acetates K31P1 (A), K81P1 (B) and 
K31P2 (C) at 10 mg/mL (w/v) in water stored at 25°C for over three weeks. Histograms used 
to present the length statistics have been obtained from nearly independent measurements. 
Panel shows the representative TEM micrographs. Error bars correspond to standard errors 
of the means of 10 independent measurements. (Scale bar is 200 nm) 





Figure 6.8: Zoomed TEM micrographs of peptide acetates K31P1 (A), K81P1 (B) and K31P2 
(C) at 10 mg/mL in water. (D) Histogram shows the width distribution of the extended filament 
like nanostructures collected for 300 particles. Red lines indicate the Error bars correspond 
to standard errors of the means of 10 independent measurements. (Scale bar is 50 nm) 
 
These results showed that the peptide sequences designed from the consensus sequence motif 
of type I and type II hard α-keratin specific to wool fibers self-assembled in isolation into 
nanostructures with extended morphology. Further, the self-assembly of peptides involved 
formation of short rod like structures which further self-assembled into extended filaments with 
dimensions similar to those described for intermediate filaments of full length keratins14,15. 
 




6.4.3   Effect of pH on peptide self-assembly  
Solutions conditions like pH, ionic strength and the presence of reducing agents can affect the 
solubility of peptide acetates in solution45,46. In the case of mammalian epidermal keratins, 
basic pH and non-reducing conditions are known to favor filament assembly and thus decrease 
solubility18,47. The presence of a large number of charged residues distributed across the peptide 
sequences investigated make them susceptible to change in solution pH. Protonation and 
deprotonation as a function of pH is known to affect peptide the self-assembly process48. 
 
As mentioned above, the salt bridge between the glutamic acid residue of strand 1 and the 
arginine residue of strand 2 and the hydrogen bond between the tyrosine residue of strand 1 
and the arginine residue of strand 2 within the consensus sequence motif are highly conserved 
interactions of the coiled-coil protein interface32 (Figure 6.2 B). Such specific and essential 
non-covalent interactions of the parent interface can be conserved in the self-assembly process 
of the isolated peptide sequences. Therefore, the self-assembly of the peptides was studied:  
 
(I) At different pH conditions (4.0 to 7.6) and in presence of salt (150 mM sodium 
chloride)  
 
Peptide acetate samples prepared in different buffer solutions with pH in the 4.0 to 7.6 range 
and in buffer with 150 mM sodium chloride were monitored overtime. Peptide acetate K31P1 
was found to soluble over the pH 4.0 to 7.6 range. Absence of any particulate matter or turbidity 
suggested no self-assembly of the peptide acetates (Figure 6.9 A).  





Figure 6.9: Peptide acetates at 10 mg/mL at different pH conditions (A) and in buffer 
containing 150 mM sodium chloride (B) stored for 3 weeks at 25°C. pH 4.0: 20 mM sodium 
acetate; pH 5.0: 20 mM sodium acetate; pH 6.0: 20 mM MES; pH 7.6 20 mM Tris-HCl. 
 
Peptide acetates K81P1 and K31P2 were soluble only under basic pH, however, at acidic pH 
< 6.0 visible precipitates observed for both K81P1 and K31P2 peptides indicated a saturated 
peptide solution. This decrease in solubility of the peptide acetates can be explained by the 
solution pH nearing the iso-electric point (pI) of the peptide acetates, which falls between 3.5 
and 4.6 for all the three peptides.  




The turbid appearance of the peptide acetate samples, similar to that observed for peptide 
acetates in water (Figure 6.9 A) however, suggested the formation of extended peptide 
assemblies. Peptide acetate samples prepared in buffer containing 150 mM sodium chloride 
were similar in appearance to the buffer only samples and did not show any substantial 
difference in solubility (Figure 6.9 B). 
 
Figure 6.10: Negative stained transmission electron micrographs of peptide acetates at 10 
mg/mL in 20 mM buffer solution at different pHs stored at 25°C in over three weeks. (A) 20 
mM sodium acetate pH 4.0 ;(B) 20 mM sodium acetate pH 5.0 ;(C) 20 mM MES pH 6.0 ;(D) 
20 mM Tris-HCl pH 7.6. (Scale bar is 200 nm) 




Electron microscopy analysis of the peptide acetate samples in buffer at near neutral pH of 7.6 
revealed that the K31P2 peptide self-assembled into nanostructures, with the presence of short 
rod like fragments (Figure 6.10 D). Such assemblies with extended morphology have been 
previously described for synthetic peptide designed from consensus sequence motif mixed with 
epidermal keratins41. No such assembly was observed for either of the shorter peptides K31P1 
and K81P1 under these conditions.  
 
At a slightly acidic pH of 6.0, all three peptides self-assembled in solution with short rod like 
fragments and wide extended tapes observed for both K31P1 and K81P1, and extended 
filament like nanostructures observed for the K31P2 peptide (Figure 6.10 C). The extended 
filament assembly of the K31P2 peptide was found to be stable over the pH range 4.0 to 6.0 
(Figure 6.10 A-C). In the case of the K81P1 peptide, the extended filament like assembly was 
favored under more acidic pH 5.0, consistent with that observed for the peptide acetate in water 
sample (Section 6.3.2). At pH 4.0, the specific self-assembly of the K81P1 peptide was found 
to be more pronounced with the presence of extended filament like nanostructures (Figure 6.10 
A). For the shorter peptide K31P1, no specific extended filament like assembly was observed 
under the conditions investigated. However, the presence of short rod like fragments and 
nanostructures with tape like morphology, consistent at all acidic pH conditions trialed, 
suggested that the K31P1 peptide self-assembled in solution. 
 
Measurements performed on the nanostructures observed for the K31P2 peptide at pH 4.0 were 
on an average ~ 800 to 1000 nm in length and ~ 10 nm in width, consistent with those observed 
for control pH sample (Figure 6.11 C).  





Figure 6.11: Measurement of nanostructures of peptide acetates K31P1 (A), K81P1 (B) and 
K31P2 (C) at 10 mg/mL in buffer at different pH. Panel shows the representative TEM 
micrographs. Error bars correspond to standard errors of the means of 10 independent 
measurements. (Scale bar is 50 nm). 




The histogram shows the distribution of the width the different self-assembled peptide 
nanostructures collected from ~ 300 particle measurements done using ImageJ software. The 
zoomed EM micrograph is produced using ImageJ by applying bandfass filter, shows the 
details of the peptide nanostructures. 
 
However, at higher pH 6.0 the extended nanostructures were less wide ~ 5 nm, which suggested 
that the specific self-assembly of the K31P2 peptide into extended filaments similar in 
dimension to keratin intermediate filaments is favored at low pH ≤ 5.018,49. In the case of 
K81P1, the extended filament assemblies observed at pH 4.0 were similar in dimension to those 
observed for the control pH sample, consistent with the K31P2 peptide. Measurements 
performed on the nanostructures observed for the shorter K31P1 peptide at pH 6.0 revealed 
that the peptide nanotapes were 60-90 nm in length.  
 
6.4.4   Effect of redox state on peptide self-assembly  
As mentioned earlier, disulfide crosslinking of keratin oligomers is inherent to the self-
assembly of hard α-keratins into cross-linked fibrous networks15,32. However, the significance 
of disulfide crosslinking between cysteine residues that are part of the coiled coil protein-
protein interface at the lower level of self-assembly is not well understood. The peptide 
sequences derived from the consensus sequence motif of wool hard α-keratins type I and type 
II, were modified by addition of a cysteine residue at both ends of the peptide. This was done 
with an aim to build peptide tectons that can be triggered for self-assembly. Therefore, to study 
the effect of change in peptide assembly as a function of redox state of the peptide, the 
experiments were conducted with peptide acetates dissolved in buffer containing TCEP 
(reducing conditions) and buffer containing hydrogen peroxide (oxidising conditions).  




Earlier results showed that all the three peptides under non-reducing conditions and in the 
presence of air, and under acidic conditions self-assembled into nanostructures (Section 6.3.2). 
As the peptide assembly was found to be sensitive to pH change, the experiments were carried 
out in the solution most favorable for peptide self-assembly (pH 5.0 sodium acetate buffer at 
25°C). The control peptide sample for each of the three peptides was prepared by dissolving 
the lyophilized peptide acetate in pH 5.0 buffer devoid of any oxidising or reducing agent.  
 
Peptide acetate samples stored at 25°C for over three weeks for each of the conditions 
investigated self-assembled into nanostructures, with extended tape like assembly observed for 
K31P1 peptide and extended filaments observed for both K81P1 and K31P2 peptides (Figure 
6.12). The extent of self-assembly of the peptides into tapes or extended filaments for each of 
the three peptides, however was found to be favored in presence of a 10-fold molar excess of 
hydrogen peroxide (oxidising conditions). For peptide acetates dissolved in buffer containing 
TCEP, no specific tape like assembly was observed for the K31P1 peptide, though the 
appearance was consistent with the presence of relatively smaller nanostructures. Both K81P1 
and K31P2 peptides self-assembled into extended filament like nanostructures, however these 
filaments were larger in width and appear unraveled than the extended filaments observed 
under oxidising conditions for the peptides (Figure 6.12, B and C). Keratin filaments under 
TEM are usually characterized as smooth, unbranched, flexible individual filaments that may 
be sometimes bundled. Unraveled filaments usually correspond to disentangled protofibrils 
that are no longer in tight contact with each other along the length of the filament and thus 
appear wider. Furthermore, long stretches of unraveled filaments are interspersed with shorter 
more compact stretches50. 
 
 





Figure 6.12: TEM of peptide acetates in reducing and oxidising conditions: Negative stained 
electron micrographs of peptide acetates K31P1 , K81P1 and K31P2 dissolved in pH 5.0 buffer 
(buffer only);peptide acetate dissolved in pH 5.0 buffer with TCEP (Reducing) and peptide 
acetate in pH 5.0 with H2O2 (oxidising). TEM micrographs for peptide acetate samples stored 
at 25°C were taken at the end of three weeks. (Scale bar is 200 nm) 
 
To further examine the effect of reducing conditions (TCEP) on peptide self-assembly, the self-
assembled extended peptide nanostructures formed under oxidising conditions were dialyzed 
into buffer containing TCEP. TEM analysis of such peptide samples revealed nanostructures 
with extended morphology for two of the three peptides (Figure 6.13).  
 





Figure 6.13: TEM of peptide acetates under reducing conditions: Negative stained electron 
micrographs of peptide acetates K31P1 , K81P1  and K31P2  dissolved in pH 5.0 with H2O2 
(oxidising) stored over three weeks at 25°C dialyzed into pH 5.0 buffer with TCEP. TEM 
micrographs for peptide acetate were taken 24 hours after dialysis into reducing buffer. Both 
K81P1 (B) peptide and K31P2 peptide (C) form extended nanostructures under these 
conditions. (Scale bar is 200 nm) 
 
Measurement of the peptide nanostructures, revealed that the structures observed for K31P1 
peptide were smaller in size and much wider in dimension than the peptide nanotapes observed 
under oxidising conditions (Figure 6.14).  





Figure 6.14: Measurement of nanostructures formed by peptide acetates K31P1 (A), K81P1 
(B) and K31P2 (C) at 10 mg/mL dissolved in buffer with TCEP pH 5.0 as shown in figure 6.13. 
300 measurements from the data set for the peptide at the conditions investigated were used to 
present length and width statistics. Error bars correspond to standard errors of the means of 
10 independent measurements. 




In the case of the K81P1 peptide the extended nanostructures were similar in length but nearly 
twice as wide. For the K31P2 peptide the nanostructures were much smaller in length compared 
to those formed under non-reducing conditions and in presence of hydrogen peroxide. These 
results suggested that disulfide cross-linking is not necessary for peptide self-assembly. The 
differences in the overall morphologies and dimensions of the peptide assemblies observed 
under non-reducing conditions and under oxidising conditions, however, suggest a role for 
cysteine residues in the specific self-assembly of the peptides into extended tapes or individual 
extended filaments.  
 
The absence of the specific self-assembly of K31P1 peptide into upon dialyzing into buffer 
with TCEP suggested that the peptide self-assembly into nanotapes is not favored under 
reducing conditions. These peptide nanostructures were similar in dimension to those observed 
under reducing conditions. TEM of K81P1 and K31P2 peptide acetates dialyzed into reducing 
buffer revealed disordered peptide aggregates and some bundles of extended filaments. Such, 
bundles of filaments have been described for full length keratins subjected to proteolysis14. 
This indicated that the change in redox state of the peptide affects hierarchical self-assembly 
of the peptide. 
 
To examine the morphology and size of the extended filaments formed by peptides K81P1 and 
K31P2 at acidic pH, under oxidising conditions, single particle analysis was performed from 
EM micrographs taken from different sample preparations (Figure 6.15).  
 





Figure 6.15: Measurement of filament like nanostructures of peptide acetates K81P1 (A) and 
K31P2 (B) at 10 mg/mL in pH 5.0 buffer with H2O2 stored at 25°C for over three weeks. Data 
for measurements shown has been obtained from three different independent experiments. 300 
measurements from the data set for each of the peptide acetates was used to present the width 
and length statistics. Very short nanostructures are <150 nm, short IFs are 200 - 500 nm, 
intermediate nanostructure are 500 to 1000 nm long and long nanostructure are > 1000 nm51. 




Image analysis of the nanostructures done using ImageJ software revealed the average width 
of the nanostructures to be between 8 nm to 10 nm, with most of the filaments having a diameter 
of 10 nm. The size of the extended filaments under oxidising conditions was found to be larger 
than those observed for the peptide in water or pH 5.0 buffer with measured average overall 
length of ~600 nm for K81P1 peptide and ~1 µm for K31P2 peptide.  
 
6.4.5   SDS-PAGE analysis of peptide nanostructures 
To study the redox sensitivity of the peptides in solution, peptide samples prepared in pH 5.0 
buffer stored at room temperature over 24 hours were analyzed by gel electrophoresis. Peptide 
solutions were centrifuged at 10,000 rpm for 10 minutes to pellet down suspended high 
molecular weight (HMW) peptide aggregates. The samples were run on gel (4% to 12%) 
containing sodium dodecyl sulfate (SDS) under reducing with TCEP and non-reducing without 
TCEP. 
 
The peptide acetates were equilibrated at room temperature (~25°C) for 24 hours. To examine 
the effect of reducing conditions on peptide self-assembly, peptide acetates dissolved and 
equilibrated for 24 hours in pH 5.0 buffer were dialyzed into pH 5.0 buffer with TCEP 
overnight. Peptide acetate samples were mixed with PAGE loading buffer with TCEP, while 
other samples were mixed with non-reducing PAGE loading buffer in a 1:1 ratio. Figure 6.16 










Figure 6.16: SDS-PAGE of the peptide acetates in pH 5.0 buffer under different conditions: 
+TCEP, peptide acetate in buffer with 10 mM TCEP (reducing conditions); NR, peptide in 
buffer only (non-reducing conditions); + H2O2, peptide acetate in buffer containing 100 mM 
of hydrogen peroxide (oxidising condition); oxidising -> TCEP, peptide acetate sample 
equilibrated under oxidising conditions dialyzed into reducing buffer. Black arrows indicate 
the low molecular weight peptide monomer of ~ 1.4 kDa and dashed blue bracket indicate the 
faint ladder like bands for peptide acetate equilibrated under oxidising conditions. 
Note: The SDS-PAGE gel shown in Figure 6.16 A has been compiled from three different gel 
analysis to show the behavior of the peptide acetates in gel for the different conditions 
investigated. 
The reducing gel (Lane 2, 3, 4 in Figure 6.16) showed an intense band near the 15 kDa 
molecular marker and faint bands at low molecular weights which suggested that these band 
corresponded to peptide that is not cross-linked by disulfide bonds (possible SDS-resistant 
species). Further, the presence of higher intensity band below 3.5 kDa molecular weight for all 




the three peptides under reducing conditions suggested that the most of the peptide in solution 
existed in the monomer form (Mw of K31P1: 1.3 kDa; K81P1: 1.4 kDa; K31P2: 1.7 kDa). 
In the non-reducing gel (lanes 5, 6 and 7 in Figure 6.16) a number of faint bands observed 
between 20 kDa to 3 kDa for peptide K31P1; between 50 kDa to 3.5 kDa for peptide K81P1 
and peptide K31P2 suggested the presence of peptide oligomers. Additionally, peptide acetate 
samples equilibrated in buffer with 100 mM hydrogen peroxide, showed several faint bands 
with molecular weights above the 15 kDa band. Further, low molecular weight bands 
corresponding to smaller peptide oligomer appeared faint under non-reducing conditions, but 
gain considerable intensity under reducing conditions as evident in lane 2,3 and 4 (Figure 6.16). 
These results suggested that under non-reducing conditions (pH 5.0 buffer only) and oxidising 
condition (pH 5.0 buffer + 100 mM hydrogen peroxide) the peptide oligomer contains disulfide 
bonds. The current results show that TCEP was effective in breaking the disulfide linkage 
resulting in LMW bands compared to the non-reducing and oxidized sample for each of the 
peptide acetates.  
Under oxidising conditions all three peptide sequences exhibit covalently linked oligomers 
visualized as multiple bands in the gel (lane 8, lane 9 and lane 10). As the gel and sample 
loading dye contains the detergent SDS, most of the non-covalent interactions between the 
peptide molecules are disrupted51. All the three peptide sequences contain a cysteine residue 
present at both the N- and C- terminal end of the peptide sequence with the respective amino 
group and carboxyl group capped. The absence of reducing agent and/or presence of oxidising 
agent favors the formation of inter-peptide disulfide bonds between cysteine residues.   
Additionally, the LMW bands observed for the peptide samples under non-reducing conditions 
are faint (Lane 5,6 and 7) and develop considerably in intensity under reducing conditions (lane 
2,3 and 4). Bands corresponding to HMW oligomers observed for peptide K31P1, peptide 




K81P1 and K31P2 (lane 5, lane 6 and lane 7) under non-reducing conditions further suggested 
that these bands could correspond to disulfide linked peptide oligomers.  
The faint HMW bands observed for the peptide samples under reducing conditions (lane 2,3 
and 4) consistent with the peptide samples under non-reducing conditions can be explained by 
the formation of SDS-resistant species. SDS resistant complexes can result from formation of 
strong hydrophobic interactions or non-disulfide cross-links. Studies focused on such protein 
complexes identified in context of important biological functions, have highlighted the role of 
some critical amino acid residues and the molecular interactions involved52,53. Mass 
spectrometry analysis of peptide acetates equilibrated under reducing and oxidising conditions 
would therefore need to done to confirm the identity of the bands observed in SDS-PAGE gel 
under both reducing and oxidising conditions. 
Overall the SDS-PAGE results are consistent with the extended nanostructure assembly 
observed under oxidising condition by TEM. The HMW aggregates (Mr over 260 kDa) and 
LMW aggregates (Mr between 10 kDa and 40 kDa) observed as the ladder for all the three 
peptides potentially suggest a hierarchical extended filament like nanostructure with 
oligomeric units that are resistant to SDS. 
 
6.5   Discussion 
Peptide sequences with a heptad pattern show a natural propensity to exist in a helical 
conformation in solution and can self-assemble into a range of extended fibrous 
nanostructures54. In this work, peptide sequences (K31P1, K81P1 and K31P2) corresponding 
to the consensus sequence motif of ovine type I and type II hard α-keratins flanked with 
cysteine at both N- and C-terminus were investigated as molecular tectons.  




All the three peptide sequences showed propensity to exist in the parent conformation as a α-
helix in solution indicated by the double minima at 208 nm and 222 nm. Peptide acetates 
dissolved in water to assess the self-assembly of the peptide in solution showed visible 
precipitates for two out of the three peptides: K81P1 and K31P2. Electron microscopy analysis 
of these peptide acetate samples revealed that all the three peptides stored at room temperature 
self-assembled over time with mostly short rod shaped structures for the K31P1 peptide and 
K81P1 peptide, and bundles of extended filament like nanostructures for K31P2 peptide. These 
conditions are prone to allow inter- and intra-molecular disulfide crosslinking over time as 
reported by Sun and Green in 1978 for extracted epidermal keratins in filament assembly in 
the presence of air55.  
 
Protonation and deprotonation of charged residues as a function of pH is known to influence 
the conformation of peptides in solution and subsequent self-assembly. In the case of keratins 
pH of 7.6 is known to favor the self-assembly into filaments. Samples of peptide acetates 
dissolved in Tris-HCl buffer at pH 7.6 were found to be soluble in each of the three cases with 
no visible particulates. EM revealed that only peptide K31P2 self-assembled, with mostly short 
rod like fragments and thin filaments predominant under this condition. Peptide acetates 
dissolved in acidic buffer, however, were found to be less soluble with visible precipitates 
observed for peptides K81P1 and K31P2 below pH 6.0. Acidic conditions favored the self-
assembly of the peptides into extended tape like filaments of the K31P1 peptide at and below 
pH 5.0; bundles of extended filament like nanostructures for both peptide K81P1 and K31P2 
at pH 4.0 and pH 5.0 respectively. Assembly of IF proteins including keratins is reported to 
occur at near neutral or alkaline pH and ionic strength between 10 mM to 50 mM16.  
 




The self-assembly of the peptide sequences with their design inspired from the IF consensus 
sequence motif into extended filaments favored under acidic condition has previously not been 
observed. The C-terminus coil 2B region of the central coiled coil rod domain of IF proteins 
including keratins shows more negative surface potential, arising from the localization of 
glutamic acid and aspartic residues in this region. Therefore, neutral or slightly alkaline pH 
would favor the non-covalent interactions between the two protein helical domains. However, 
acidic pH seems to be an important driving force in the self-assembly of these peptide 
sequences as no significant difference is observed for filament like nanostructures for peptides 
in water and in 25 mM ionic strength buffer.  
 
Further, the self-assembly of the isolated peptide sequences under more acidic conditions 
suggested that the complementary non-covalent interactions of the parent interface were 
retained during peptide self-assembly. Also, the protonation of the charged residues: aspartic 
acid (E), glutamic acid (D), asparagine (R) and lysine (K) as a function of pH did not 
substantially affect the peptide self-assembly process.  
 
Studies on native epidermal keratin and recombinant keratin with an incorporated cysteine 
residue showed that in absence of reducing agent, and upon exposure to air, disulfide bonded 
HMW keratin aggregates form32. Also, when such a keratin sample was left for five days under 
the same conditions, very high HMW aggregates formed that could not enter the gel55. When 
such aggregates are exposed a reducing environment in the presence of DTT or β-
mercaptoethanol, LMW protein aggregates and monomers are present confirming disulfide 
linked keratin oligomers55.  
 




Study of the designed peptide sequences under oxidising and reducing conditions was 
suggestive of disulfide linking between the peptides. Samples of the peptide in presence of 
TCEP did not favor the specific self-assembly of the peptide under acidic conditions. However, 
in the absence of the reducing agent and on exposure to air, all the three peptides self-assembled 
in solution with extended filament like nanostructures observed for two out of the three 
peptides (K81P1 and K31P2).  
 
SDS-PAGE gel electrophoresis of the peptide acetate samples stored in buffer with excess of 
hydrogen peroxide revealed a smear of multiple bands that collapse upon reducing with TCEP, 
further supported the presence of disulfide linking in the peptide assembly. Hydrogen peroxide 
added to the peptide solution at ~10 fold molar excess to the peptide resulted in the self-
assembly of the peptide in solution into extended filaments. The ladder like bands observed, 
specifically for peptides K81P1 and K31P2 under oxidising conditions bear similarity to the 
multiple bands observed for cross-linked fibrinogen and bis(Gly-Pro-Arg-Pro)peg complexes56 
and heated whey protein isolates57. Collapse of these ladder like bands upon subjecting to 
reducing conditions indicated disulphide linking. Similar behavior was observed for the peptide 
sequences under non-reducing and reducing SDS-PAGE, which supports the inference that 
within the extended nanostructures the peptide is disulfide cross-linked.  
 
The results showed that the terminal cysteine residues take part in chemical cross-linking of 
the peptide into oligomers and in the elongation of the peptide oligomers into short rod like 
filaments and extended filaments. Further, the smear of closely placed ladder like multiple 
bands observed on SDS-PAGE gel under non-reducing conditions and oxidsing conditions for 
the peptides suggested a linear daisy chain like. This type of crosslinking could potentially arise 
from the end to end association of peptide oligomers. 




These findings presents a potential alternate mode of molecular self- assembly of keratin 
derived peptide motifs in vitro, mediated by cysteine residues. This is different to the earlier 
reported work by Steinert et al., 1976 and a recent discovery of a transdimer disulfide bond in 
vitro occurring during keratin assembly which limits filament elongation and impairs filament 
maturity 32,50. Mature filaments assembled from heteromeric assembly of K8-K18 and K5-K14 
are reported to be a smooth extended rod shape 41,58. The extended filament like assemblies 
observed for the peptides investigated in this work appear to be smooth, similar to the reported 
IFs formed by the in vitro assembly of full length epidermal keratins. The results of this work 
show that peptide sequences of the IF consensus motif inspired from cuticular keratins can 
interact in a complementary fashion to each other as homo-oligomers and further self-assemble 
into extended filament like nanostructures. Such filament nanostructures are comparable to the 
mature wild type filaments formed by type I and type II keratins assembling as heterodimers. 
 
These findings indicate that the highly conserved consensus sequence motif of keratins shows 
a propensity to assemble as a homomer, not reported previously for keratin protein assembly. 
The results allow for some speculation for keratin homodimer assembly to be present in vitro 
and even in vivo. As the type I and type II keratins are differentially expressed in a 
differentiating cuticle. The cysteine residues found naturally flanking the consensus motif at 
the C-terminus end of the coil 2 B motif of the central helical rod domain found specifically in 
type I can potentially be involved in disulfide linking.  
 
To build further on our findings in the future, a detailed study of the peptide sequences by mass 
spectrometry, molecular dynamic simulation and crystallization, if possible, would allow for a 
more realistic view of the homomer assembly of the peptide sequences and the predicted 
intramolecular disulfide bonds. 
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7   Chapter Seven 
 
Summary, conclusions and suggestions for future work 
 
7.1   Introduction 
Self-assembling peptides have marked their niche amongst other biological molecules and 
biomolecular assemblies as molecular tectons with applications ranging from biotemplating, 
biomineralization for use in regenerative medicine, tissue engineering, 3D cell culture and 
biosensing devices 1. The aims of this research work were to explore the protein-protein 
interfaces as a novel design source for self-assembling peptide tectons and to characterize the 
different self-assembled nanostructures formed by the peptide sequences. A large number of 
peptide sequences inspired from natural assemblies and biological sequences self-assemble 
into an array of different nanostructures2. Many such self-assembling peptide sequences have 
successfully found use as biomaterials, for example self-assembled peptide nanofibers and 
hydrogels in 3D cell culture as well as tissue engineering3, responsive peptide gels and peptide 
based drug amphiphile for biomedical applications4,5 and peptide nanowires bionanodevices6,7. 
Further, modifications in sequence and design strategy have allowed for the production of 
designer nanostructures such as honeycomb suitable for production of rationally designed bio-
inspired surfaces and nanorings linked with functional biomolecules 8,9. This approach provides 
a chance to exploit the natural self-assembly for the production of peptides that assemble in a 
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To design peptide sequences from a bottom-up approach for use as molecular bio-based 
materials, it is important to explore new biological sources for the design of stable tectons and 
to understand their self-assembly process. Many self-assembling peptide sequences designed 
to date are largely limited to a set of biologically inspired sequences and designs11,12,13,14,15. 
Therefore, search for new design sources is warranted as they would add to the current library 
of self-assembling peptide sequences and provide for specific applications in 
bionanotechnology such as building blocks for design of conductive nanotubes/nanowires for 
nanocircuitry16,17.  
 
Molecular building blocks should have properties that make them suitable for downstream 
applications including responsive hydrogels for biomedical sciences, biotemplating, sensing, 
and conductive nanowires, and also to have better control over the self-assembly process. An 
important property the building blocks should possess foremost is the ability to self-assemble 
independently into well-ordered and defined forms. This is the basic feature to develop general 
principles of self-assembly into hierarchical structures from simple peptide sequences18.  
 
The second important feature is that the building blocks should have a specific chemistry that 
can be explored for control over the self-assembly process. The chemistry of the peptide 
sequence defines the behaviour of the peptide in response to a physiological trigger such as 
concentration, hydrophobicity, pH, and ionic strength. Specific sequence modifications to 
existing self-assembling peptide sequences have allowed for growth and fabrication of peptide 
assemblies on surface19 and self-assembling peptide linked to metal nanoparticles20,21.  
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Peptides offer a huge advantage of customization through attachment points for decoration and 
chemical modifications, thus providing unique functionality to the peptide nanostructures. 
Certain peptide sequences that are made up of two or more blocks such as the multi-domain 
peptides containing charged residues, chemically linked to an active peptide sequence self-
assembled into extended fibrillar assemblies with the biologically functional sequence 
expressed on the surface22.  
 
Peptide sequences containing an extended histidine sequence due to their affinity for metal ions 
such as Ni2+ could be functionalized with gold nanoparticles23. Peptide functionalized with 
gold nanoparticles can provide a range of surface functionalities and the peptide element 
provides a rich resource to control structures and properties of gold particles. This is 
particularly attractive towards creating probes for sensing molecules including ions, minerals 
and biomolecules as well as excellent models as drug delivery vehicles. 
  
Thirdly, it is very important that the self-assembled peptide structure is stable, especially from 
the perspective of a viable downstream application such as scaffolds for templating synthetic 
and biological polymers, nanofabrication and nanolithography. The availability of peptide 
tectons those are tolerant to a range of pH, ionic strength and exhibit reversible self-assembly 
are desirable for their fabrication and incorporation into bio-nanodevices. Additionally, peptide 
sequences tolerant to small sequence modifications provide an added advantage to explore as 
bio-organic building blocks that are responsive to change in pH, redox state, and ionic strength. 
These properties are particularly interesting for the use of peptide based material as biomaterial 
in regenerative medicine3 and to build nanodevices7 .  
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Interface sequences within different protein oligomers that exist in complementary non-
covalent close contacts were identified to meet these requirements. Protein interfaces are 
evolutionarily optimized to drive self-assembly of protein units in a controlled and regulated 
manner24,25. This property makes them attractive as sources of peptide sequences that can self-
assemble while retaining some properties of the parent interface.  
 
Although many self-assembling peptide sequences designed from biological motifs are 
reported, protein-protein interfaces, more specifically protein-β interfaces, and coiled-coil 
interface as the source for self-assembling peptide tectons is investigated here for the first time. 
This thesis aimed to investigate the self-assembly of short peptide sequences designed from 
interfaces of oligomer proteins, as a molecular biomaterial. A bottom-up approach was 
undertaken to design peptide sequences from protein-protein interfaces, naturally fine-tuned 
for self-assembly.  
 
The self-assembly of the peptide sequences in solution was characterized using CD 
spectroscopy and ThT binding assays. The structure and morphology of the peptide assemblies 
were determined using biophysical techniques like SAXS, FTIR, and TEM. The β-sheet type 
self-assembling peptide sequences were further used to template the higher order nanotubular 
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7.2   Self-assembled β-sheet type peptide nanostructures 
The first part of the design strategy focussed on the simple β-continuous protein-protein 
interfaces reported in nearly 15% of protein homo-oligomers26. A PDB-wide search for protein 
homo-oligomers focused on simple β-continuous interfaces led to the selection of four different 
oligomer protein sources. Such interfaces within protein homo-oligomers have not been 
previously described as a source for peptide building blocks that could self-assemble in 
isolation.  
 
The peptide sequences exhibited intrinsic ability to form β-sheets in a solution that formed 
birefringent hydrogels. EM showed that the peptide sequences self-assembled in solution to 
form extended nanostructures. SAXS showed that the molecular organization of β-sheets 
within the extended peptide nanostructures was consistent with those previously described for 
peptide hormones27 and peptide sequences that self-assemble into amyloid-like fibrils28. The 
liquid crystallinity of the peptide hydrogels that is described for reversibly self-assembling 
peptide sequences29, however, makes them different to the insoluble amyloid aggregates. This 
property makes them highly attractive as responsive self-assembling building blocks. ThT 
binding assays also led to predict self-assembly models for the peptide sequences that was 
largely a single state model, with the only exception of DAPDC peptide.  
 
Conclusions derived from this work:  
(I) Peptide sequences derived from protein-β interfaces of unrelated protein oligomers 
self-assemble in solution into extended nanostructures in a reversible manner. 
(II) The DAPDC peptide derived from the homo-tetramer interface of M. tuberculosis 
DAPDC protein showed a higher critical assembly concentration compared to the 
other peptides.  
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The results show the inherent ability of diverse peptide sequences designed from unrelated 
protein oligomers to self-assemble in solution, with properties arising from the parent interface 
motifs30. This work adds to the current repertoire of peptide tectons and also show the potential 
of the peptide sequences as stable building blocks for nanofabrication and functionalization. 
 
7.3   Prx3 peptide self-assembly is tolerant to specific sequence variations  
A mutational approach was used as a tool to understand the self-assembly of the Prx3 peptide 
through judiciously varying the histidine residue in the peptide sequence. The introduction of 
a subtle change in the chemistry of the peptide sequence is a quick and easy way to identify 
key interactions necessary for self-assembly31,32. The variant peptide sequences exhibited self-
assembling properties noted for the parent Prx3 peptide, consistent with β-sheet propensity. 
ThT binding studies showed that the self-assembly of peptide sequence into extended β-sheets 
is tolerant to the specific change of the histidine residue. ThT assays also highlighted that the 
specific sequence change of histidine to tyrosine and the larger tryptophan residue contributed 
to the higher critical assembly concentration of the parent Prx3 peptide.  
 
EM and SAXS were useful in stating that the variant peptide sequences self-assembled in 
solution into extended nanostructures that exhibited the generic architecture of β-sheets 
organized in a repetitive manner over a long distance, consistent with amyloid-like fibrils33. 
EM also revealed that the H3Y peptide variant self-assembled into polymorphic nanostructures 
ranging from nanotapes to wide peptide nanosheets favoured at high concentration of the 
peptide in water. Polymorphism is a generic feature of amyloid-like fibrils34. Such assembly, 
however, is also reported to occur through lateral association of individual extended amyloid-
like fibrils into wider tapes as a consequence of the compaction of the nanostructures adsorbed, 
and air dried onto the EM grids35.  
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This property of the peptide sequence is attractive to be exploited for production and 
subsequent fabrication of peptide nanosheets to create bio-inspired surfaces for 
nanofabrication.  Characterization of hPrx3 muteins containing the mutations to the peptide 
sequence at the homodimer protein-β interface suggested a correlation in the behaviour of the 
variant peptide motif within the 3-dimensional protein fold and the isolated peptide sequence.  
 
Conclusions derived from this work:  
(I) Hydrophobic variations introduced in the Prx3 peptide through replacement of 
histidine residue does not substantially affect the self-assembly of the peptide 
sequence.  
(II) The specific sequence change of the Prx3 peptide by replacement of histidine with 
aromatic tyrosine (H3Y) and the larger tryptophan group (H3W) shows a higher 
critical assembly concentration compared to the other variations.  
(III)  The specific mutation of the histidine residue to tryptophan within the parent 
protein (H136W) weakened the protein β-interface. 
 
7.4   Self-assembling peptides template higher order assembly of hPrx3  
In an attempt to produce supramolecular protein assemblies, the strategy mixing of self-
assembled Prx3 peptide nanotapes with hPrx3 protein toroids was trailed. This strategy 
interestingly led to the formation of micron-long nanotubes of hPrx3 protein toroids templated 
through extended peptide nanotapes. Such extended assembly of the protein is described here 
for the first time. The strategy used to produce the extended protein nanostructures is described 
in figure 7.1. 




Figure 7.1: Schematic diagram of the strategy for production of different extended 
nanostructures of hPrx3 protein (PDB: 5JCG) using peptide nanostructures. Three different 
outcomes were achieved in this thesis work by mixing peptide nanostructures with hPrx3 
protein toroids: (i) Extended nanotubes, (ii) Peptide tapes decorated with protein toroids and 
(iii) Extended nanosheets.  
 
The specific assembly of the hPrx3 toroids is induced by all the self-assembling β-sheet type 
peptide sequences described in this thesis work. Furthermore, mixing of wide extended 
nanotapes of the H3Y variant peptide with hPrx3 led to the formation of decorated peptide 
tapes and protein nanosheets.  
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Conclusions derived from this work:  
(I) Self-assembling peptide sequences template higher order assembly of hPrx3 protein 
toroids into extended micron long nanotubes, peptide tapes decorated with toroids 
and protein nanosheets. 
(II) The self-assembly of the extended peptide nanostructures with the hPrx3 protein 
toroids is of electrostatic nature. 
(III) Varying ratio of peptide mixed with hPrx3 protein toroids allow some control on 
the overall size of nanotubular structures. 
 
The results highlighted the ability of self-assembling peptide nanostructures with diverse 
chemistry to template complex protein molecules in solution into an ordered array of 
nanostructures. The extended protein nanotubes show potential to be used for the creation of 
functionalized nanostructures that can be fabricated into bio-nanodevices. 
 
7.5   Self-assembled helical coiled coil peptide nanostructures  
In another approach to design responsive self-assembling peptide tectons, the coiled-coil 
interface of ovine IF protein keratin was investigated. IF protein is rich in coiled-coil motifs 
and self-assemble into extended filaments36 and fibres37 that show good mechanical strength 
and are biodegradable. The hallmark of many such coiled coil assemblies is the organization 
of the amino acid residues as seven residue heptad sequence, with a specific distribution of 
hydrophobic and hydrophilic residues. This amphipathic design is the basis of the diverse set 
of nanostructures formed by heptad based sequences38. In the specific case of IF hard α-
keratins, the central coiled coil region is richly distributed with cysteine residues that make 
them redox sensitive.  
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Peptide sequences designed from the consensus sequence motif of type I and type II keratins 
self-assembled in solution into extended filament-like nanostructures. The dimensions and 
appearance of the formed nanostructures closely resembled the IFs formed by full-length 
keratins that self-assemble as obligate heteromers. The extended filament assembly of the 
specific peptide sequences has been described here for the first time. SDS-PAGE suggested 
that the peptide strands within the extended nanostructures be potentially involved in 
disulphide linking.  
 
Conclusions derived from this work: 
(I) Peptide sequences derived from the consensus sequence motif of ovine IF keratins 
self-assembled in solution with extended filament-like nanostructures observed for 
K81P1 and K31P2 peptides. 
(II) The extent of self-assembly of the peptide sequences into extended filaments is 
favoured under oxidising conditions and acidic pH. 
(III) The self-assembly of the peptide sequences exhibits some sensitivity to the change 
in the redox state of the peptide. 
 
The results highlight coiled-coil interface of ovine keratins as a source of peptide tectons.  
 
7.6   Suggestions for future work 
In this thesis work, self-assembly of peptide sequences derived from protein-β interfaces and 
coiled-coil protein interface was described. Despite promising results, it was difficult to 
crystallize these sequences and model the atomic level structural arrangements of the peptide 
strands within the extended nanostructures. EM showed that the peptides self-assembled into 
extended nanostructures with polymorphism observed in the case of Prx3 peptide and a variant 
of the peptide H3Y. Polymorphism is an important feature of amyloid fibrils formed by diverse 
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peptide sequences and proteins. In contrast, it has also been noted that the wide tape like 
assemblies observed by EM is a consequence of air drying of the sample on EM grid that leads 
to the lateral association of the peptide fibrils into tapes or ribbons that coil35. Future work 
should, therefore, be focused on the in-solution analysis of the extended peptide nanostructures 
through cryo-EM. It will allow a good comparison between the morphology of the peptide 
nanostructures in solution and that observed by TEM.  
 
3-D reconstruction of the cryo-EM micrographs developed using single particle analysis can 
provide insight into the arrangement of the β-sheets within the extended peptide nanostructures. 
MAS NMR coupled with cryo-EM have been successful in generating atomic resolution 
structures of amyloid-like fibrils and provide a detailed structural arrangement of β-sheets 
within the extended amyloid fibrils39. This technique can further allow gazing on the different 
arrangements of the β-sheet in the polymorphic nanotapes of H3Y peptide variant. Molecular 
dynamic simulation studies of the Prx3 parent peptide and the hydrophobic peptide variants 
can provide detailed insight into the arrangement of the β-strands and sheets in the peptide 
tapes and the molecular interactions involved in the self-assembly.  
 
Crystallization trials performed with an aim to understand the molecular model of the self-
assembled peptide β-sheet did not show any positive outcome, for the conditions trailed. It is 
difficult to crystallize peptide sequences that rapidly self-assemble into extended amyloid-like 
fibrils. Only a few peptide sequences have been crystallized thus far40. One important factor 
that hinders in the crystallization of the peptide sequences is the change in solute concentration. 
Solute effects are known to alter the dynamic equilibrium between the β-sheets and aggregates, 
and increase in solute concentration accelerate the aggregation of the peptide41. ThT binding 
assays suggested a higher critical assembly concentration for the DAPDC peptide, and aromatic 
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variants of Prx3 peptide: H3W and H3Y respectively. These peptide sequences would prove to 
be beneficial for the purpose of crystallization. Therefore future work can be directed towards 
screening for conditions that favor crystallization of these peptides sequences.  
 
Self-assembled peptide nanostructures were used to template extended nanotubes and 
nanosheets of hPrx3 protein toroids. Despite DLS suggesting the presence of large extended 
structures in solution however, it was difficult to detect the extended peptide-protein 
nanotubular assembly by AUC. Also, it was difficult to characterize the extended nanotubular 
structures observed by TEM for peptide-protein mix containing a large molar excess of peptide 
mixed with protein by DLS or AUC due to the increase in macroscopic viscosity of the 
sample42. Future work in this direction should focus on the in solution cryo-EM analysis of the 
viscous peptide-protein mixes to characterize the extended nanotubular structures observed by 
TEM. This will help to address, whether the extended protein-peptide assembly exists in 
solution, or the templating of the hPrx3 toroids onto peptide nanostructures is a consequence 
of air-drying of the sample onto EM grid due to macromolecular crowding43.  
 
TEM showed that the peptide-protein assembly is specific to hPrx3, and the interaction 
between the peptide nanostructures and hPrx3 protein toroids is of electrostatic nature. 
However, it was difficult to describe the role of specific residues or regions within the hPrx3 
protein toroid that are involved in the specific association of the protein toroids to the extended 
peptide nanostructures. 3-D reconstructions of the cryo-EM micrographs would give insight 
into the different associated states of the peptide nanostructures with hPrx3 protein toroids as 
observed with the H3Y variant peptide. Modeling of the different associated states with the 
crystal structure of extended stacks of hPrx3 toroids44 would help to predict the specific regions 
of the hPrx3 protein toroid involved in the interaction with the extended peptide nanostructures.  
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Mutations specific to these identified regions would further allow targeting of the specific 
molecular interactions that drive the assembly of the hPrx3 protein toroids to the peptide 
nanostructures.  
 
Peptide sequences derived from the coiled-coil interface of ovine keratin protein self-assembled 
into extended filament-like nanostructures. The peptide sequences were designed incorporated 
with cysteine residues with an aim to develop responsive peptide tectons. SDS-PAGE 
suggested a potential role of disulfide linking in peptide self-assembly, although it was difficult 
to differentiate disulfide-linked peptide aggregates from SDS-resistant species. Mass 
spectrometry (MS) provides a potent tool to differentiate between the different disulfide cross-
linked forms of the peptide and the resistant species45. Future work should, therefore, involve 
MS analysis of the peptide sequences under oxidizing/non-reducing and reducing conditions 
to characterize the different peptide aggregates detected by SDS-PAGE.  
 
The self-assembling peptide sequences described here have a diverse surface chemistry that 
can be exploited for the development of functional biomaterial. One such approach was trailed 
through judicious modification of the Prx3 peptide sequence, which led to the development of 
a prototype model of functional organic semiconductor (Appendix II).  
 
7.7   Final conclusion 
To conclude, this thesis illustrates new sources for the design of peptide tectons that self-
assemble into well-ordered nanostructures in solution. Moreover, practical approaches for 
characterization of peptide self-assembly in vitro and high-resolution techniques that provided 
structural organization of the peptide within the self-assembled nanostructures are presented.  
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A1.1   Supplementary figures for chapter 5 
 
Figure A1: Deconvoluted mass spectrum of tagged 6*His hPrx3 and cleaved hPrx3 (tag 
removed): The difference in the mass of the cleaved protein confirms cleavage and absence of 
any band corresponding to the ~ 3kDa peptide His-tag confirmed a pure sample of untagged 





Figure A2: TEM of peptide-protein mix in reducing pH 8.0 buffer with 150 mM NaCl dialyzed 
into high salt pH 8.0 buffer overnight, showing mostly free peptide fibrils, short nanotubes, 
and free protein toroids. The arrows point to the protein toroids associated with peptide-fibrils 
in a non-specific manner. (I) Peptide control sample at 5 mg/mL shows extended 
nanostructures and (II) Control protein sample concentration at 0.1 mg/mL shows mostly 






Figure A3: Representative TEM micrographs of control Prx3 peptide acetate in reducing pH 
8.0 buffer at different concentrations. The peptide acetate concentration is: (A)5mg/mL, (B)2.5 
mg/mL, (C)1 mg/mL, (D)0.5 mg/mL, (E)0.17 mg/mL, (F)17 µg/mL, (G)0.34 µg/mL (equimolar 
concentration to protein) and (H) 6.8 ng/mL (below equimolar concentration to protein). 






A2.1    Collaboration work done with Hodgkiss group 
 
Functional organic semiconductor functionalised through self-assembling peptides: 
This work was done in collaboration with the Hodgkiss group at Victoria University, 
Wellington (N.Z.). With an aim to develop self-assembling peptide-polymer conjugates, 
variants of the Prx3 peptide were designed with composition as detailed in table 2.1. 
 
Table 2.1: Variant peptide sequences 
Peptide Composition Comments 
Prx3 Ac-IKHLSVN-NH2 Bovine peroxiredoxin 3 
V1 Ac-IRHLSVN 





Note: The variant peptide sequences were supplied as lyophilized powder with purity of 95%  
as judged by NMR. 
 
Characterization of the variant peptides in solution: 
Far UV circular dichroism spectra of the variant peptide sequences in water at 0.01 mg/mL 
(Section 2.6.4) showed that the synthetic variant peptides suggested that the peptide sequences 
show a spectral shape that is characteristic that for β-sheets in the native Prx3 peptide sequence 
(Figure A2.1). The formation of β-sheets by the variant peptide sequences was further 
confirmed by ThT-binding assays (Section 2.6.6), for peptide samples in the 1-10 mg/mL 






Figure A2.1: Far UV circular dichroism spectra of Prx3 peptide and variant peptide acetates 
in water at 0.01 mg/mL. The peptide acetate in water samples was equilibrated for 24 hours at 
4°C and degassed before analysis. 
 
Figure A2.2: ThT binding assay by dilution for Prx3 peptide and variant peptide acetates in 




Characterization of the variant peptides by TEM: 
The variant peptide acetates in water at 1-5 mg/mL analysed by TEM (Section 2.6.8) showed 
that the variant peptide sequences self-assembled in water into nanostructures with extended 
morphology. Variant peptide sequence Ac-IRHLSVN however, was the only exception with 
the absence of any extended self-assembly (Figure A2.3).  
 
 
Figure A2.3: Representative TEM micrographs of peptide acetates in water equilibrated for 
24 hours at 4°C: (A) Ac-EEEIRHLSVN-ethyl-NH2, (B) –GIRHLSVNEEE-, (C) –GIRHLSVN-, 





The sequences described here were further used to design perylene diimide-peptide conjugates 
that were used to fabricate functional semiconductor prototype. The details of this work have 
been published in Eakins et al. (2015). 
